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Synopsis 
Bacterial gene expression is primarily regulated at the initial step of transcription initiation. 
This regulation has traditionally been viewed as due to the DNA sequence of promoters and 
factors that bind to them. However, the bacterial chromosome is a highly compacted and 
ordered structure. To date, the effects of position within the chromosome on promoter activity 
have barely been investigated.  
Here, I report that activity of a single promoter, inserted at different loci in the 
Escherichia coli chromosome, is dependent upon position within the chromosome. 
Quantification of genomic DNA at a number of loci showed this was unrelated to gene 
dosage. Drastic changes in position-dependent hierarchies of promoter activity were observed 
on entry into stationary phase. However, no correlation between the orientation of a promoter, 
with respect to replication, and its activity was found. 
Several factors are involved in this variation, including local sequence context. Increased 
promoter activity at origin-proximal loci was shown to be due to DNA supercoiling, 
maintained by the action of DNA gyrase. Transcription was shown to have a negative 
influence on the activity of downstream promoters. Further to this, the position of a promoter, 
with respect to a repressor-encoding gene, had an effect on its repression, further suggesting a 
role for genome organisation in the regualtion of transcription. Finally, extended protein 
occupancy domains were shown to repress activity of inserted promoters, indicating that these 
domains act to silence the genes they encode. The combined data show that the position of a 
promoter within the E. coli chromosome plays a significant part in transcriptional regulation, 
and that structure of the chromosome is also likely to play a role. 
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Chapter 1: 
Introduction 
 2 
1.1 The model bacterium Escherichia coli 
Bacteria are unicellular, prokaryotic microorganisms, which are able to inhabit and shape any 
niche on the planet, including human and animal hosts. The adaptability required for bacteria 
to survive, and thrive, in variable environments is achieved through the ability to regulate 
expression of a variety of genes in response to changing environmental signals. The key 
distinguishing feature between prokaryotic and eukaryotic organisms is the way that 
chromosomal DNA is packaged within the cell. Unlike eukaryotic chromosomes, bacterial 
DNA is not separated from the rest of the cell by a membrane, but is instead concentrated into 
a region of the cell called the nucleoid. While the textbooks argue that this constitutes a less 
complex arrangement than in eukaryotic cells, one might argue that the lack of a membrane 
requires complicated organisation of the bacterial chromosome, to allow access by the gene 
expression machinery at the appropriate time (Campbell and Reece, 2004; Madigan and 
Martinko, 2006). 
Bacteria usually come under public interest due to their role in health and disease, especially 
as the human gastrointestinal tract plays host to a wide range of bacteria, some of which can 
be pathogenic (Madigan and Martinko, 2006). Escherichia coli are members of the enteric 
bacteria, enterobacteriaceae, which are gram-negative, facultatively anaerobic rods containing 
a circular chromosome. E. coli inhabits the gastrointestinal tract of humans and other animals 
and is widely accepted as a model bacterium for the study of bacterial biochemistry, 
physiology and genetics (Madigan and Martinko, 2006; Murray et al, 2009). Most E. coli 
cells measure approximately 2 μm in length and 0.5 μm in diameter, which can make E. coli a 
difficult organism to study (Zaritsky and Woldringh, 1978). However, new microscopy 
techniques have now been developed to allow visualisation of the inner workings of the cell 
(Hohlbein et al., 2010).  
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There are many pathogenic and non-pathogenic E. coli strain types, which are closely related 
to the well known pathogenic Salmonella and Shigella species (Falkow, 1996; Fukushima et 
al., 2002). However, the lab-cultivated, non-pathogenic, E. coli K-12 MG1655 strain is often 
used as a model organism, due to the strain having lost the surface “O” antigens 
(lipopolysaccharide) and being considered harmless. The MG1655 strain is a derivative of the 
original E. coli K-12 strain, maintained with minimal genetic manipulation, however the 
strain was cured of the F plasmid and phage lambda by acridine orange and UV radiation 
treatment (Bachmann, 1996). Further to this, the genome of E. coli K-12 MG1655 was 
sequenced in 1997 and detailed sequence annotation is now available via the EcoCyc website. 
Therefore E. coli K-12 MG1655 is an ideal strain for the study of bacterial genetics and 
general molecular microbiology (Blattner et al., 1997; Keseler et al., 2011). Studies of E. coli 
cellular processes create data that is applicable to any bacteria that uses those processes. 
Therefore, study of the E. coli model bacterium can, and has, yielded transferrable 
information to be applied to other important or pathogenic strains of bacteria (Madigan and 
Martinko, 2006). 
 
1.2 The Escherichia coli chromosome 
1.2.1 The nucleoid 
Although bacteria have been studied intensively for many years as models for systems in 
higher organisms, we have, until recent years, remained unaware of the complexities of their 
internal cellular structures. This problem was mainly due to a lack of technology sufficient to 
probe these minute structures, however new techniques and better technology have allowed 
some of these structures to be explored in greater detail (reviewed in Hohlbein et al., 2010). 
The chromosomes of bacteria are unlike those of eukaryotes, in that they are not separated 
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from the cytoplasm by a nuclear membrane, however they still form a tightly compacted 
nucleus-like body, referred to as the nucleoid (Robinow, 1956; Kleppe et al., 1979). The 
nucleoid is defined as a pseudo-compartment occupying a distinct region of the cell, 
characterised by the presence of highly condensed chromatin and an absence of ribosomes 
(reviewed in Kleppe et al., 1979 and Robinow and Kellenberger, 1994; Figure 1.1). The 
nucleoid was first isolated in its folded and supercoiled state by Stonington and Pettijohn 
(1971). Their method was utilised by Kavenoff and Bowen (1976) to visualise the nucleoid by 
electron microscopy, which revealed that the chromosomal DNA formed rosette structures of 
approximately 140 supercoiled DNA loops, radiating from a central core containing RNA and 
protein (Figure 1.1d). Previous work, analysing nucleoid superhelicity through the assessment 
of nucleoid sedimentation rates, demonstrated that the folded chromosome could not be 
entirely relaxed by a single DNase-induced nick and that many were required for full 
relaxation (Worcel and Burgi, 1972). This result showed that the nucleoid is organised into 
many independently supercoiled, topologically distinct domains, separated by barriers to 
supercoil diffusion. These results were the first suggestions that the bacterial nucleoid is 
structured and organised into separate domains.  
The E. coli chromosome must indeed be highly structured and organised to fit into the 
nucleoid, which occupies only a fraction of the space within the cell. For example, the size of 
a single E. coli genome is 4,639,221 bp, resulting in an extended length of approximately 1.58 
mm, based on there being a residue on each chain every 3.4 Å (Watson and Crick, 1953; 
Blattner et al., 1997). This exceptionally large molecule must be compacted into a cell that 
measures approximately 2 μm in length and 0.5 μm in diameter (Zaritsky and Woldringh, 
1978). Several mechanisms are used to sufficiently compact the chromosome into the E. coli 
nucleoid region, which represents a condensation from free coiled DNA of approximately 
1000-fold (Holmes and Cozzarelli, 2000). The mechanisms of compaction occur on different 
scales, much like that of eukaryotes, and include DNA supercoiling, binding of nucleoid  
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a.
b.
c.
d.
 
Figure 1.1: Electron micrograph images of the E. coli nucleoid 
Electron micrograph images of the E. coli nucleoid. a. Thin section micrograph of growing 
E. coli preserved by freeze-substitution (CFS). b. The same section as a. however the 
ribosome-free spaces have been enhanced by hand coloring. c. A similar E. coli cell, 
immunostained specifically for DNA. The images in panels a. to c. demonstrate that the 
ribosomes of the cell are specifically segregated from the DNA-containing nucleoid (from 
Robinow and Kellenberger, 1994). d. Typical electron micrograph of an isolated and spread 
E. coli exponential-phase membrane-free chromosome. The chromosome had 141 ± 3 loops 
demonstrating supercoiling and radiating from a single, central, electron-dense core. (from 
Kavenoff and Bowen, 1976).  
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associated proteins (NAPs) and macromolecular crowding. Further to this small scale 
structuring, the E. coli chromosome is organised into micron-scale domains, referred to as 
macrodomains. While a severe compaction of the chromosome must be achieved, the 
nucleoid must also remain functional and accessible to allow the processes of replication, 
transcription, translation and recombination to be maintained. Hence the folded chromosome 
is dynamic and responsive to the ever-changing processes required for bacterial survival 
(reviewed in Thanbichler et al., 2005 and Dame et al., 2011). 
 
1.2.2 DNA supercoiling 
Sedimentation analysis by Worcel and Burgi (1972) first demonstrated that the E. coli 
chromosomal DNA is negatively supercoiled. Electron microscopy images of the E. coli 
nucleoid, produced by Kavenoff and Bowen (1976), also suggested that the chromosomal 
loops were inter-wound and supercoiled (Figure 1.1d). DNA supercoiling is an effective 
mechanism by which the volume of the DNA molecule is reduced. The relatively 
hydrophobic base pairs of DNA molecules avoid interactions with water by close stacking on 
top of each other. Due to the backbone phosphate bonds being relatively rigid, the molecule 
forms a right-handed double helix through twisting of the base pairs to allow optimal base 
stacking interactions. Therefore, these optimal interactions define the number of helical turns 
present in a DNA molecule of defined length, such as a bacterial chromosome, which is a 
closed circle of DNA (Watson and Crick, 1953; Benham and Mielke, 2005; Travers and 
Muskhelishvili, 2005). If the optimal number of turns were allowed then the molecule would 
be relaxed. However if the ends were rotated with respect to each other, before the molecule 
was covalently joined, then this would mean that the molecule was either overwound 
(positively supercoiled) or underwound (negatively supercoiled) and torsional strain would be 
applied to the molecule (Figure 1.2). The strain on the molecule would cause slight variations  
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Figure 1.2: Schematic representation of DNA supercoiling 
a. Representation of a double-stranded DNA molecule, with the thin black and grey lines each 
representing the single strands of DNA. Upon rotation by 360˚ the single strands of the 
molecule cross each other and become twisted. The twist is relieved by writhing of the 
molecule to allow the duplex to cross itself and become more compact. b. Representation of a 
circular, double-stranded DNA molecule, with each of the black lines representing a strand. 
Unwinding of the duplex to form a bubble increases the torsional strain in the remainder of 
the molecule, therefore leading to writhe of the molecule to inter-wind around itself. 
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in the number of helical turns, but the larger effect is to cause the DNA to writhe, which is 
when the double helix coils around itself to form a “coiled coil” (Benham and Mielke, 2005; 
Travers and Muskhelishvili, 2005; Figure 1.2). 
Supercoils are introduced, and removed, by topoisomerases, which increase or decrease the 
number of times that the two strands of a DNA double helix are wrapped around each other. 
Sedimentation analysis of chromosomes, and chloroquine agarose gel electrophoresis of 
plasmid DNA by Pruss et al. (1982), demonstrated that the superhelicity of the E. coli 
chromosome is maintained by the opposing action of the DNA-relaxing topoisomerase, 
Topo I, and DNA gyrase. Topo I is known to relax DNA molecules, whereas DNA gyrase has 
been shown to introduce negative supercoils into DNA (Wang, 1971; Gellert et al., 1976; 
reviewed in Nöllmann et al., 2007). Transcription of the gene encoding Topo I, topA, is 
regulated through a complex homeostatic control mechanism to increase transcription of topA 
in response to increased DNA supercoiling. In contrast, transcription of the genes encoding 
the DNA gyrase subunits is increased in response to decreased levels of DNA supercoiling 
(Menzel and Gellert, 1983; Tse-Dinh and Beran, 1988).  
Plasmid and chromosomal DNA in E. coli stationary phase cells becomes more relaxed (less 
super-coiled) than the negatively supercoiled state during exponential growth (Balke and 
Gralla, 1987). The mechanism behind this relaxation has yet to be explicitly investigated. 
However, DNA gyrase is the target of the sbmC (gyrI) gene product, which binds to and 
inhibits the action of DNA gyrase (Nakanishi et al., 1998). Expression of the gyrase inhibitor 
is increased upon growth transition to stationary phase and this increase of DNA gyrase 
inhibitor concentration is likely to be the causative agent of DNA relaxation in stationary 
phase cells (Baquero et al., 1995; Oh et al., 2001). 
The work of Worcel and Burgi (1972) showed that the chromosome of E. coli is organised 
into topologically isolated, supercoiled loops. The presence of independently supercoiled 
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domains was confirmed by work on the closely related Salmonella typhimurium, using the 
supercoiling sensitive γδ resolution system (Higgins et al., 1996). These topologically isolated 
loops give rise to variation in effective superhelicity, which is a measure of the locally 
available superhelical density, therefore differing from the global superhelicity of the genome. 
Differences in effective superhelicity across the genome could have an effect on local cellular 
processes, such as transcription, replication and recombination. The compaction caused by 
supercoiling and the constraint of topologically isolated loops brings distant regions of the 
genome closer together and allows further compaction of the genome by the binding of NAPs 
(Travers and Muskhelishvili, 2005; Luijsterburg et al., 2008; Saier, 2008). 
 
1.2.3 Nucleoid associated proteins 
The idea of bacterial proteins with similar DNA-structuring functions to those of eukaryotic 
histones was first suggested by the isolation of the histone-like protein, HU, from E. coli 
extracts (Rouvière-Yaniv and Gros, 1975). The E. coli genome is associated with and 
structured by several major DNA-binding proteins, referred to as NAPs. The work of Azam et 
al. (1999) was the first to catalogue and characterise NAPs, measuring intra-cellular 
concentrations, binding affinities and preferred DNA binding sites of 12 NAP species. In vitro 
studies, utilising techniques such as atomic force microscopy (AFM), revealed that binding of 
individually purified NAPs can cause bending, wrapping, bridging and clustering of DNA, 
some of which can be seen in figure 1.3 (reviewed in Luijsterburg et al., 2006). It is by these 
mechanisms of DNA manipulation that NAPs contribute to the overall structuring and 
compaction of the E. coli chromosome. 
The NAP, H-NS (histone-like nucleoid structuring protein), is commonly referred to as the 
“universal repressor” or “sentinel”, due to its role in gene silencing (Browning et al., 2010). 
H-NS functions as a dimer or higher oligomers, interacting first with a single, high-affinity, 
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Figure 1.3: DNA structuring properties of nucleoid associated proteins 
The diagram represents the DNA structuring properties exhibited by some E. coli nucleoid 
associated proteins (NAPs). Black lines represent DNA, whereas shaded spheres represent 
NAPs. a. Free supercoiled circular DNA. b. DNA-bridging properties of H-NS protein form a 
dumbbell structure out of small circular DNA, but can also form nucleo-protein filaments. c. 
Extreme bending of DNA, by 160˚, caused by binding of IHF. d. Formation of rigid filaments 
by HU binding at high concentrations. e. Binding of FIS at nodes where two DNA segments 
cross each other. f. Highly compacted Dps-DNA complexes caused by DNA-Dps 
co-crystallisation. Dps is highly abundant during stationary phase only. 
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DNA binding site followed by cooperative binding to multiple sites. This can lead to 
nucleo-protein filament formation, which was recently shown to be the mechanism behind 
gene silencing (Lim et al., 2012). H-NS can also bridge between DNA strands, therefore 
bringing distant regions closer together and compacting the DNA (Lang et al., 2007; Dame et 
al., 2000; Dame et al., 2005; Figure 1.3b). Recent work by Wang et al. (2011) utilised 
H-NS::fluorescent protein fusions and 3C technology (chromosome conformation capture) to 
show that H-NS forms two compact clusters in vivo, per chromosome. This work also 
demonstrated that H-NS sequesters operons, regulated by the protein, within these clusters, 
bringing broadly distributed regions of the chromosome into close proximity. Therefore this 
work emphasises the importance of H-NS in the structuring and organisation of the E. coli 
chromosome.  
Wang et al. (2011) also analysed the distribution of the NAPs: FIS (factor for inversion 
stimulation), IHF (integration host factor), StpA (a paralogue of H-NS) and HU within the 
cell by tracking of fluorescently labelled proteins. However, FIS, IHF, HU and StpA were 
found to be dispersed throughout the E. coli nucleoid, despite StpA being a paralogue of the 
H-NS protein. Regardless of the lack of clustering, these proteins are still expected to 
contribute to chromosome compaction and structuring. For example, HU and its 
sequence-specific homologue IHF, bend DNA upon binding and, at high concentrations, HU 
forms nucleoprotein filaments, therefore counteracting the compaction caused by H-NS in 
supercoiled plasmid DNA (van Noort et al., 2004; Ljusterburg et al., 2006; Browning et al., 
2010; Figure 1.3c and d).  
Fis is another DNA bending NAP, which is the most abundant during exponential growth 
phase and has approximately 68,000 binding sites in the E. coli genome. However, the 
concentration of FIS protein drops to undetectable levels on entry into stationary phase (Azam 
et al., 1999). The pattern of decreasing FIS concentration upon entry into stationary phase is 
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the opposite to that of Dps (DNA protection during starvation) and CbpA (curved DNA 
binding protein) proteins, which are strongly induced during stationary phase (Azam et al., 
1999). Dps forms sheets of dodecamers, with DNA threaded through the pores created by the 
structure. Therefore Dps tightly packages the chromosome to form Dps-DNA co-crystals, 
which protect the chromosome from damage (Ceci et al., 2004; Frenkiel-Krispin et al., 2004; 
Luijsterburg et al., 2006; Figure 1.3f). It is likely that all of the NAPs identified so far, and 
potentially those left undiscovered, contribute towards structuring the chromosome into 
higher order structures, such as topologically isolated loops and the micron-scale 
macrodomains. 
 
1.2.4 Macrodomains 
Work published by Boccard and co-workers, since 2004, has developed an excellent body of 
evidence in support of the E. coli chromosome being structured into micron-scale 
organisational structures, referred to as “macrodomains” (reviewed in Dame et al., 2012). The 
origin of this idea stems from work completed by Niki et al. (2000), in which fluorescence in 
situ hybridisation (FISH) was used to visualise the chromosome at approximately 230 kb 
intervals. The results of this study revealed that several DNA segments within a large 920 kb 
chromosomal section encompassing the origin of replication, oriC, localised to a similar 
position. Similar results were found for a second 920 kb chromosomal section encompassing 
the dif site, which is positioned directly opposite to oriC on the circular chromosome and is a 
target for the XerCD site-specific recombinase involved in the resolution of chromosome 
dimers (Louarn et al., 1994). These two large domains were referred to as the Ori and Ter 
domains. Work by Valens et al. (2004) confirmed the presence, and more precise boundaries, 
of the Ori and Ter macrodomains, by measuring the recombination efficiency of λ att sites 
scattered throughout the E. coli chromosome. Recombination between att sites is dependent 
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upon spatial proximity and recombination frequencies revealed that interactions were 
restricted to sites within the same sub-domain, with little interaction of sites in different 
domains. This analysis revealed two extra macrodomains, which flank the Ter macrodomain 
and are referred to as Left and Right, and two less structured regions (NSR and NSL) flanking 
the Ori macrodomain. The four macrodomains (Ori, Right, Ter and Left) are large and each 
contains approximately 1 Mbp of DNA, therefore forming the largest chromosomal sub-
structures (Figure 1.4). 
Further work from the Boccard group utilised arrays of binding sites for fluorescently labelled 
ParB, positioned throughout the chromosome, to track chromosomal loci throughout the cell 
cycle (Espeli et al., 2008). This work revealed that the macrodomains occupy distinct 
territories within the cell throughout the cell cycle with the Ori and Ter macrodomains 
positioned at mid-cell and the Left and Right domains positioned close to the poles in 
newly-divided cells. Newly replicated Ori domains migrate towards the cell poles while Ter 
domain segregation occurs shortly before cell division and the original positions are resumed 
in daughter cells (Figure 1.5). Constraints on mobility of the macrodomains were clear, 
however markers in the two less structured regions demonstrated a greater mobility than that 
of markers in the macrodomains, which could account for the greater frequency of interaction 
with other domains (Espeli et al., 2008). 
Macrodomain structure and location within the cell was hypothesised to be due to 
organisational proteins, therefore in silico methods were used to search for domain-specific 
consensus binding motifs (Mercier et al., 2008). This work discovered a 13 bp motif, referred 
to as matS, which was found to be repeated 23 times specifically within the 800 Kb Ter 
macrodomain. Electrophoretic mobility shift assays using E. coli crude cell extracts helped to 
identify the product of the ycbG gene, renamed matP, as the factor specifically binding the 
matS site. The MatP protein was found to accumulate in the cell as a discrete focus that  
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Figure 1.4: Macrodomain organisation of the E. coli chromosome 
Circular map of the E. coli MG1655 chromosome, which is 4,639,221 bp in total. Shaded 
black arcs represent the positions of the four macrodomains (Ori, Right, Ter, and Left), while 
the gaps represent the less structured domains (NSL and NSR). Macrodomain boundaries are 
given in kb with respect to the coordinate system origin defined by Keseler et al. (2011) in the 
construction of the EcoCyc database. The position of the origin of replication (oriC) and dif 
site, involved in resolution of sister chromosomes, are indicated by black lines and labelled. 
Also, the positions of the tidL and tidR palindromes, involved in insulation of the Ter domain, 
are indicated. The figure is approximately to scale. 
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Figure 1.5: Localisation of E. coli chromosomal macrodomains throughout the cell cycle 
Schematic representation of E. coli chromosomal macrodomain localisation throughout the 
cell cycle. Black rectangles represent the E. coli cell membrane, while the black oval 
represents the E. coli chromosome, with the positions of the macrodomains (Ori, Right, Left 
and Ter) indicated by thick shaded grey lines. The Ori and Ter macrodomains are positioned 
at mid-cell and the Left and Right domains positioned close to the poles in new-born cells. 
Newly replicated Ori domains migrate towards the cell poles while Ter domain segregation 
occurs shortly before cell division and the original positions are resumed in daughter cells. 
The Ter macrodomain is anchored to the septal ring through interaction between Ter-specific 
sequences, MatP protein and the divisome component ZapB. (Figure adapted from Dame et 
al., 2011). 
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co-localises with the Ter macrodomain. Deletion of the MatP protein causes the DNA to 
become less compacted, the markers within the domain to become more mobile and the Ter 
macrodomain to segregate earlier in the cell cycle (Mercier et al., 2008). Recent work from 
the Boccard group has solved the structure of the MatP protein. Visualisation of MatP-matS 
complexes by atomic force microscopy and electron microscopy has demonstrated that the 
protein flexibly links distantly located matS sites by formation of MatP tetramers through 
interaction of flexible C-terminal coiled-coil domains (Dupaigne et al., 2012). MatP 
localisation was analysed in strains containing mutations in proteins involved in formation of 
the division apparatus. This experiment showed that MatP localised the Ter macrodomain to 
mid-cell through interaction with matS sites and the septal ring protein, ZapB (Espeli et al., 
2012). These results were confirmed through use of a two-hybrid assay demonstrating a 
strong direct interaction between ZapB and the C-terminal region of MatP. However, this 
interaction was only observed when ZapB was associated with the septal ring (Espeli et al., 
2012). Interaction of the Ter macrodomain with the division machinery, via the MatP protein, 
causes constrained mobility of the domain.  Finally, the Boccard group has identified two 
palindromic sequences, tidR and tidL, positioned in the Right and Left macrodomains, which 
are required to insulate the rest of the chromosome from the effects of Ter macrodomain 
interaction with the division machinery (Thiel et al., 2012; Figure 1.4). The tidR and tidL 
sequences are bound by the protein YfbV and this interaction was found to be required to 
maintain mobility of the less structured NS macrodomains (Thiel et al., 2012). This large 
body of work evidenced the mechanism by which the Ter macrodomain is structured, 
compacted, insulated and spatially linked to the cell division cycle. 
While the Ter domain-specific MatP protein has been extensively characterised, 
organisational proteins for the other domains have yet to be characterised. However, 
macrodomain-specific DNA-binding properties have been shown for the SeqA and SlmA 
proteins (reviewed in Dame et al., 2012). The SeqA protein recognises pairs of 
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hemi-methylated GATC motifs in newly replicated DNA and prevents multiple initiation of 
chromosome replication from the origin. (von Freiesleben et al., 1994; reviewed in 
Waldminghaus and Skarstad, 2009). Recent ChIP-chip  (ChIP – Chromatin 
immuno-precipitation followed by microarray) analyses of SeqA binding throughout the 
chromosome demonstrated that the origin of replication oriC is most densely populated with 
binding sites, however SeqA binding was detected at sites distal to oriC (Sánchez-Romero et 
al, 2010). Strikingly, the work of Sánchez-Romero et al. (2010) showed that SeqA binding is 
present within the Ori, Left, Right and less-structured macrodomains, however SeqA is 
entirely excluded from the Ter macrodomain. The work of Hiraga et al. (1998) utilised 
immunofluorescence microscopy to show that the SeqA protein forms discrete, localised, 
fluorescent foci, which are tethered at mid-cell until septal ring formation, after which foci 
migrate to the quarter cell position. It is also known that SeqA associates with the cellular 
membrane, therefore, due to the dynamic replication-dependent distribution of SeqA binding, 
SeqA may be involved in chromosome organisation during DNA replication (reviewed in 
Dame et al., 2011). The work reviewed in this section outlined how the E. coli chromosome is 
structured by DNA supercoiling, binding of NAPs and macrodomain scale organisation into 
the densely compacted structure, referred to as the nucleoid. While this compaction must be 
achieved, the chromosome must remain accessible to the transcription machinery in order for 
the process of gene expression to begin. 
 
1.3 An overview of the regulation of transcription in Escherichia coli 
The ability of bacteria to effectively and efficiently regulate cell physiology in response to 
environmental conditions is essential to survival. The necessary amount of the appropriate 
protein must be produced in response to the correct signal at the proper time. To achieve this 
gene expression is regulated in response to intra- and extra-cellular signals at every stage, 
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including rate of transcription, translation initiation, mRNA decay and the stability of the 
finished protein product. However, transcription initiation is the first and perhaps the most 
efficient stage at which the level of gene product can be modulated. The regulation of 
transcription involves interactions of the RNA polymerase with sigma factors, promoter 
sequence elements, transcription factors, small ligands, and chromosomal architecture 
(reviewed in Browning and Busby, 2004). 
 
1.3.1 RNA polymerase 
Eukaryotes contain multiple RNA polymerase (RNAP) enzymes, however in bacteria, a single 
multi-subunit RNA polymerase (RNAP) enzyme is solely responsible for all DNA-dependent 
RNA synthesis (Ebright, 2000). The number of RNAP molecules present in a single E. coli 
cell is dependent upon growth rate. This number has been estimated at approximately 4600 
molecules per cell during growth with a doubling time of 51 minutes (Pedersen et al., 1978; 
Bremer and Dennis, 1996; Bakshi, 2012). The structure of core RNAP enzyme from Thermus 
aquaticus was determined by x-ray crystallography and correlates very well with low 
resolution cryoelectron microscopy images of E. coli core RNAP (Zhang et al., 1999; Finn et 
al., 2000). The core RNAP enzyme resembles a “crab-claw structure”, similar to that of the 
yeast RNAP II, and has a molecular mass of approximately 400 kDa. The enzyme is 
comprised of the β and β’ subunits, two identical α subunits and the ω subunit (Darst et al., 
1998; Fu et al., 1999; Zhang et al., 1999; Figure 1.6). The pincers of the “crab-claw” are 
formed by the β and β’ subunits and the active site of the enzyme is contained at the base of 
the cleft, which is formed in the jaw of the structure (Figure 1.6). The active site contains an 
essential catalytic Mg
2+
 ion chelated by the three aspartic acid residues of the conserved 
-NADFDGD- motif in the β’ subunit (Zhang et al., 1999). During transcription, the channel 
containing the active site is occupied by the DNA template and the 3’ end of the RNA 
transcript (Naryshkin et al., 2000).  
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Figure 1.6: Schematic representation of RNA polymerase subunit architecture 
Schematic diagram of the bacterial RNA polymerase core enzyme. The large β (black oval) 
and β’ (dotted oval) subunits form a “crab-claw” structure with the active site (white circle) 
contained in the cleft formed by the jaws of the “crab-claw”. The ω subunit (dark grey) is 
thought to be required for folding of the β’ subunit to allow core enzyme formation. The two 
α-subunits (grey) dimerise and consist of two separate domains, the carboxy-terminal-domain 
(αCTD) and amino-terminal-domain (αNTD), which are connected by a flexible linker (black 
lines).  
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The two α subunits dimerise and each consists of two separate domains, the α subunit 
carboxyl-terminal-domain (αCTD) and the α subunit amino-terminal-domain (αNTD), the 
latter of which is responsible for assembly of the β and β’ subunits (Blatter et al., 1994; Zhang 
et al., 1999). The αCTD is connected to the αNTD, and the rest of the enzyme complex, by a 
flexible linker and has an important role in promoter recognition during transcription 
initiation at certain promoters (Gaal et al., 1996; Murakami et al., 1996). The ω subunit is 
small and has no direct effect on transcription, however it is thought to function as a 
chaperone to assist in folding of the β’ subunit (Mukherjee and Chatterji, 1997; Minakhin et 
al., 2001). The core enzyme is catalytically competent, however for transcription to be 
initiated at specific promoters, the core enzyme must interact with another subunit, the sigma 
subunit (σ), to form what is known as the holoenzyme (Burgess et al., 1969). 
 
1.3.2 Sigma factors and promoter recognition 
Most bacteria have multiple σ factors, which allow the global expression of different 
specialised regulons in response to different growth phases, external stimuli or stresses. The 
major σ factor of E. coli, σ70, is referred to as the “housekeeping” σ factor due to the 
σ70-containing holoenzyme being responsible for the majority of transcription during the 
exponential growth phase. E. coli has six alternative σ factors, which direct transcription of 
subsets of genes enabling the cell to respond and cope with different stresses (Ishihama, 2000; 
Gruber and Gross, 2003). For example the E. coli general stress sigma factor, σ38, is 
responsible for transcription of genes required for survival during stationary phase (Lange and 
Hengge-Aronis, 1991; Loewen et al., 1998). The work of Kusano et al. (1996) shows that the 
stationary phase σ38-containing holoenzyme is more efficient on relaxed DNA templates, 
therefore it is likely that relaxation of the chromosome during stationary phase plays a major 
role in transcription of the σ38 regulon (Kusano et al., 1996; Balke and Gralla, 1987). The 
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majority of σ factors are part of a family with homology to the E. coli primary σ factor, σ70 
(Stragier et al., 1985; Gribskov and Burgess, 1986). Members of this family consist of up to 
four conserved, structurally autonomous domains, σ1, σ2, σ3, σ4, connected by flexible linkers 
and comprising conserved regions 1.1, 1.2–2.4, 3.0–3.1, and 4.1–4.2, respectively (reviewed 
in Lonetto et al., 1992; Campbell et al., 2002). The role of the σ subunit in transcription 
initiation is to recognise specific sequences at promoters, which will allow the holoenzyme to 
be positioned correctly at the target promoter, and to facilitate unwinding of double stranded 
DNA around the transcription start site (Gross et al., 1998; Murakami et al., 2002a; 
Murakami et al., 2002b). 
Transcription initiation occurs by the recognition of specific DNA sequence elements within 
the upstream regulatory regions of genes, referred to as promoters, by the RNAP holoenzyme. 
Each E. coli cell encodes over 4000 genes, which are transcribed by the limited supply of 
RNAP molecules (Pedersen et al., 1978; Bremer and Dennis, 1996; Bakshi, 2012). Therefore, 
the sequence elements present at each promoter, and their similarity to the consensus, are a 
major contributor to the competition for limited RNAP holoenzyme molecules. The 
interactions of RNAP, carrying the major σ factor, with promoter elements have been 
elucidated by combining previous biochemical and genetic analyses (reviewed by Gross et al. 
(1998)) with structural data for different combinations of the RNAP, σ factor and DNA 
complexes (Murakami et al., 2002a; Murakami et al., 2002b; Vassylyev et al., 2002). The 
principal interactions at most promoters are between regions 2.4 and 4.2 of σ70 and promoter 
DNA sequence motifs, positioned 10 and 35 bp upstream of the transcription start site, 
respectively (Fenton et al., 2000; Campbell et al., 2002; Murakami et al., 2002b; Figure 1.7). 
These promoter elements have the consensus sequence 5’-TTGACA-n17-TATAAT-3’, with 
similarity to the consensus defining the strength of promoter activity. However it should be 
noted that not all positions of the consensus sequence are equal in importance for promoter 
recognition (Rosenburg and Court, 1979; McClure, 1985; Miroslavova and Busby, 2006).  
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Figure 1.7: Promoter recognition and transcription initiation by RNA polymerase 
Schematic representation of promoter recognition and transcription initiation by the bacterial 
RNA polymerase. The β (black oval) and β’ (dotted oval) subunits, the active site (white 
circle) and two α-subunits (grey) of RNAP are represented and the promoter DNA is 
represented by a black line. a. The promoter -10, extended -10, and -35 elements (white 
boxes) are recognised by the σ subunit of the RNAP holoenzyme to form the promoter closed 
complex. The αCTD is attached to the αNTD and the rest of the holoenzyme by a flexible 
linker and recognises the promoter UP element. b. Isomerisation from the closed complex to 
the promoter open complex is signified by unwinding of the promoter DNA around the -10 
and transcription start site (bent arrow). c. Transcript formation begins in the presence of 
nucleotide triphosphates. 
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After recognition of the -10 sequence by region 2.4 of the σ subunit, region 2.3 of σ initiates 
and stabilises DNA melting from position -11 bp to + 3 bp. The template strand is then 
directed into the main RNAP channel, with the transcription start site positioned at the active 
site ready for transcription to begin (Gross et al., 1998; Fenton et al., 2000; Campbell et al., 
2002; Murakami et al., 2002b; Figure 1.7). 
The sigma factor makes contact with one other promoter element at some promoters, which is 
the extended -10 element. The extended -10 promoter element is located immediately 
upstream of the -10 element and is 3-4 base pairs, with the consensus sequence TGn (Burr et 
al., 2000). This element is recognised by region 3.0 of the σ70 subunit, significantly increasing 
promoter strength, and is capable of compensating for poor -10 and -35 sequences at some 
promoters (Barne et al., 1997; Mitchell et al., 2003; Murakami et al., 2002a; Murakami et al., 
2002b; Figure 1.7). In addition to contacts made by the σ subunit, the αCTDs of the RNAP 
holoenzyme interact with another promoter element at some promoters, the UP element, 
which is a ~ 20 bp A/T rich sequence located upstream of the -35 motif (Ross et al., 1993; 
Gourse et al., 2000; Figure 1.7). Many promoters are known to contain UP elements, however 
they are particularly associated with highly active promoters driving expression of genes 
encoding ribosomal and transfer RNA (Gourse et al., 2000). 
In summary, the RNAP core enzyme must first interact with a σ factor before it is competent 
for promoter directed transcription. The αCTD of the RNAP enzyme can then interact with 
UP elements at some promoters to assist in recognition of the -10 and -35 promoter elements 
by region 2.4 and 4.2 of the σ70 subunit. Binding of the DNA double helix by RNAP 
holoenzyme results in what is referred to as the closed complex RPc (reviewed in Browning 
and Busby, 2004; Figure 1.7). Region 2.3 of the σ70 subunit then promotes and stabilises 
unwinding of the DNA double helix around the transcription start site, allowing the template 
strand to be moved into the active site to form the open complex RPo, a process referred to as 
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isomerisation (reviewed in Browning and Busby, 2004; Figure 1.7). The complex is then 
ready for RNA synthesis to begin, eventually leading to promoter escape and dissociation of 
the σ factor from the elongation complex. 
 
1.3.3 Regulation of transcription initiation by transcription factors 
Regulation of the E. coli transcriptional output is hierarchical, with sigma factors giving the 
upper level of hierarchical control in general response to stresses, growth phases or external 
stimuli. Subsets of promoters controlled by different sigma factors can be large and the next 
level of specificity in control of genes is achieved by interaction of transcription factors at 
specific subsets or individual promoters. Transcription factors are sequence-specific 
DNA-binding proteins, which bind to specific consensus sequences at or near to target 
promoters to up- or down-regulate transcription in response to specific signals (Ishihama, 
2000; Lee et al., 2012). There are more than 300 genes in the E. coli genome coding for DNA 
binding proteins, which may represent the E. coli set of transcription factors, 35% of which 
are specifically activators of transcription, 43% repressors of transcription and 22% are dual 
regulators (Pèrez-Rueda and Collado-Vides, 2000). The promoters under control of one 
transcription factor are referred to as a regulon, however the majority of E. coli transcription 
factors act at only one or a few promoters. In contrast to this, seven global regulator proteins 
(CRP, IHF, FIS, FNR, NarL, ArcA and Lrp) have large regulons and, together, directly 
modulate the activity of 51% of E. coli promoters (Gottesman, 1984; Martinez-Antonio and 
Collado-Vides, 2003). 
Binding of transcription factors at a target promoter can activate transcription from that 
promoter, however binding of transcription factors can also act to repress transcriptional 
activity. Activators of transcription typically function by direct protein-protein interaction 
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with the holoenzyme either to recruit RNAP to the promoter or by assisting open complex 
formation. Other activators function through alteration of promoter DNA conformation to 
allow more efficient binding by the RNAP holoenzyme (Ebright and Busby, 1995; 
Hochschild and Dove, 1998; Lee et al., 2012). Activation of transcription at many promoters 
works by a single transcription factor acting via one of 3 simple mechanisms often referred to 
as; class I or class II activation, or activation by induction of a conformational change in the 
target promoter (Lee et al., 2012; Figure 1.8). However, at many promoters, several factors 
interact and integrate different intra- or extra-cellular signals into transcriptional responses.  
In the case of simple class I activation, the activator protein binds to a target DNA site 
upstream of the promoter -35 element (Figure 1.8a). This allows the activator to recruit 
holoenzyme to the promoter via direct protein-protein contact with the RNAP αCTD. The 
αCTD is connected to the αNTD by a flexible linker, which permits variation in the position 
of the activator binding site. However, activation can be lost if the binding site does not reside 
on the same face of the DNA helix as the -10 and -35 promoter elements (Gaston et al., 1990; 
Busby and Ebright, 1999; Browning and Busby, 2004). One of the best characterised 
examples of class I activation is the lac promoter, which is part of the paradigm for genetic 
regulation first used to describe the operon model by Jacob and Monod (1961). The lac 
promoter controls expression of genes required for the transport and metabolism of lactose in 
the absence of glucose. The three genes under control of this promoter are transcribed as a 
single mRNA and are lacZ, lacY and lacA, which encode the following proteins, 
β-galactosidase, lac permease and thiogalactoside transacetylase, respectively. Transcription 
of the lacZYA operon is driven by σ70 RNAP holoenzyme and is activated by the cyclic AMP 
receptor protein (CRP) binding at a DNA site centred at position -61.5 bp (Dickson et al., 
1975; Simpson, 1985; Schmitz, 1981; Reznikoff, 1992; Figure 1.9). The CRP protein acts via 
a class I mechanism, directly interacting with the αCTD of RNAP to recruit the holoenzyme 
to the promoter (Meiklejohn and Gralla, 1985; Ebright, 1993). The CRP protein is only active  
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Figure 1.8: Simple mechanisms of transcription activation 
Simple mechanisms of activation by a transcription factor. a. Class I activation. The activator 
protein (black sphere) binds a DNA site upstream of the -35 element (white box), usually at 
position -61.5 bp, and contacts (white stars) one or both α subunit caboxy-terminal-domains 
(αCTD) to assist in recruitment of RNAP to the promoter. b. Class II activation. The activator 
binds close to RNAP, usually at position -41.5 bp, and can make contacts with one of the 
αCTD subunits, the αNTD subunit or the σ subunit of the holoenzyme to assist in recruitment. 
c. Activation by conformational change. The activator binds to a site between the -35 and -10 
promoter elements, inducing a conformational change in the promoter DNA, which allows 
full interaction of RNAP with the promoter. Figure adapted from Lee et al. (2012). 
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Figure 1.9: Regulation of the lacZYA promoter region by CRP and Lac repressor 
a. Schematic representation of the lacZYA upstream regulatory region. The 3’ end of the lacI 
and 5’ end of lacZ genes (white boxes on top of DNA strand (black line)) flank the regulatory 
region. The lac promoter is activated by CRP (grey spheres) binding to a target DNA site 
(inverted grey arrows) centred at position -61.5 bp. The -35 and -10 promoter elements are 
represented by white boxes and the transcription start site by the bent arrow labelled +1. 
Promoter activity is repressed by binding of the Lac repressor (black sphere) to different 
combinations of the 3 DNA  lac operator sites (black boxes). b. Repression of the lacZYA 
operon. The Lac repressor can bind to the O
1
 binding site, overlapping the transcription start 
site, therefore blocking RNAP by steric hindrance. The Lac repressor can also bind as a 
tetramer to interact with O
1
 and one of the auxiliary operator sites, O
2
 or O
3
, to cause looping. 
This blocks RNAP access to the promoter elements, therefore repressing transcription. 
t h  
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when bound by the inducer molecule cAMP, the production of which is repressed in the 
presence of glucose. Therefore activation of the lac promoter is directly linked to the absence 
of glucose through the interaction of cAMP, CRP and the lacZYA regulatory region (Pastan 
and Perlman, 1970; Busby and Ebright, 1999). 
Class II activation is unlike class I activation in that there is less flexibility in the positioning 
of the activator binding site. This is because class II activation not only requires contact with 
the α-subunit, but also direct contact of the activator with domain 4 of the σ70 subunit of 
RNAP (Figure 1.8b). Therefore the binding site is usually centred at position -41.5 bp, 
relative to the transcription start point, overlapping the promoter -35 element (Gaston et al., 
1990; Busby and Ebright, 1997; reviewed in Dove et al., 2003). During class II activation, the 
activator may also contact other subunits of the RNAP holoenzyme, for example the FNR 
(regulator of fumarate and nitrate reductase) protein can also make contact with the αNTD 
along with contacts to the αCTD and σ70 (Blake et al., 2002; Figure 1.8b).  
In contrast to class I and class II activation, activation by conformational change usually 
requires binding of the activator protein to the spacer region between the -10 and -35 
promoter elements instead of to sites upstream of the -35 element (Figure 1.8c). The spacing 
of the core -10 and -35 promoter elements is not optimal at these promoters, thus upon 
binding of the UP and -35 elements by the RNAP holoenzyme, the -10 element is misplaced 
and open complex formation cannot continue. Binding of the activator to a target site within 
the spacer region induces a twist that brings the -10 promoter element back into alignment 
with the -35 (Figure 1.8c). This allows promoter melting around the transcription start site 
through interaction of σ region 2 with the -10 element and subsequent RNA synthesis 
(reviewed in Brown et al., 2003 and Lee et al., 2012). 
 29 
Transcription factors can also repress promoter activity by simple or complex mechanisms 
through interaction of one or many proteins in response to intra- or extra-cellular signals. 
Simple mechanisms of repression by a protein include the following; steric hindrance of either 
RNAP or an activator, DNA looping, or modulation of an activator, which all reduce the level 
of transcription initiation at the target promoter (reviewed in Browning and Busby, 2004; 
Figure 1.9b). Repression by modulation of an activator functions by direct protein-protein 
interactions, between the repressor and activator proteins, to stop interaction with RNAP 
holoenzyme (Browning and Busby, 2004).  
An excellent example of a promoter repressed by steric hindrance and DNA looping is the 
previously mentioned paradigm of transcription regulation, the lac promoter. The lac 
promoter is repressed by the protein product of the lacI gene, which is located immediately 
upstream of the lacZYA regulatory region and is under transcriptional control of a weak 
constitutively active promoter (Jacob and Monod, 1961; Calos, 1978; Wilson, 2007; Figure 
1.9b). The Lac repressor is a target for the inducer allo-lactose, which binds the repressor 
protein and reduces its affinity for the DNA binding site, therefore relieving repression of the 
lacZYA operon (Jobe and Bourgeois, 1972). In the absence of inducer, the Lac repressor binds 
the primary operator site (O
1
) which is situated directly over the transcription start site, 
therefore sterically hindering RNAP binding to promoter DNA (Figure 1.9b). However, 
binding to this site alone is insufficient for complete repression of transcriptional activity. 
Two auxiliary “pseudo-operators” (O2 and O3) are situated within the lacZ and lacI genes and 
lac repressor tetramers bound at these sites can form “repression loops” by interaction with 
the primary operator O
1
 (Figure 1.9b). Formation of DNA loops allows full repression of the 
operon by exclusion of the transcription initiation machinery from the promoter (Reznikoff et 
al., 1974; Oehler et al., 1990; Oehler et al., 1994; Wilson et al, 2007). 
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1.4 Effects of chromosome structure on transcription 
1.4.1 Regulation of transcription initiation by nucleoid associated proteins 
Three of the seven global regulators of transcription, FIS, IHF and Lrp, are also defined as 
NAPs. Recent ChIP-chip studies by Grainger et al. (2006) have shown that the majority of 
binding sites for the NAPs H-NS, FIS and IHF, are positioned within intergenic regions. 
Therefore it is unsurprising that NAPs not only structure the chromosome, but also affect 
transcription on a genome-wide scale, performing both roles simultaneously (reviewed in 
Dillon and Dorman, 2010). The NAP, IHF, of E. coli binds to a specific target consensus 
sequence and introduces a sharp 160˚ U-turn into the DNA, centred around the target binding 
site (Rice et al., 1996; Figure 1.3c). Binding, and bending, by IHF is essential for the 
regulation of approximately 120 genes in E. coli (Arfin et al., 2000). IHF can directly interact 
with the RNAP holoenzyme complex to regulate transcription. However, the majority of 
regulation, by IHF, is through modulation of promoter architecture to allow interaction 
between RNAP and distally bound activators (reviewed in Goosen and van de Putte, 1995). 
IHF can also function through another mechanism, which involves redistribution of energy 
stored in the IHF binding site to assist in promoter open-complex formation. For example, the 
E. coli ilvGMEDA operon is activated by binding of IHF, which displaces torsional energy 
stored in the negatively-supercoiled IHF binding site. Displaced torsional energy is 
transferred to the neighbouring promoter region, which is prone to base-pairing disruption. 
The single-stranded bubble is then formed around the transcription start site, therefore 
allowing promoter open complex formation (Sheridan et al., 1998; reviewed in Dillon and 
Dorman, 2010).  
The FIS protein, like IHF, can also affect transcription initiation through a range of different 
mechanisms, including direct interaction with RNAP and manipulation of local superhelicity 
(reviewed in Browning and Busby, 2010). For example, binding of the FIS protein to 
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helically-phased sites, positioned upstream of the tyrT promoter, stabilises a DNA microloop, 
constraining a microdomain of negative superhelicity at the promoter. Stabilisation of local 
negative superhelicity facilitates open complex formation and therefore transcription of tyrT 
(Auner et al., 2003; Dillon and Dorman, 2010). As at the tyrT promoter, local DNA 
superhelicity can affect the activity of many promoters throughout the E. coli chromosome. 
Variation in local negative superhelicity (over or under-twisting) can affect the position of 
promoter elements with respect to each other, much like the mechanism of activation by 
conformational change, as described in section 1.3.3 (Lee et al., 2012; Figure 1.8c). Whether 
this conformational change will affect transcription initiation positively or negatively depends 
upon the specific structure of individual promoter elements. 
 
1.4.2 DNA supercoiling effects on transcription 
Peter et al. (2004) utilised inhibitors of DNA gyrase and Topo IV to reduce the negative 
superhelical density of the E. coli chromosome, causing the molecule to become more 
relaxed. Microarray analysis was used to measure changes in transcriptional output. This 
work revealed that transcription of 106 genes was up-regulated and 200 genes were 
down-regulated in response to inhibition of DNA gyrase. Blot et al. (2006) utilised a 
microarray-based approach to assess the combined effects of global relaxation of 
chromosomal superhelicity and mutations in the fis and hns genes. This work confirmed that 
the transcriptome of E. coli is sensitive to relaxation of negative supercoiling, but also 
demonstrated that the spatial distribution of superhelicity is dependent upon NAPs. As 
described in section 1.1., the nucleoid is structured into dynamic, topologically isolated, 
supercoiled domains, which were recently found to be approximately 10 kb in size (Postow, 
2004; Figure 1.1). NAPs have long been proposed as the organising barriers to supercoil 
diffusion, due to their DNA architectural role, which is in agreement with the work of Blot et 
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al. (2006). These barriers were potentially identified by the work of Vora et al. (2009) that 
sought to identify the protein occupancy landscape of the E. coli genome. Formaldehyde 
cross-linking was used to stabilise protein/DNA complexes within the cell, which were 
released by lysis and sonication then reduced to ~ 50 bp footprints with DNase I treatment. 
Protein/DNA complexes were then extracted from the interface between the aqueous and 
organic phases of a phenol-chloroform extraction. Sections of DNA bound by large quantities 
of protein were then de-crosslinked and identified by use of microarray, which identified 
extended protein occupancy domains (EPODs) of the chromosome (Vora et al., 2009). These 
are large regions of the chromosome, between 1 and ~ 14 kb, contiguously bound by protein. 
This data was compared to transcription profiling data and RNAP ChIP-chip data presented 
by Grainger et al. (2005) to demonstrate that the EPODs were either highly expressed, in 
which case most of the protein could be RNAP, or transcriptionally silent (tsEPODs) (Vora et 
al., 2009). Comparison of the tsEPOD data with the NAP ChIP-chip study of Grainger et al. 
(2006) revealed that tsEPODs were enriched for NAP binding sites. Therefore the tsEPODs 
are suggested to be the organising centres of the chromosome, acting as barriers to diffusion 
of negative superhelicity. 
 
1.4.3 Transcription factories and uneven distribution of RNA polymerase 
A review by Cook, (2010) proposed that RNAP could also be the driving force behind 
formation of topologically isolated, superhelical chromosomal loops. Cook based this 
hypothesis primarily on the observation that the E. coli nucleoid is unfolded after treatment 
with rifampicin, an inhibitor of RNAP, or with RNase (Dworsky and Schaechter, 1973; 
Kavenoff and Bowen, 1976; Cook, 2010). Cook proposed a model of organisation for all 
species in which RNAP is static, pulling the DNA template through the complex instead of 
tracking along it, and clustered into “transcription factories” (Figure 1.10). Transcription  
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Figure 1.10: Model of chromosome structure by formation of transcription factories 
Aggregation of actively transcribing RNA polymerase molecules (grey spheres) and nucleoid 
associated proteins (NAPs), or transcription factors, would lead to compaction of the 
chromosome. Stationary, inactive, polymerase molecules bound to DNA would also serve to 
compact the chromosome. This model of compaction would be dynamic and potentially 
contribute to the regulation of transcription as promoters are pulled into closer proximity to a 
transcription factory. Adapted from Cook, (2002). 
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factories could include transcription factors, topoisomerases and RNAP molecules gathered in 
one specific locus. Evidence for transcription factories is observed during fast growth of E. 
coli, in which fluorescently labelled RNAP forms distinct clusters on the periphery of the 
nucleoid (Cabrera and Jin, 2003; reviewed in Jin and Cabrera, 2006; Figure 1.11a). However, 
no obvious clusters of RNAP are observed during moderate growth (Jin and Cabrera, 2006; 
Bakshi et al., 2012). Chromosomal superhelicity can be affected by the process of 
transcription, with the actively transcribing elongation complex causing positive supercoiling 
ahead and negative supercoiling behind the complex (Wu et al., 1988; Tsao et al., 1999). 
Therefore transcription factories would greatly influence chromosomal architecture, due to 
their tethering effect and the effect on DNA superhelicity. Transcription factories could also 
play a role in the variation in local DNA superhelical density throughout the chromosome, 
which was reported by Postow, (2004). Therefore activity of a supercoiling-sensitive 
promoter could be affected by changes in location within the chromosome and promoters in 
closer proximity to a transcription factory would be more likely to initiate transcription.  
 
1.4.4 The localisation of transcription and translation within the cell 
The hypothesis that some chromosomal positions may be more permissive for transcription 
than others has been around since the early years of study into E. coli nucleoid structure. 
Ryter and Chang (1975) visualised the sites of active transcription in cells supplemented with 
radioactive uracil by high resolution autoradiography. This study revealed that the sites of 
active RNA synthesis are located on the nucleoid periphery and far out into the cytoplasm. 
However, this work found no sign of transcription within the nucleoid area and the authors 
proposed that transcription would occur on genes spread out into the cytoplasm (Figure 
1.11a).  
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Figure 1.11: Uneven distribution of RNA polymerase and ribosomes in E. coli 
a. Schematic representation of fluorescence microscopy images of GFP-tagged RNA 
polymerase (RNAP) in fast growing E. coli. RNAP aggregates into clusers (grey areas) 
situated on the nucleoid (black area) periphery and out into the cytoplasm. The model to 
explain this suggests that DNA loops are extended into the cytoplasm during transcription by 
clustered RNAP molecules. Therefore loops located far fro each other in the genome are 
brought into close proximity by active transcription. Figure adapted from Jin et al. (2006). b. 
Schematic representation of super-resolution microscopy images of fluorescently labelled 
ribosomes, collected by Bakshi et al. (2012). Ribosomes are observed to be strongly 
segregated from the nucleoid and form clusters at the cell poles. Distributions of RNAP and 
ribosomes were observed to extend up to the cytoplasmic membrane, however RNAP was not 
observed near the membrane of the end-caps (Bakshi et al., 2012). 
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The work of Ryter and Chang (1975) correlates with recent studies by Cabrera and Jin, (2003) 
and Bakshi et al. (2012), which visualised the position of fluorescently labelled RNAP using 
fluorescence microscopy and super-resolution microscopy, respectively. The super-resolution 
study by Bakshi et al. (2012) found that RNAP localised to the nucleoid lobes and also 
extended throughout the cytoplasm to the cytoplasmic membrane. However, due to the cell 
being a three-dimensional shape, the study could not distinguish whether large numbers of 
RNAP molecules were within or merely on top of the nucleoid in the images produced. When 
taken with the observations of Ryter and Chang (1975), these data suggest that RNAP is 
excluded from the nucleoid. Further to this, the nucleoid is a space devoid of ribosomes, as 
reviewed by Robinow and Kellenberger (1994), and recently demonstrated by 
super-resolution microscopy studies of fluorescently labelled ribosomes in E. coli (Bakshi et 
al., 2012). The work of Bakshi et al. (2012) discovered a strong segregation between the 
nucleoid and ribosome rich regions, with the ribosomes forming dense clusters at the cell 
poles. This would suggest that genes positioned near to the nucleoid periphery would be more 
accessible to the translation machinery than those in the centre of the compacted nucleoid. 
Therefore certain positions within the E. coli chromosome are expected to be more conducive 
to transcription initiation than others. 
 
1.4.5 Previous studies on position-dependent modulation of promoter activity 
The effect of position within the chromosome on promoter activity has been investigated by 
only a few research groups (Beckwith et al., 1966; Schmid and Roth, 1987; Sousa et al., 
1997), with one recent study being published during the course of this Ph.D. thesis (Block et 
al., 2012). Beckwith et al. (1966) utilised recent advances, which allowed transposition of 
E. coli genes to new chromosomal locations, to study the transposed lac operon. Expression 
of the lac operon from an F’lac episome integrated at 10 different chromosomal loci, some of 
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which were in both orientations, was studied during growth on minimal medium. Beckwith et 
al. reported up to two-fold differences in expression of the lac genes and an increase in gene 
expression with proximity to the origin of replication. Later work showed that during rapid 
bacterial growth, the chromosome may have multiple replication points, which all initiate 
from the single origin of replication (Caro and Berg, 1968; Wolf et al., 1968; Figure 1.12). 
Therefore the average dosage of chromosomal positions is expected to be different, with more 
copies of the origin proximal area than that of the replication terminus (Figure 1.12). This 
effect is referred to as gene dosage and the results of Beckwith et al. (1966) correlate with the 
increased gene copy number expected by the Helmstetter and Cooper gene dosage model 
(Helmstetter and Cooper, 1968). 
Schmid and Roth (1987) demonstrated similar results for the his operon in S. typhimurium. 
The first four genes and the promoter of the his operon, hisGDCB, flanked by Tn10 insertion 
elements, was translocated to 16 known Tn10 insertion sites throughout the chromosome. 
Expression of the hisD gene product was measured during different growth conditions and the 
results correlated with that expected due to gene dosage effects, expression was reduced, as 
expected, at slower growth rates. Sousa et al. (1997) also sought to assess the effects of 
position within the chromosome on promoter activity. The regulator of the nah genes of 
P. putida was fused to lacZ and carried by a mini-Tn5 transposon to various locations on the 
E. coli chromosome. Like the studies of Beckwith et al. (1966) and Schmid and Roth (1987) 
an increase in gene expression, with increasing proximity to the origin of replication, was 
noted. This work also attempted to measure local DNA supercoiling by inserting the 
supercoiling sensitive gyrB promoter, fused to lacZ, into each of the chromosomal loci. No 
correlation between position-based modulation of gene expression and local superhelicity 
could be made. However this work did not consider that the gyrB promoter may also be 
sensitive to other local chromosomal factors, such as NAP binding. 
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Figure 1.12: Schematic representation of the gene dosage model 
Schematic representation of E. coli chromosome replication and the gene dosage model. The 
oval represents the E. coli chromosome, with the positions of the origin of replication (oriC), 
dif site and random position X marked. The dif is involved in separation of sister 
chromosomes after replication. Early in the replication process the replication forks (black 
circles) have not reached position X, but have duplicated the origin proximal region, therefore 
creating more copies of oriC than position X or the dif site. During rapid growth multiple 
replication forks can form, therefore in the scenario at the bottom of the figure there are four 
copies of oriC and two copies of position X for each copy of the dif site. Figure adapted from 
http://www.science-projects.com/V10A.htm. 
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The most recent attempt to assess position-dependent modulation of gene expression was 
completed by Block et al (2012). The exceptionally strong PL promoter of phage lambda was 
modified, by Lutz and Bujard (1997), to be regulated by the Lac repressor, therefore allowing 
induction of promoter activity by the addition of IPTG to the medium. The modified PL 
promoter, fused to the yfp gene, was flanked by transcription terminators and inserted into the 
coding region of six different pseudogenes and at two reference loci within the chromosome 
of E. coli (Block et al., 2012). Gene expression was analysed during various growth rates, 
however the pattern of expression was as expected from the Helmstetter and Cooper gene 
dosage model (Helmstetter and Cooper, 1968). This experiment was repeated without the 
flanking transcription terminators and some anomalies to the gene dosage model were 
discovered. However, anomalies to the gene dosage model were attributed to “local sequence 
effects”, such as clashing elongation complexes, mRNA degradation or reduced translation 
(Block et al., 2012). The work of Block et al. (2012) also sought to analyse the effect of 
varying distance between the gene encoding a transcription factor and the target promoter, 
however no effect was detected. 
These studies used approaches to move the same promoter and reporter to various 
chromosomal locations to answer the question of whether location affects transcription level. 
However several features of these experiments need to be highlighted. For example, the 
promoter elements in all of the above experiments were flanked by the vehicles used to insert 
them into the genome, thus, the lac promoter was contained within the F’lac episome, the 
hisGDCB operon was flanked by two Tn10 insertions and the psaI-lacZ reporter was 
contained within Tn5. All of these elements, along with the general large size of the inserts, 
could serve to shield the regulatory elements under study from location-specific modulation 
effects. Another shortcoming of these studies is that the insertion location of the Tn5 and 
Tn10 elements is biased, therefore not allowing direct targeting of the probe to specific 
locations. Further to this, the inserted pieces of DNA are relatively large, thus potentially 
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altering the local chromosomal architecture purely by their presence (Beckwith et al., 1966; 
Schmid and Roth, 1987; Sousa et al., 1997).  
 
1.5 Aims and outline of the project 
A study was required in which a small promoter::reporter probe would be inserted into the 
genome, at several locations, utilising a recent homologous recombination technique to allow 
greater accuracy in targeting and choice of insertion locus. The non-coding DNA between 
convergent genes should be targeted, with a natural E. coli promoter fused to a reporter, in 
order to minimise disruption to neighbouring genomic processes, such as transcription. 
Therefore chapter 3 describes an investigation into the effects of position within the 
chromosome of E. coli on promoter activity during exponential growth and the relation of 
gene dosage to position-based modulation of promoter activity was also determined. The 
effect of position within the chromosome on promoter activity has not previously been 
assessed during stationary phase, however E. coli do experience conditions of substrate 
limitation and starvation (Beckwith et al., 1966; Schmid and Roth, 1987; Sousa et al., 1997; 
Block et al., 2012; Navarro-Llorens et al., 2010). Consequently, a second aim of the project 
was to measure position-based effects on promoter activity during stationary phase.  
The third aim of this project was to describe the mechanisms of position-based modulation of 
promoter activity. Therefore chapter 4 describes studies into potential mechanisms of 
position-dependent variation of promoter activity, including orientation with respect to 
replication, neighbouring promoter activity, local superhelical density and positioning within 
tsEPODs. Finally, plasmid-based reporter gene technology is utilised on a regular basis for the 
characterisation of promoters. Therefore chapter 5 describes experiments to compare the 
activities of various promoters located either on the chromosome of E. coli or on a plasmid.
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Chapter 2: 
Materials and Methods 
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2.1 Suppliers 
Unless otherwise stated, all chemicals were supplied by Sigma-Aldrich, BDH Prolabo or 
Fisher-Scientific. Restriction endonucleases, calf alkaline phosphatase, T4 DNA Ligase and 
Phusion DNA polymerase were purchased from New England BioLabs. Biomix Red DNA 
polymerase, cDNA Synthesis Kit, Sensimix Hi-ROX Kit and dNTP mix were supplied by 
Bioline. Enzymes were used as described by the manufacturer and in the buffers supplied by 
the manufacturer. Oligodeoxyribonucleotides were supplied by Alta Bioscience, University of 
Birmingham. 
 
2.2 Bacterial growth media 
2.2.1 Liquid media 
All liquid media were made using distilled water, sterilised by autoclaving for 20 min at 
120°C and 15 psi, and stored at room temperature. One litre of LB medium contained: 20 g
 
tryptone; 10 g
 
yeast extract and 10 g
 
NaCl dissolved in distilled water. M9 minimal medium 
was made as a 10 x solution, which contained: 60 g Na2HPO4; 30 g KH2PO4; 5 g
 
NaCl; 10 g 
NH4Cl; 10 mg Biotin and 10 mg thiamine dissolved in distilled water. 10 x M9 minimal 
medium was then adjusted to pH7.4 before autoclaving. The constituents of M9 salts medium 
were made up individually, autoclaved, and fresh medium was prepared aseptically when 
required. For 100 ml medium 10 ml 10 x M9 salts, 200 µl 1 M MgSO4, 100 µl 0.1 M CaCl2 
and 0.5 ml 20% casamino acids were mixed aseptically and made up to 100 ml with sterile 
distilled water. M9 minimal salts medium was always supplemented with 0.3% fructose as the 
carbon source and was supplemented with 0.2% melibiose where required.  
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One litre of minimal salts medium (MS) contained: 4 g KH2PO4; 10.5 g K2HPO4; 1 g 
(NH4)2SO4; 0.05 g MgSO4.7H2O; 0.6 g trisodium citrate. The medium was then supplemented 
with 10 ml ammonium molybdate (1 mM), 10 ml sodium selenate (1 mM) and 10 ml of 
E. coli sulphur free salts to a total of 1 litre. The composition of one litre of E. coli sulphur 
free salts was: 82 g MgCl.7H2O; 10 g MnCl2.4H2O; 4 g FeCl2.6H2O and 1 g CaCl, 
supplemented with 20 ml of concentrated HCl per litre of distilled water. Minimal medium 
was supplemented with 10% LB, 20 mM fumarate, 20 mM TMAO and 0.4% (v/v) glycerol as 
a carbon source. SOC medium is a rich media used in the recovery step of E. coli competent 
cell transformations to maximise the transformation efficiency. Ready-made SOC solution 
was purchased from Sigma-Aldrich. 
 
2.2.2 Solid media 
All solid media were made using distilled water and sterilised by autoclaving for 20 mins at 
120°C and 15 psi. Media were cooled to ~50°C before addition of antibiotics or other 
supplements. Agar plates were poured under sterile conditions (approximately 25 ml agar per 
Petri dish) and stored at 4°C. Nutrient agar was prepared by adding 23 g nutrient agar powder 
(Difco) to distilled water to a total volume of one litre before autoclaving. LB agar was 
prepared by the addition of 20 g
 
tryptone, 10 g
 
yeast extract, 10 g
 
NaCl and 10 g
 
agar to 
distilled water to a total volume of one litre. 50 g MacConkey lactose agar (Difco) was added 
to distilled water to a total volume of one litre before sterilisation. One litre of lactose M9 
minimal salts agar contained: 100 ml 10 x M9 salts; 1 g α-lactose and 15 g bacteriological 
agar (Oxoid). 
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2.2.3 Antibiotics and other supplements 
All stock solutions of antibiotics and other supplements were sterile filtered through 0.2 µm 
syringe filters and stored at -20°C. For stock solution, 40 mg/ml ampicillin was dissolved in 
sterile distilled water. Stock solutions of kanamycin were 50 mg/ml in sterile distilled water. 
Chloramphenicol and tetracycline were each dissolved in methanol at concentrations of 25 
mg/ml and 10mg/ml, respectively. X-gal (5-bromo-4-chloro-3-indolyl β-D-galactopyranoside) 
(Bioline), the chromogenic substrate for β-galactosidase, was stored at a concentration of 20 
mg/ml in dimethylformamide. The gratuitous inducer of the lac operon, IPTG (isopropyl β-D-
1-thiogalactopyranoside) (Bioline), was stored at 100 mM in sterile distilled water. The DNA 
gyrase inhibitor, novobiocin, was stored at 100 mg/ml in sterile distilled water. 
To select for bacterial strains carrying antibiotic resistance genes, antibiotics were added to 
liquid or solid media, after autoclaving, at the following final concentrations: 80 µg/ml 
ampicillin, 35 µg/ml tetracycline, 50 µg/ml kanamycin, 25 µg/ml chloramphenicol. 
Blue-white colour selection of Lac
+ 
and Lac
-
 colonies was achieved by the addition of 40 
µg/ml X-gal to molten LB agar, after autoclaving. To induce expression of the lac operon 
during blue-white selection, IPTG was added to media to a final concentration of 0.1 mM. 
IPTG and novobiocin were added to media after sterilisation and cooling as required and 
specified in results chapters. 
 
2.3 Bacterial strains and plasmids 
2.3.1 Bacterial strains and growth conditions 
The bacterial strains used in this study are listed in Table 2.1. Strains were stored as glycerol 
stocks in LB media supplemented with 15% glycerol at -80°C. Strains were streaked onto the 
appropriate agar plate and incubated overnight at 37°C before use. Overnight cultures were 
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prepared by inoculation of 5-10 ml of the appropriate sterile medium with a single fresh 
colony and incubation at 37°C with aeration for 14-16 h (LB) or up to 20 h (minimal 
medium). Growth of liquid cultures was monitored by measuring the optical density at 
650 nm or 620 nm, using a Helios Gamma Spectrophotometer or a Labsystems Multiskan MS 
plate reader, respectively (Thermo Fisher Scientific Inc.).  
 
2.3.2 Plasmids 
Plasmids used in this study are listed in table 2.2. Plasmid maps are shown in figures 2.1-2.6. 
Plasmid pRW50 carrying various promoter fragments as transcription fusions to lacZ was 
used to quantify promoter activities by measuring β-galactosidase activity. Derivatives of 
plasmids pKH3 and pKH5 carrying various promoter fragments as transcription fusions to 
lacZ were used to insert these fusions into the chromosome by gene gorging. Plasmid pKH5 
was also used to create pJB3, in which the lacI and lacZ homology regions are replaced by 
cloning sites and the translation initiation region fused to the emerald gfp gene in place of 
lacZ. Plasmid pJB15 was created from pJB3 with the lacI and lacZ homology regions cloned 
into the multiple cloning sites. The lac promoter region, from position -92 bp to +122 bp 
relative to the transcription start site, was also fused to emerald gfp. Plasmids pJB16 and 
pJB17 were created from pJB15 to target the lac28::egfp fusion to the ara and mel loci, 
however the gene gorging method was not very effective without red/white selection. 
Therefore plasmids pJB20 and pJB22 were created by cloning the donor fragments from 
pJB16 and pJB17 between the SceI recognition sites of the gene doctoring plasmid pDOC-C. 
Plasmids based on pJB22 carrying various homology regions to the E. coli chromosome were 
used to insert the lac28::gfp fusion at various chromosomal loci in single copy. Plasmid 
pCP20 was used in the removal of the kan gene from the chromosome. 
 46 
Table 2.1: E. coli strains used in this study (continued on pages 47-49) 
Strain Description
1
 Origin 
MG1655 E. coli K12 strain Blattner et al. (1997) 
RLG221 E. coli K-12 Δlac ΔrecA used for manipulating plasmids R. Gourse 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ 
proAB lacI
qZ∆ M15 Tn10 (TetR)] 
Stratagene 
KH000 MG1655 lacI
-
 Hollands (2009) 
KH001 Derivative of KH000 in which the lac promoter has been 
replaced with the cloning site from pKH3 
Hollands (2009) 
KH002 Derivative of KH001 carrying a chromosomal TB10a::lacZ 
translation fusion at the lac locus 
Hollands (2009) 
BRY01 Derivative of KH001 in which the lac promoter has been 
replaced with a phcp::lacZ transcription fusion 
This study 
BRY03 Derivative of KH001 in which the lac promoter has been 
replaced with a CC-41.5::lacZ transcription fusion 
This study 
BRY05 Derivative of KH001 in which the lac promoter has been 
replaced with a CC-61.5::lacZ transcription fusion 
This study 
BRY07 Derivative of MG1655 in which the lac promoter region is 
replaced by a kan gene and lac00::egfp fusion 
This study 
BRY08 Derivative of MG1655 in which the lac promoter region is 
replaced by a kan gene and lac28::egfp fusion. 
This study 
BRY09 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 72143 bp (ara locus) 
This study 
BRY11 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 4342915 bp (mel locus) 
This study 
BRY12 Derivative of BRY08, from which the kan gene has been 
removed. Position 365529 - 365652 bp (lac+O2 locus) 
This study 
BRY13 Derivative of BRY09, from which the kan gene has been 
removed. Position 72143 bp (ara locus) 
This study 
BRY15 Derivative of BRY11, from which the kan gene has been 
removed. Position 4342915 bp (mel locus) 
This study 
BRY17 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 72143 bp in the opposite orientation to that 
of BRY09. yabI<kan lac28::gfp>thiQ (Inverse ara locus) 
This study 
 
 47 
Table 2.1: E. coli strains used in this study (continued) 
Strain Description
1 
Origin 
BRY18 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 238142 bp (yafT locus) 
This study 
BRY19 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 313681 bp (eaeH locus) 
This study 
BRY21 Derivative of BRY17, from which the kan gene has been 
removed. Position 72143 bp (Inverse ara locus) 
This study 
BRY22 Derivative of BRY18, from which the kan gene has been 
removed. Position 238142 bp (yafT locus) 
This study 
BRY23 Derivative of BRY19, from which the kan gene has been 
removed. Position 313681 bp (eaeH locus) 
This study 
BRY26 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 2314948 bp (rcs locus) 
This study 
BRY27 Derivative of BRY26, from which the kan gene has been 
removed. Position 2314948 bp (rcs locus) 
This study 
BRY28 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 1005714 bp (ycb locus) 
This study 
BRY29 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 1606129 bp (tam locus) 
This study 
BRY30 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 3104995 bp (nupG locus) 
This study 
BRY31 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 3982359 bp (asl locus) 
This study 
BRY32 Derivative of BRY28, from which the kan gene has been 
removed. Position 1005714 bp (ycb locus) 
This study 
BRY33 Derivative of BRY29, from which the kan gene has been 
removed. Position 1606129 bp (tam locus) 
This study 
BRY34 Derivative of BRY30, from which the kan gene has been 
removed. Position 3104995 bp (nupG locus) 
This study 
BRY35 Derivative of BRY31, from which the kan gene has been 
removed. Position 3982359 bp (asl locus) 
This study 
BRY36 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 4342915 bp in the opposite orientation to 
that of BRY11. melB<gfp::lac28 kan>yjdF (Inverse mel 
locus) 
S. E. Russell 
(Unpublished) 
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Table 2.1: E. coli strains used in this study (continued) 
Strain Description
1
 Origin 
BRY37 Derivative of BRY36, from which the kan gene has been 
removed. Position 4342915 bp (Inverse mel locus) 
S. E. Russell 
(Unpublished) 
BRY38 Derivative of MG1655, in which the lac promoter and the 
start of the lacZ gene (including lacI O2) was replaced with a 
kan gene and lac28::egfp fusion (lac locus) 
This study 
BRY39 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 365131-365652 bp in the opposite 
orientation to that of BRY38.  
lacZ<kan lac28::gfp>lacI (Inverse lac locus) 
This study 
BRY40 Derivative of BRY38, from which the kan gene has been 
removed. Position 365131 - 365652 bp (lac - O
2
 locus) 
This study 
BRY41 Derivative of BRY39, from which the kan gene has been 
removed. Position 365131 - 365652 bp (Inverse lac locus) 
This study 
BRY44 Derivative of BRY27 in which the lac promoter has been 
replaced by the pKH3 cloning site by gene gorging (Lac
-
)  
This study 
BRY47 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 2987820 bp (yqe locus) 
This study 
BRY48 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 3132854 bp (pitB locus) 
This study 
BRY51 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 229046 bp (dkgB locus) 
This study 
BRY52 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 237530-239300 bp  
(ΔyafT locus) 
This study 
BRY53 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 312940-315678 bp  
(ΔeaeH locus) 
This study 
BRY54 Derivative of BRY47, from which the kan gene has been 
removed. Position 2987820 bp (yqe locus) 
This study 
BRY55 Derivative of BRY48, from which the kan gene has been 
removed. Position 3132854 bp (pitB locus) 
This study 
BRY58 Derivative of BRY51, from which the kan gene has been 
removed. Position 229046 bp (dkgB locus) 
This study 
BRY59 Derivative of BRY52, from which the kan gene has been 
removed. Position 237530 - 239300 bp (ΔyafT locus) 
This study 
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 Table 2.1: E. coli strains used in this study (continued) 
Strain Description
1
 Origin 
BRY60 Derivative of BRY53, from which the kan gene has been 
removed. Position 312940 - 315678 bp (ΔeaeH locus) 
This study 
BRY61 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 2984331 - 2995806 bp (Δyqe locus) 
This study 
BRY62 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 3131588 - 3133385 bp (ΔpitB locus) 
This study 
BRY66 Derivative of MG1655 carrying a kan gene and lac28::egfp 
fusion at position 2509358 bp (mntH locus) 
This study 
BRY68 Derivative of BRY61, from which the kan gene has been 
removed. Position 2984331 - 2995806 bp (Δyqe locus) 
This study 
BRY69 Derivative of BRY62, from which the kan gene has been 
removed. Position 3131588 - 3133385 bp (ΔpitB locus) 
This study 
BRY73 Derivative of BRY66, from which the kan gene has been 
removed. Position 2509358 bp (mntH locus) 
This study 
 
 
1 
Position refers to location of the insert in the E. coli genome in base pairs (bp) with respect 
to the coordinate-system origin, as described by www.EcoCyc.org (Keseler et al., 2011). 
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Table 2.2: Plasmids used in this study (continued on pages 51-54) 
Plasmid Description
1
 Origin 
pRW50 Low copy number, broad host range lac 
expression vector used for cloning EcoRI-HindIII 
promoter fragments as fusions to lacZYA (Tet
R
) 
(Figure 2.1) 
Lodge et al. (1992) 
pRW50/phcp3831NS pRW50 derivative carrying an EcoRI-HindIII hcp 
regulatory region fragment, from –125 bp to 
+42 bp, in which the NsrR binding site has been 
knocked out.
 
Chismon (2011) 
pRW500 pRW50 derivative in which the EcoRI-SacI 
fragment has been replaced with the cloning site 
and lacZ EcoRI-SacI fragment from pKH3. (Tet
R
) 
(Figure 2.2) 
This study 
pRW500/phcp3831NS pRW500 derivative carrying an EcoRI-BamHI 
hcp regulatory region fragment from -125 bp to 
+11 bp as a transcription fusion to lacZ. 
This study 
pRW500/CC-41.5 pRW500 derivative carrying the CC-41.5 
promoter from -76 bp to +1 bp cloned as a 
transcription fusion to lacZ 
This study 
pRW500/CC-61.5 pRW500 derivative carrying the CC-61.5 
promoter from -96 bp to +1 bp cloned as a 
transcription fusion to lacZ 
This study 
pRW500/TB10a pRW500 derivative carrying the melR promoter 
from-100 to +52 cloned as a translation fusion to 
lacZ 
This study 
pRW500/plac pRW500 derivative carrying the lac promoter on 
a EcoRI-SacI fragment naturally fused to lacZ 
from -92 to the natural SacI site in lacZ 
This study 
pACBSR Mutagenesis plasmid for use in gene gorging 
(Cm
R
) (Figure 2.3) 
Scarab Genomics 
pCP20 Temperature sensitive plasmid encoding FLP 
recombinase (Amp
R 
Cm
R
) (Figure 2.4) 
Cherepanov and 
Wackernagel (1995)  
pKH3 Derivative of pBR322. Donor plasmid for 
construction of chromosomal promoter::lac 
fusions by gene gorging (Amp
R
) (Figure 2.5) 
Hollands (2009) 
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Table 2.2: Plasmids used in this study (continued) 
Plasmid Description
1
 Origin 
pKH5 Derivative of pKH3 containing a kan gene upstream 
of the promoter cloning site. Donor plasmid for 
construction of chromosomal promoter::lac fusions 
by gene gorging (Amp
R
) (Figure 2.5) 
Hollands (2009) 
pDEX-G Gene doctoring plasmid, which allows homology 
regions to be cloned either side of gfp with flanking 
SceI sites. 
(Lee et al., 2009) 
pDOC-C Gene doctoring plasmid used as a source of the 
pEX100T backbone for pJB gene doctoring plasmids 
(Amp
R
sacB) 
(Lee et al., 2009) 
pJB3 Derivative of pKH5 in which the lac homology 
regions are replaced with cloning sites and the 
translation initiation region fused to gfp. 
This study 
pJB4 Derivative of pJB3 in which a lac00 promoter 
fragment is cloned into the EcoRI-HindIII sites. 
This study 
pJB6 Derivative of pJB4 in which homology regions for 
the lacI and lacZ genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively 
This study 
pJB15 Derivative of pJB6 in which the lac00 promoter 
fragment is replaced by the lac28 promoter fragment. 
Used to create the BRY08 strain 
This study 
pJB16 Derivative of pJB15 in which the homology regions 
for the thiQ and yabI genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively 
This study 
pJB18 Derivative of pJB15 in which the homology regions 
for the melB and yjdF genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively 
This study 
pJB20 Derivative of pDOC-C, in which the donor fragment 
from pJB16 has been cloned between the I-SceI 
recognition sites. Used to create the BRY09 strain 
(Figure 2.6) 
This study 
pJB22 Derivative of pDOC-C, in which the donor fragment 
from pJB18 has been cloned between the I-SceI 
recognition sites. Used to create the BRY11 strain 
This study 
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Table 2.2: Plasmids used in this study (continued) 
Plasmid Description
1
 Origin 
pJB27 Derivative of pJB22, in which the homology regions 
for the lacZ and lacI genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY16 strain 
This study 
pJB28 Derivative of pJB22, in which the homology regions 
for the yabI and thiQ genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY17 strain 
This study 
pJB29 Derivative of pJB22 in which the homology regions 
for the yafT and ykfM genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY18 strain 
This study 
pJB30 Derivative of pJB22 in which the homology regions 
for the eaeH pseudogene are cloned into the 
MfeI-XmaI and NheI-SacI sites. Used to create the 
BRY23 strain 
This study 
pJB32 Derivative of pJB22 in which the homology regions 
for the rcsB and rcsC genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY26 strain 
This study 
pJB37 Derivative of pJB22 in which the homology regions 
for the ycbW and ycbX genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY28 strain 
This study 
pJB38 Derivative of pJB22 in which the homology regions 
for the tam and yneE genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY29 strain 
This study 
pJB39 Derivative of pJB22 in which the homology regions 
for the nupG and speC genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY30 strain 
This study 
pJB40 Derivative of pJB22 in which the homology regions 
for the aslB and aslB genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY31 strain 
This study 
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Table 2.2: Plasmids used in this study (continued) 
Plasmid Description
1
 Origin 
pJB42 
 
Derivative of pJB22 in which the homology regions 
for the lacI and lacZ -02 genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY38 strain 
This study 
pJB43 Derivative of pJB22 in which the homology regions 
for the lacZ -02 and lacI genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY39 strain 
This study 
pJB45 Derivative of pJB22 in which the homology regions 
for the yjdF and melB genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY36 strain 
S. E. Russell 
(Unpublished) 
pJB53 Derivative of pJB22 in which the homology regions 
for the yqeJ and yqeL genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY47 strain 
This study 
pJB54 Derivative of pJB22 in which the homology regions 
for the yghT and pitB genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY48 strain 
This study 
pJB57 Derivative of pJB22 in which the homology regions 
for the aspU and dkgB genes are cloned into the 
MfeI-XmaI and NheI-SacI sites respectively. Used to 
create the BRY51 strain 
This study 
pJB58 Derivative of pJB22 in which the homology regions 
for the ΔyafT strain are cloned into the MfeI-XmaI 
and NheI-SacI sites. Used to create the BRY52 strain 
This study 
pJB59 Derivative of pJB22 in which the homology regions 
for the ΔeaeH strain are cloned into the MfeI-XmaI 
and NheI-SacI sites. Used to create the BRY53 strain 
This study 
pJB66 Derivative of pJB22 in which the homology regions 
for the Δyqe strain are cloned into the MfeI-XmaI and 
NheI-SacI sites. Used to create the BRY61 strain 
This study 
pJB67 Derivative of pJB22 in which the homology regions 
for the ΔpitB strain are cloned into the MfeI-XmaI 
and NheI-SacI sites. Used to create the BRY62 strain 
This study 
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Table 2.2: Plasmids used in this study (continued) 
Plasmid Description
1
 Origin 
pSB3 Derivative of pJB22 in which the homology regions 
for the mntH strain are cloned into the MfeI-XmaI 
and NheI-SacI sites. Used to create the BRY73 strain 
S. Bevan 
(unpublished) 
 
1 
- and + numbers refer to the size of the promoter fragment in base pairs (bp) with respect to 
the transcription start site. 
 55 
EcoRI HindIII
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Figure 2.1: Map of the lac expression vector pRW50 
The pUC9 linker (shaded grey) allows EcoRI-HindIII promoter fragments to be cloned as 
translation fusions to the trpBA fragment (white) and lacZYA operon. Therefore the promoter 
of interest drives expression of the lac genes (grey). The tetracycline resistance gene (tet
R
), 
plasmid replication genes trfA and trfB and the origin of replication (oriV) are also indicated. 
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Figure 2.2: Map of the lac expression vector pRW500 
pRW500 carries the pKH3 cloning region fused directly to the lacZYA operon. The plasmid is 
a derivative of pRW50 (Lodge et al., 1992) in which the trpBA fragment has been removed by 
replacement of the EcoRI-SacI fragment with that encoded by the chromosome of the KH001 
strain (Hollands, 2009). Promoter fragments are cloned into the pKH3 cloning region as 
transcription (EcoRI-BamHI) or translation (EcoRI-HindIII) fusions to the lacZYA operon 
(grey), therefore allowing the promoter of interest to drive expression of the lac genes. The 
tetracycline resistance gene (tet
R
), plasmid replication genes trfA and trfB and the origin of 
replication (oriV) are also indicated. 
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Figure 2.3: Map of the mutagenesis plasmid pACBSR 
pACBSR is used as a mutagenesis plasmid in gene gorging and gene doctoring. Genes 
encoding the Saccharomyces cerevisiae I-SceI endonuclease and λ-Red recombination 
proteins (grey) are under transcriptional control of the arabinose inducible araBAD 
(paraBAD) promoter. The λ-Red system consists of three genes: exo, bet and gam, however 
for simplicity the boundaries are not shown. The araC gene, which encodes a regulator of the 
araBAD promoter, chloramphenicol resistance gene (Cm
R
) and origin of replication (ori) are 
also indicated. 
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Figure 2.4: Map of pCP20 
pCP20 is used to express FLP recombinase to allow recombination of FRT sites to remove 
chromosome-encoded kanamycin resistance cassette. The flp recombinase (grey) is under 
control of the λpR promoter, which is regulated by the phage λ temperature-sensitive 
repressor c1857. Replication of the plasmid is dependent on the temperature-sensitive origin 
repA101ts. Chloramphenicol (Cm
R
) and ampicillin (amp
R
) resistance genes are also indicated. 
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Figure 2.5: Map of the pKH3 and pKH5 gene gorging donor plasmids 
pKH3 is a gene gorging donor plasmid carrying a promoter cloning site flanked by homology 
regions the 3’ end of lacI (grey) and the 5’ end of lacZ (black dotted), which are flanked by 
18 bp DNA recognition sites for the Saccharomyces cerevisiae I-SceI endonuclease. Promoter 
fragments are cloned as transcription (EcoRI-BamHI) or translation (EcoRI-HindIII) fusions 
to the lacZ 5’ homology region, the former of which utilises the lacZ translation initiation 
region (lacZ TIR). The λ oop terminator is indicated by a stem-loop structure and is positioned 
upstream of the promoter cloning site to prevent transcriptional read-through. pKH5 is a 
derivative of pKH3 in which a kanamycin resistance gene (kan
R
) has been inserted at the XbaI 
restriction site. The kan
R
 gene is flanked by FRT (flippase recognition target) sites, which 
allow removal of the kanamycin resistance cassette after transfer of the promoter::lacZ fusion 
to the chromosome. Stop codons are also included in all three reading frames to prevent 
translational read-through (X). The ampicillin resistance gene (amp
R
), origin of replication 
(colE1 ori) and plasmid replication gene, rop, are also shown. 
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Figure 2.6: Map of pJB gene doctoring donor plasmid 
The pJB series of gene doctoring plasmids are derivatives of the pDOC-C gene doctoring 
plasmid (Lee et al., 2009) and are used to insert the lac28::egfp fusion at any desired position 
of the E. coli chromosome. Approximately 500 bp regions of homology, flanking the desired 
position of insertion on the chromosome, are cloned into the multiple cloning sites which 
flank the lac28::egfp fusion. The FRT flanked kanamycin resistance cassette (kan
R
) and λ oop 
transcription terminator (Stem-loop) of pKH5 (Hollands, 2009) are included upstream of the 
fusion to allow selection of recombinants and prevention of transcriptional read-through from 
neighboring operons. The plasmid carries the sacB sucrose sensitivity gene (sacB) allowing 
selection against retention of the donor plasmid. The ampicillin resistance gene (amp
R
) and 
origins of replication (colE1 ori, oriT) are also shown. 
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Figure 2.7 Sequence of the pJB plasmid I-SceI donor molecule 
Figure on page 62. The base sequence of the pJB plasmid I-SceI donor molecule. The I-SceI 
DNA target recognition sites are double underlined and labelled. Restriction endonuclease 
target sites are boxed and labelled. The FLP recognition targets (FRT) DNA site are shaded 
grey and labelled. ATG start codon and open reading frames are in capitals with the start and 
stop codons in bold and underlined. The kanamycin resistance (kan
R
) and egfp genes are in 
capitals and labelled. The lacZ start codon and the lacZ gene are shown in bold capitals with 
the Shine-Dalgarno sequence underlined. The promoter -10, -35 are underlined, with the 
transcription start site (+1) bold and underlined. The lacI operator sequences are boxed and 
labelled and the DNA site for CRP is double underlined. Additional stop codons in different 
reading frames were included and are denoted by an X and underlining. 
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 I-SceI     MfeI  XmaI   KpnI   AgeI 
tagggataacagggtaatcaattgtatgccccgggttgtaggtaccaactaccggtggctgg 
        FRT 
Agctgcttcgaagttcctatactttctagagaataggaacttcggaataggaacttcaagatc
ccctcacgctgccgcaagcactcagggcgcaagggctgctaaaggaagcggaacacgtagaac
ttaagggaattgccagctggggcgccctctggtaaggttgggaagccctgcaaagtaaactgg
atggctttcttgccgccaaggatctgatggcgcaggggatcaagatctgatcaagagacagga 
   kan
R
 
tgaggatcgtttcgcATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTG
GAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTC
CGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAAT
GAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCT
GTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAG
GATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGG
CGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAG
CGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAG
GGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTC
GTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGA
TTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGT
GATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCC
GCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAgcgggactc
tggggttcgaaatgaccgaccaagcgacgcccaacctgccatcacgagatttcgattccaccg
ccgccttctatgaaaggttgggcttcggaatcgttttccgggacgccggctggatgatcctcc
agcgcggggatctcatgctggagttctcgcccaccccagcttcaaaagcgctctgaagttcct 
  FRT        X    X  X 
atactttctagagaataggaacttcggaataggaactaaggtaagctagactaagtaattcag 
   λ-oop terminator        EcoRI  LacI O3 
aacgctcggttgccgccgggcgttttttattagatctctcgaggaattcggcagtgagcgca 
   CRP         -35 
acgcaattaatgtgagttagctcactcattaggcaccccaggctttacactttatgcttccgg 
 -10  +1  LacI O1       SD  lacZ 
ctcgtatgttgtgtggAattgtgagcggataacaatttcacacaggaaacagctATGACCATG 
ATTACGGATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAA 
   HindIII egfp 
CTTAATCGCCTTaagcttAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTC
GAGCTGGACGGCGACGTAAACGGCcACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCC
ACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCC
ACCCTCGTGACCACCTTGACCTACGGCGTGCAGTGCTTCGCCCGCTACCCCGACCACATGAAG
CAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTC
AAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAAC
CGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAG
TACAACTACAACAGCCACAAGGTCTATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGTG
AACTTCAAGACCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAG
AACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCC
GCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCC 
         X X    
GCCGGGATCACTCTCGGCATGGACGAGCTTTACAAGTAAgtaactaacgaatgtacagccata 
SpeI   NheI    SacI  I-SceI 
actagtacttgctagcgcacaagagctctagggataacagggtaat 
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2.4 Gel electrophoresis 
2.4.1 Agarose gel electrophoresis of DNA 
DNA fragments greater than 500 bp in length were analysed using agarose gel 
electrophoresis. 0.8-1.2% solutions of agarose in 1 x TAE buffer (40 mM Tris acetate, 2 mM 
Na2EDTA) (National Diagnostics) were heated to 100°C for 2 min in a microwave to dissolve 
the agarose. Agarose solutions were then were cooled to approximately 50°C and poured onto 
a gel casting plate. DNA samples were mixed in a 1:1 ratio with DNA loading dye (0.025% 
bromophenol blue; 0.025% xylene cyanol F; 20% glycerol; 10 mM Tris, pH 7.5; 1 mM 
EDTA) before being loaded into the wells. The DNA markers used were the 100 bp and 1 kb 
DNA ladders (New England BioLabs), which were diluted 6-fold in DNA loading dye, 
supplied by the manufacturer. Samples were subjected to electrophoresis in 1 x TAE buffer at 
3-5 V/cm for 30 – 45 min. Gels were stained in a solution of 0.5 µg/ml ethidium bromide 
(BioRad) for 15 min, viewed and photographed under 300 nm ultraviolet light using a gel 
documentation system (Bio-Rad). However, to reduce damage to DNA fragments to be 
purified by extraction, gels were stained with SYBRSAFE (Invitrogen) and visualised using a 
blue light box. 
 
2.4.2 Chloroquine agarose gel electrophoresis of DNA 
Chloroquine agarose gel electrophoresis was used to monitor the superhelicity of the reporter 
plasmid pBR322. 300 ml of 1% agarose solution containing 2 x TBE (178 mM Tris borate pH 
8.3, 4 mM Na2EDTA) (National Diagnostics) was heated to 100°C in a microwave to dissolve 
agarose. The solution was allowed to cool to approximately 50°C then supplemented with 2.5 
μg/ml chloroquine. The solution was poured into a large gel casting tank to give a gel that was 
approximately 1.5 cm thick with wells of ~20 μl capacity. Plasmid DNA samples (1 μg of 
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DNA in 20 μl final volume) were mixed in a 1:1 ratio with 6 x DNA loading dye (New 
England BioLabs) and loaded into the wells. The samples were subjected to electrophoresis in 
2 x TBE at 3 V/cm for 24 h. After electrophoresis, gels were washed repeatedly with 
deionised water for approximately 2 h before being stained with 1 μg/ml ethidium bromide 
(BioRad) for approximately 30 min. Gels were briefly washed again with water then viewed 
and photographed under ultraviolet light of 300 nm using a gel documentation system 
(Bio-Rad). The intensity of each lane was plotted against distance travelled (relative front) to 
measure migration and resolution of different plasmid topoisomers. 
 
2.4.3 Polyacrylamide gel electrophoresis of DNA 
DNA fragments smaller than 1 kb were analysed by polyacrylamide gel electrophoresis. 
Polyacrylamide gels contained 7.5% (w/v) stock acrylamide (ProtGel) (National Diagnostics), 
4% glycerol and 1 x TBE. Gels were polymerised by the addition of 0.01 volumes of 10% 
(w/v) ammonium persulphate and 0.001 volumes TEMED 
(N,N,N′,N′-tetramethylethylenediamine). Samples were mixed in a 1:1 ratio with DNA 
loading dye before being loaded into the sample wells. The DNA markers used were the 
100 bp and 1 kb DNA ladders (New England BioLabs), which were diluted 6-fold in DNA 
loading dye, supplied by the manufacturer. Samples were subjected to electrophoresis in 
1 x TBE at 30-40 mA for 30 min to 4 hours, then stained in ethidium bromide solution and 
visualised under UV light as described in section 2.5.1. 
 
2.5 Extraction and purification of nucleic acids 
2.5.1 Phenol/chloroform extraction of DNA 
Contaminating proteins were removed from DNA solutions by phenol/chloroform extraction. 
DNA solutions were mixed with an equal volume of phenol/chloroform/isoamylalcohol 
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solution (composition 25/24/1 v/v, pH 8.0) (Fisher Scientific), mixed by vortex for 15 s and 
the aqueous and organic phases separated by centrifugation for 3 min at ~18000 x g. The 
aqueous layer, which contained the DNA, was transferred to a fresh tube. The remaining 
organic phase was then mixed with an equal volume of TE buffer (10 mM Tris pH 8.0, 
0.5 mM EDTA) by vortex and centrifuged for 3 min at ~18000 x g. The DNA-containing 
aqueous layer was combined with that removed previously and concentrated by ethanol 
precipitation. 
 
2.5.2 Ethanol precipitation of DNA 
DNA solutions were concentrated by ethanol precipitation. 0.1 volumes of 3 M sodium 
acetate (pH 5.2) and 2.5-3 volumes of ice-cold 100% ethanol were added to the DNA 
solution. 1 µl 20 mg/ml
 
glycogen was also added to solutions containing DNA fragments 
smaller than 500 bp. Samples were incubated at –20°C for 30 min, then centrifuged for 
15 min at 4°C at ~18000 x g. After removal of the supernatant, the pellet was washed with 
1 ml ice-cold 70% ethanol and centrifuged for 10 min at 4°C at ~18000 x g. The supernatant 
was removed again and the pellet dried for 10-15 minutes under vacuum. The dry pellet was 
resuspended in the desired buffer, as indicated. 
 
2.5.3 Purification of DNA using QIAquick PCR Purification kit  
DNA was purified after PCR or restriction digestion using the QIAquick PCR Purification Kit 
(Qiagen), as described by the manufacturer. Purified DNA was eluted from QIAquick 
columns in 50 µl sterile distilled water. 
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2.5.4 Extraction of DNA fragments from agarose gels 
DNA samples were subjected to electrophoresis in 0.8-1.2% agarose gels as described in 
section 2.4.1. DNA bands were excised from the gel and eluted using the QIAquick Gel 
Extraction Kit (Qiagen) as described by the manufactuer. DNA fragments were eluted from 
QIAquick columns in 50 µl sterile distilled water. 
 
2.5.5 Electroelution of DNA fragments from polyacrylamide gels 
Small DNA fragments (<1 kb) were purified by the process of electroelution (Maniatis et al., 
1982) after PCR or restriction digestion. DNA samples were subjected to electrophoresis 
using a 7.5% polyacrylamide gel as described in section 2.4.3. DNA bands were excised from 
the gel and placed into 6.3 mm dialysis tubing (Medicell International Ltd.), filled with 
0.1 x TBE buffer and sealed. Elution of DNA was achieved by passing a current of 30 mA 
through the gel for 20-30 mins. The DNA-containing buffer was then removed from the 
dialysis bag and transferred to a microcentrifuge tube. DNA was extracted from the buffer by 
phenol/chloroform extraction and ethanol precipitation as described in sections 2.5.1 and 
2.5.2. 
 
2.5.6 Small-scale preparation of plasmid DNA (“mini-prep”) 
An overnight culture of the strain carrying the plasmid to be extracted was grown in 5 ml LB 
medium supplemented with the appropriate antibiotic. Plasmid DNA was extracted from 
overnight culture using the QIAprep Spin Miniprep kit (Qiagen), as described by the 
manufacturer. Plasmid DNA was eluted from the QIAprep column in 50 µl (high copy 
number plasmids) or 25 µl (low copy number plasmids) sterile distilled water. 
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2.5.7 Purification of genomic DNA 
To extract genomic DNA, an overnight culture of the appropriate E. coli strain was grown in 
5 ml M9 minimal salts medium, supplemented with 0.3% fructose. 10 ml M9 minimal 
medium (plus fructose) was inoculated with 200 µl overnight culture, and the culture grown 
under appropriate culture conditions to an OD650 of 0.4-0.5. Cells were pelleted from 5 ml 
aliquots of culture by centrifugation for 20 min at ~2700 x g, 4°C. Cell pellets were stored at 
–80°C. Genomic DNA was then extracted from bacteria using the illustra bacteria 
genomicPrep Mini Spin Kit (GE Healthcare), as described in the manufacturer’s protocol, 
eluted in 200 μl of elution buffer and stored at -20°C. An aliquot was digested with HindIII to 
check the purity of the sample and the DNA concentration determined using a NanoDrop 
ND-1000 spectrophotometer (Thermo Scientific). 
 
2.5.8 Preparation of total cellular RNA  
Total cellular RNA was extracted for use in qRT-PCR using the QIAGEN RNeasy mini kit. 
Solutions for use in work with RNA were treated with diethyl pyrocarbonate (DEPC) to 
inhibit RNase activity. DEPC was added to solutions to a final concentration of 0.1%, and left 
overnight in a fume hood to allow the DEPC to evaporate before autoclaving. An overnight 
culture of the appropriate strain was grown in 5 ml M9 minimal salts medium, supplemented 
with 0.3% fructose, which were prepared as previously described. 10 ml M9 minimal medium 
(plus fructose) was inoculated with 200 µl overnight culture, and the culture grown under 
appropriate culture conditions to an OD650 of 0.4-0.5. Three 2.5 ml aliquots of culture were 
each mixed with 5 ml RNAlater (Ambion) to stabilise RNA, incubated at room temperature 
for 5 min, and the cells pelleted by centrifugation for 20 min at ~2700 x g, 4°C. Cell pellets 
were stored at –80°C. The RNA purification was completed using the Qiagen RNeasy Mini 
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Kit as described by the manufacturer. RNA was eluted from each column in 30 µl RNase-free 
water, and the two eluates for each sample were combined. To remove any DNA 
contamination the Qiagen RNase-Free DNase Set was used for on-column DNase digestion 
during the RNA purification, as described by the manufacturer. RNA concentrations and 
A260/A280 were determined using a NanoDrop ND-1000 spectrophotometer (Thermo 
Scientific) and an aliquot analysed by agarose gel electrophoresis to check the integrity of the 
RNA. RNA samples were stored at -80°C. 
 
2.6 Bacterial transformations 
2.6.1 Preparation of competent cells using the calcium chloride method 
1 ml of an overnight culture of the strain to be transformed was used to inoculate 50 ml LB 
medium, which was incubated at 37°C with aeration until mid-exponential phase (OD650 
0.3-0.5). The culture was then incubated for 10 min on ice after which the cells were 
harvested by centrifugation for 5 min at ~3400 x g at 4°C. The cell pellet was resuspended in 
25 ml ice-cold calcium chloride (100 mM CaCl2, 10 mM Tris-HCl, pH 7.5), incubated for 10 
min on ice after which the cells harvested by centrifugation for 5 min at ~3400 x g at 4°C. 
The cells were resuspended in 3 ml ice-cold buffer freeze-thaw buffer (100 mM CaCl2, 10 
mM Tris-HCl, pH 7.5, 15% glycerol) and the cells kept on ice for 24 h before use. Competent 
cells were stored as 200 µl aliquots at –80°C. 
 
2.6.2 Preparation of competent cells using the rubidium chloride method 
The rubidium chloride method was used to maximize the transformation efficiency of 
competent cells, needed for difficult cloning procedures or double transformations. The 
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desired strain was grown as described in section 2.6.1. and the culture incubated on ice for 10 
mins before harvest of the cells by centrifugation for 5 min at ~3400 x g at 4°C. The 
supernatant was discarded and the cell pellet resuspended in 1/2.5 volume of ice-cold TFB1 
buffer (30 mM potassium acetate, 10 mM CaCl2, 50 mM MnCl2, 100 mM RbCl, 15% 
glycerol, pH 5.8 with 1 M acetic acid). Cells were incubated on ice for 10 min and centrifuged 
at ~3400 x g for 5 min at 4°C. Cells were resuspended in 1/25 volume ice-cold TFB2 buffer  
(10 mM PIPES, pH 6.5, 75 mM CaCl2, 10 mM RbCl, 15% glycerol, pH 6.5 with 1 M KOH) 
and incubated on ice for 1 h. Cells were stored as 200 μl aliquots in sterile microfuge tubes at 
-80°C. 
 
2.6.3 Transformation of competent cells with plasmid DNA 
The desired strain was made competent by the previously described procedures after which 
50-100 μl competent cells were mixed with 100 ng plasmid DNA on ice, and incubated on ice 
for 45-60 min. Cells were heat-shocked at 42°C for 90 s and returned to ice for 2 min. 1 ml 
37°C SOC medium was added to the cells, which were incubated for 30-60 minutes at 37°C 
with aeration. Cells were harvested by centrifugation at ~18000 x g, and then resuspended in 
approximately 100 μl of the supernatant. Cells were spread onto nutrient agar or MacConkey 
agar supplemented with required antibiotic(s), and incubated overnight at 37°C. 
 
2.7 Recombinant DNA techniques 
2.7.1 Routine PCR 
Polymerase chain reaction (PCR) was carried out using Finnzymes Phusion™ High-Fidelity 
DNA polymerase (New England BioLabs) or Biotaq polymerase (Bioline) in the buffer 
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supplied with the relevant enzyme. Reaction conditions for different enzymes were adjusted 
according to manufacturer’s instructions. Phusion polymerase was used for PCR throughout 
the study whilst Biotaq polymerase was used mainly for colony PCR and difficult PCR. 
dNTPs (Bioline) were used at a final concentration of 1 mM (0.25 mM each) and the 
appropriate oligonucleotide primers were used at a final concentration of 1 µM each. PCR 
reaction mixes were made up to 50 µl in sterile distilled water and the relevant buffer, 
supplied by the manufacturer. DNA amplification was performed in an oil-free thermal cycler 
(GeneAmp® PCR System, Applied Biosystems) and cycling conditions are shown in table 
2.3. 
 
2.7.2 Colony PCR 
Colony PCR was used to amplify homology regions and promoter fragments from the 
chromosome and to screen for the presence of chromosomal insertions/deletions. 100 µl 
sterile distilled water was inoculated with one single fresh colony and heated to 100°C for 10 
min. Cell debris was harvested by centrifugation for 1 min at ~18000 × g. 10 µl of the 
genomic DNA-containing supernatant was used in a 50 µl Biotaq polymerase PCR as 
described in section 2.7.1. 
 
2.7.3 Site directed mutagenic PCR 
Site directed mutagenic PCR was used to introduce point mutations in a DNA sequence of 
interest. To do this, the desired base change was incorporated into an oligonucleotide primer, 
which was used to amplify the DNA fragment carrying desired mutations. To create point 
mutations in the BsrGI site encoded by the pJB2 plasmid, primers were designed to contain 
the desired mutation in the middle of the primer (~10-15 bp of correct sequence either side) 
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Table 2.3: Standard PCR cycle 
An annealing temperature (TA°C) of 3-5°C below the melting temperature of the primers was 
used. The extension time (X min) was calculated based on PCR product length and rate of 
extension of the polymerase used (according to the manufacturer’s instructions). 
 
 
Temperature Time Purpose 
94°C 5 min “hot start” 
94°C 30 s Melting 
TA°C 30 s               30-35 cycles Annealing  
72°C X min  Extension 
72°C 5 min Final extension 
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and anneal to the same sequence on opposite strands of the plasmid. These primers were used 
in routine PCR using Phusion polymerase with annealing temperature of 55°C for 1 minute 
and extension time of 5 minutes, to allow the entire plasmid to be amplified, with 12 cycles of 
the reaction. Template plasmid DNA was digested with the methylation-sensitive restriction 
endonuclease DpnI, which cleaves only when the target site is methylated, for 1 h at 37°C. 
The ΔrecA E. coli XL-1 Blue strain was then transformed with the PCR product by the 
rubidium chloride method, described in section 2.6.2, to allow recovery and amplification of 
plasmid DNA carrying the desired mutation. Several candidates were screened for the desired 
mutation using primer D55668 (Table 2.4). 
 
2.7.4 Restriction digestion of DNA 
Purified PCR product or plasmid miniprep DNA solutions were digested by the addition of 40 
units restriction enzyme (New England BioLabs) to 50 μl purified DNA solution in a final 
volume of 60 μl of the appropriate reaction buffer, supplied by the manufacturer. Reactions 
were incubated for 3 h at 37°C. Digested plasmid DNA for use in cloning was treated with 20 
units calf alkaline phosphatase (CIP) (New England BioLabs) for a further 1 h to remove 
terminal 5’ phosphate groups, in order to prevent religation of vector DNA. Digested and CIP 
treated DNA was purified as previously described in section 2.5.  
 
2.7.5 DNA ligations  
The concentration of DNA fragments to be ligated was estimated by agarose gel 
electrophoresis and comparison with molecular weight markers, such as the 100 bp and 1 kb 
DNA ladders (New England BioLabs). The optimum molar ratio of vector:insert for ligation
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Table 2.4: Oligonucleotides used for sequencing of inserts 
Name Sequence (5’ – 3’)  Use  
D54890 TGAAGGGCAATCAGCTGTTG Anneals to 3’ end of lacI gene, upstream of 
cloning site in pKH3. Used for sequencing 
inserts in pKH3. 
D55668 GAGCGGCGACGATAGTCATG Anneals downstream of SalI site in pBR322. 
Used for sequencing inserts in pBR322 during 
construction of pKH3 and pJB plasmids. 
D10520 CCCTGCGGTGCCCCTCAAG Anneals upstream of EcoRI site in pRW50. 
Used for sequencing and amplification of 
inserts in this vector. 
D56613 CTTGATGTCTCTGACCAGAC Anneals within the lacI sequence outside of 
the pKH3 homology. Used for screening gene 
gorging candidates by PCR amplification. 
D56614 TTATGCAGCAACGAGACGTC Anneals within the lacZ sequence outside of 
the pKH3 homology. Used for screening gene 
gorging candidates by PCR amplification. 
D68556 TTTACGTCGCCGTCCAG Anneals downstream of the start codon of gfp. 
Used for sequencing promoter inserts in pJB 
plasmid derivatives and BRY strains. 
D58793 GGATGTGCTGCAAGG Sequencing primer to check homology regions 
inserted between NheI and SacI. Binds 
downstream of I-sceI site 
D58794 TATGCTTCCGGCTCG 
 
Sequencing primer to check homology regions 
inserted between MfeI and XmaI. Binds 
downstream of I-sceI site 
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was found to be between 1:1 and 1:3, therefore these ratios were used routinely throughout 
the study, however individual reactions occasionally required further optimisation. Restriction 
digested and alkaline phosphatase treated vector DNA was mixed with restriction digested 
insert DNA and 1 μl T4 DNA ligase (New England BioLabs) in a final reaction volume of 
20 μl T4 DNA ligase buffer, which was supplied by the manufacturer. Reactions were 
incubated for 20 min at room temperature or 16 h at 4˚C. The rubidium chloride method of 
transformation, described in sections 2.6.2 and 2.6.3, was used to transform 50 μl RLG221 
rubidium chloride competent cells with 10 μl of each ligation reaction. Candidate recombinant 
plasmids were screened by colony PCR, described in section 2.7.2, using oligonucleotide 
primers flanking the insertion site, therefore detecting a change in size by gel electrophoresis. 
Successful candidates were further screened for the presence of the correct insert by 
sequencing using oligonucleotide primers flanking the insertion site, as described in section 
2.7.6. 
 
2.7.6 DNA sequencing 
Sequencing of plasmid and PCR products was completed by the Functional Genomics and 
Proteomics Laboratory, University of Birmingham, UK. Plasmid templates were prepared by 
“mini-prep”, as described in section 2.5.6, after which ~100 ng of plasmid miniprep was 
mixed with 1 µM sequencing primer in a final volume of 10 µl. PCR product were purified as 
described in section 2.5.3, after which 1-100 ng (dependent on fragment size) purified PCR 
product was mixed with 1 µM sequencing primer in a final volume of 10 µl. Oligonucleotides 
used for sequencing inserts in plasmids are listed in Table 2.4. 
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2.8 Gene doctoring 
2.8.1 Gene doctoring method 
A general protocol for insertion of a DNA donor fragment into the E. coli chromosome by 
gene doctoring is described here with slight modifications from the original protocol (Lee et 
al., 2009). This method requires the use of a plasmid which carries kanamycin resistance in 
the donor fragment, with ampicillin resistance and the sucrose sensitivity gene carried by the 
rest of the plasmid. Details of target site selection and donor plasmid construction can be 
found in section 2.9. The strain to be modified by gene doctoring was co-transformed with the 
mutagenesis plasmid, pACBSR (Cm
R
; Figure 2.3), and the donor plasmid (Kan
R
, Amp
R
, sacB; 
Figure 2.6), and co-transformants were selected on nutrient agar supplemented with 
chloramphenicol and ampicillin. Maintenance of a functional sacB gene on the donor plasmid 
was tested by restreaking single co-transformant colonies onto agar supplemented with 
kanamycin and 5% sucrose and then agar supplemented with kanamycin and 
chloramphenicol. A single sucrose sensitive co-transformant colony was suspended in 500 μl 
LB medium, supplemented with ampicillin and chloramphenicol, and incubated at 37˚C with 
aeration for ~3 h until the culture was turbid. Cells were harvested by centrifugation at 
~18000 x g, and then washed in 0.1 x LB by resuspension. This process was repeated twice to 
remove any residual antibiotics, as no selection is required during induction of the 
mutagenesis machinery. Cells were then suspended in 500 μl 0.1 x LB supplemented with 
0.3% L-arabinose to induce expression of the I-SceI endonuclease and λ-red homologous 
recombination proteins, which are encoded by the mutagenesis plasmid pACBSR. 0.1 x LB 
medium was used as no further growth was required during the mutagenesis procedure. The 
culture was incubated at 37˚C with aeration for a further ~3 h, after which 125 μl of the 
culture was spread onto each of 4 nutrient agar plates supplemented with kanamycin and 5% 
sucrose. Efficiency of donor plasmid linearisation was tested by spreading 100 μl of a 1/1000 
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dilution of the culture, taken before and after addition of arabinose to the culture medium, on 
nutrient agar and nutrient agar supplemented with ampicillin. Cells in which the donor 
plasmid has been linearised will not be able to grow in the presence of ampicillin, therefore 
comparison of the number of ampicillin resistant colonies pre- and post-induction 
demonstrates the efficiency of donor plasmid linearisation. All plates were incubated at room 
temperature until visible colonies were detected. 
 
2.8.2 Screening of gene doctoring candidates 
Kanamycin resistant, sucrose insensitive colonies were restreaked onto nutrient agar 
supplemented with ampicillin and nutrient agar supplemented with kanamycin and 5% 
sucrose to check for loss of the donor plasmid. Ampicillin sensitive candidates were screened 
for the presence of the chromosomal insert by colony PCR, as described in section 2.7.2, 
using oligonucleotide primers designed to bind to regions of the chromosome flanking the 
regions of homology used for recombination. PCR products demonstrating the presence of the 
insert were further screened by DNA sequencing, as described in section 2.7.6, after which 
the candidates were screened for chloramphenicol sensitivity to confirm loss of the 
mutagenesis plasmid. 
 
2.8.3 Excision of FRT flanked kan gene from the chromosomal insert 
Selection of candidates carrying the chromosomal insert requires a kanamycin resistance 
marker to be incorporated with the desired insert. The kanamycin resistance cassette is 
flanked by directly repeated FRT sites, which are targets for FLP recombinase, therefore 
allowing excision of the cassette by expression of FLP recombinase within the cell from the 
temperature sensitive plasmid pCP20 (Figure 2.4). Successful, chloramphenicol sensitive, 
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gene doctoring candidates were transformed with pCP20 by the calcium chloride method, 
described in sections 2.6.1 and 2.6.3, and selected by growth at 30˚C (permissive temperature) 
on nutrient agar supplemented with ampicillin. For each strain, 4 transformants were 
restreaked on non-selective nutrient agar and grown overnight at 37˚C (non-permissive 
temperature) to induce expression of FLP recombinase and plasmid loss. Individual colonies 
were then restreaked onto nutrient agar with and without kanamycin or ampicillin and 
incubated at 37˚C overnight. Candidates sensitive to kanamycin and ampicillin were further 
screened for loss of the kanamycin resistance gene by colony PCR using oligonucleotide 
primers positioned as described in section 2.8.2. The PCR product was ~1.3 kb smaller upon 
loss of the kanamycin resistance cassette, but still larger than that from the starting strain. 
Excision of the kan gene was further confirmed by DNA sequencing of the PCR product. 
 
2.9 Insertion of the lac28::egfp fusion at different chromosomal loci 
2.9.1 Overview of strategy 
Gene doctoring is used to transfer a promoter::egfp fusion to different chromosomal loci to 
allow the effect of chromosomal position on promoter activity to be analysed by measuring 
expression of the eGFP reporter gene. To achieve this, a master donor plasmid was created to 
allow the fusion of any promoter fragment to egfp, and the cloning of regions of homology to 
the target chromosome into sites flanking this fusion on the plasmid. Target sites for insertion 
were selected and regions of homology to the chromosome cloned into the donor plasmid. 
Gene doctoring, as described in section 2.8, was then used to transfer the lac28::egfp fusion to 
the desired target locus on the E. coli K-12 MG1655 chromosome.  
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2.9.2 Construction of the donor plasmid pJB 
The pJB gene doctoring master donor plasmid was constructed by modifying the gene gorging 
vector pKH5 to replace the lacI homology region with a multiple cloning site and the lacZ 
homology region with egfp and a multiple cloning site. The I-sceI donor fragment was then 
cloned into the gene doctoring vector pDOC-C (Lee et al., 2009). The oligonucleotide primers 
used in this construction are listed in table 2.5. Primers D67847 and D67848 were used in 
inverse PCR, with pKH5 as the template, to remove the lacI homology region from pKH5 and 
incorporate target DNA sites for the restriction endonucleases MfeI and AgeI (Figure 2.8). 
D67847 anneals to the region containing the I-sceI target site upstream of the lacI homology 
region with the 3’ end oriented away from the lacI fragment and the 5’ end incorporating a 
target site for MfeI. D67848 anneals downstream of the lacI fragment in pKH5 and 
incorporates a target site for AgeI. The PCR product was purified using the QIAquick PCR 
purification kit, digested with the restriction endonucleases MfeI and AgeI and further purified 
by extraction from a 0.8% agarose gel using the QIAquick Gel Extraction Kit. Two 
oligonucleotides, D67849 and D67876, were annealed to form an MfeI-AgeI fragment 
encoding target sites for the restriction endonucleases XmaI and KpnI. 20 μl each of 10 μM 
D67849 and D67876, which are complementary primers that form an MfeI-AgeI fragment, 
were mixed and heated to 65˚C for 10 minutes then cooled to room temperature to allow the 
oligonucleotides to anneal (Figure 2.8). The digested and purified vector was then ligated with 
the MfeI-AgeI fragment and used to transform E. coli RLG221 by the calcium chloride 
method to produce plasmid pJB1 (Figure 2.8). The insert in pJB1 was confirmed by test 
restriction digest with XmaI and KpnI and agarose gel electrophoresis. 
The second stage of master donor plasmid construction required the egfp gene to be cloned in 
place of the lacZ fragment in pJB1 to produce plasmid pJB2 (Figure 2.8). The egfp gene was 
amplified by PCR from pDEX-G using primers D67961 and D67962, which incorporate a  
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Table 2.5: DNA oligonucleotides used for construction of pJB plasmids 
Name Sequence (5’ – 3’) 1 Use  
D67847 TACGCAATTGATTACCCTGTT
ATCCCTAG 
Anneals to the SceI site upstream of the lacI 
homology in pKH5 and incorporates an MfeI 
site. Used with D67848 to create pJB1 by 
inverse PCR. 
D67848 GCTACGACCGGTGGCTGGAG
CTGCTTCGAAG 
Anneals downstream of the lacI homology in 
pKH5 and incorporates an AgeI site. Used 
with D67847 to create pJB1 by inverse PCR. 
D67849 AATTGTATGCCCCGGGTTGT
AGGTACCAACTA 
Complementary to D67876 and encodes the 
pJB1 multiple cloning site (Figure 2.8). 
D67876 CCGGTAGTTGGTACCTACAA
CCCGGGGCATAC 
Complementary to D67849 and encodes the 
pJB1 multiple cloning site (Figure 2.8). 
D67961 TACGAAGCTTAGCAAGGGCG
AGGAGCTG 
Anneals to the 5’ end of gfp in pDEX-G and 
incorporates a HindIII site. Used to create 
pJB2 
D67962 TACGGTCGACTTGTATGTGT
ACATTCGTTAGTTACTTACTT
GTACAGCTCGTCCATG 
Anneals to the 3’ end of gfp in pDEX-G and 
incorporates two extra stop codons in each 
reading frame, a BsrGI site and a SalI site. 
Used to create pJB2 (Figure 2.8). 
D68276 CTCGGCATGGACGAGCTTTA
CAAGTAAGTAACTAAC 
Anneals to the 3’ end of gfp and incorporates a 
G→T silent mutation of the BsrGI site. Used 
to create pJB2ΔB. 
D68277 GTTAGTTACTTACTTGTAAAG
CTCGTCCATGCCGAG 
Anneals to the 3’ end of gfp and incorporates a 
G→T silent mutation of the BsrGI site. Used 
to create pJB2ΔB. 
D68085 GTACAGCCATAACTAGTACT
TGCTAGCGCACAAGAGCTCT
AGGGATAACAGGGTAATG 
Complementary to D68086 and encodes the 
pJB3 multiple cloning site (Figure 2.9). 
D68086 TCGACATTACCCTGTTATCCC
TAGAGCTCTTGTGCGCTAGC
AAGTACTAGTTATGGCT 
Complementary to D68085 and encodes the 
pJB3 multiple cloning site (Figure 2.9). 
D66948 TATAGAATTCGGGCAGTGAG
CGCAACGC 
Anneals upstream of O
3
 in the lac promoter 
region and incorporates an EcoRI site. Used to 
create the lac00 and lac28 fragments. 
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Table 2.5: DNA oligonucleotides used for construction of pJB plasmids (continued) 
Name Sequence (5’ – 3’) 1 Use  
D68443 GCCGAAGCTTCATAGCTGTT
TCCTGTGTG 
Anneals to the lac promoter translation 
initiation region and incorporates a HindIII 
site downstream of the ATG. Used with 
D66948 to amplify lac00 to create pJB4. 
D69482 GCCGAAGCTTAAGGCGATTA
AGTTGGG 
Anneals to lacZ to incorporate a HindIII site 
immediately downstream of codon 28 to create 
the lac28 fragment. 
 
1
 Target sites for restriction endonucleases are underlined. 
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Figure 2.8: Schematic overview of pJB2 construction 
For details see text (section 2.9.2). Inverse PCR was used to replace the lacI homology region 
of pKH5 with an MfeI and AgeI endonuclease target sites. Oligonucleotides were annealed to 
form a MfeI-AgeI fragment containing a multiple cloning site (MCS), which was cloned into 
MfeI-AgeI digested pKH5. The resulting plasmid (pJB1) was then digested with the 
endonucleases HindIII and SalI, after which the egfp gene of plasmid pDEX-G was cloned 
into this site to form pJB2. Black circles represent plasmid DNA with the plasmid name in the 
centre. Genes are represented by block arrows with the direction of transcription depicted by 
the arrow and the gene name labelled. The position of restriction endonuclease target sites of 
interest are represented by black lines perpendicular to the plasmid or PCR DNA lines. 
Oligonucleotides are represented by thin arrow lines with the primer code number 
(DNNNNN). Cloning steps are represented by thick black arrows with the procedure labelled. 
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HindIII target site at the 5’ end of the gene and stop codons with a downstream BsrGI target 
site at the 3’ end. The PCR product was then purified using the QIAquick PCR Purification 
Kit and digested using the restriction endonucleases HindIII and SalI. pJB1 was also digested 
with HindIII and SalI, after which both vector and digested PCR product were purified by 
extraction from a 0.8% agarose gel. HindIII/SalI digested pJB1 was then ligated with the 
HindIII/SalI fragment carrying the egfp gene and used to transform calcium chloride 
competent E. coli RLG221 cells to produce plasmid pJB2. 
The next stage in plasmid construction required the insertion of a multiple cloning site and a 
target for the I-SceI endonuclease downstream of the egfp gene in pJB2. However, a target 
recognition site for the restriction endonuclease BsrGI was overlooked at the 3’ end of theegfp 
gene, therefore this first had to be deactivated by site directed mutagenesis. The mutagenesis 
primers D68276 and D68277 incorporate a G to T silent mutation within the BsrGI site and 
anneal to complementary sequences with the mutation positioned in the centre.  The primers 
were used in a Phusion polymerase PCR reaction, after which the template plasmid DNA was 
digested by adding 1μl DpnI enzyme (NEB) to the PCR reaction, which was incubated at 
37˚C for a further 1 h, leaving only the un-methylated PCR product. The PCR product was 
then used to transform rubidium chloride competent E. coli XL-1 Blue cells and transformants 
were selected on nutrient agar supplemented with ampicillin. The mutation was checked by 
sequencing using D55668 (Table 2.4). The complementary oligonucleotides, D68085 and 
D68086, encode a BsrGI-SalI fragment carrying target sites for the restriction endonucleases 
SpeI, NheI, SacI and I-SceI. These primers were annealed as previously described for the 
pJB1 multiple cloning site and cloned into BsrGI-SalI digested pJB2 to produce plasmid pJB3 
(Figure 2.9). The insert was confirmed by sequencing using D55668 (Table 2.4). 
The E. coli lacZYA promoter is well characterised and known to be a strong natural promoter, 
therefore the regulatory region of lacZYA was cloned into pJB3 to drive expression of the egfp  
 83 
pJB2
SalI
BsrGI
egfp
HindIII
kanRMCS
SalI
BsrGI
Digest
BsrGI 
SalI
SpeI
D68085
D68086NheI
SacI
I-sceI
Ligation
pJB3
MCS
egfp
HindIII
kanR
MCS
I-sceI
I-sceI
pDOC-C
ampR
sacB
colE1 
ori oriT
I-sceII-sceI
Digest
I-sceII-sceI
I-sceI I-sceI
Digest
Ligation
MCS
kanR
I-sceI
egfp
MCS
I-sceI
colE1 
ori
ampR
sacB
oriT
pJB
pDOC-C
pJB2
 
 
Figure 2.9: Schematic overview of pJB construction 
For details see text (section 2.9.2). Oligonucleotide primers were annealed to form a 
BsrGI-SalI fragment containing a multiple cloning site (MCS), which was then cloned into 
BsrGI-SalI digested pJB2 plasmid to form pJB3. The egfp containing I-sceI fragment of pJB3 
was then cloned into I-sceI digested pDOC-C plasmid to form the master gene doctoring 
plasmid pJB. Black circles represent plasmid DNA with the plasmid name in the centre. 
Genes are represented by block arrows with the direction of transcription depicted by the 
arrow and the gene name labelled. The position of restriction endonuclease target sites of 
interest are represented by black lines perpendicular to the plasmid or PCR DNA lines. 
Oligonucleotides are represented by thin arrow lines with the primer code number 
(DNNNNN). Cloning steps are represented by thick black arrows with the procedure labelled. 
 
 84 
gene. The lacZYA regulatory region, from position -93 bp to +41 bp relative to the 
transcription start site and including the lacZ ATG, was amplified by PCR from E. coli K-12 
genomic DNA using primers D68498 and D66948, which incorporate target sites for the 
endonucleases EcoRI and HindIII. The resulting promoter fragment was referred to as lac00 
and was then digested with EcoRI and HindIII, after which the promoter fragment was 
purified by extraction from a 0.8% agarose gel using the QIAquick Gel Extraction Kit. The 
digested and purified promoter fragment was then ligated into EcoRI/HindIII digested and 
CIP treated pJB3 to produce plasmid pJB4. The presence and integrity of the promoter 
fragment insert were confirmed by DNA sequencing using primer D68556 (Table 2.4). The 
insert was checked by sequencing using D68556. E. coli K-12 KH000 cells carrying pJB4 
were then checked for expression of egfp by fluorescence microscopy, however the cells were 
found to be non-fluorescent (see chapter 3). Therefore a lac promoter fragment carrying part 
of the lacZ gene was cloned into the donor plasmid in place of lac00. The lacZYA regulatory 
region, from position -93 bp to +122 bp relative to the transcription start site and including the 
first 28 codons of the lacZ gene, was amplified by PCR from E. coli K-12 genomic DNA 
using primers D68498 and D69482, which incorporate target sites for the endonucleases 
EcoRI and HindIII. The resulting promoter fragment was referred to as lac28 and cloned into 
EcoRI-HindIII digested pJB3 plasmid to produce plasmid pJB15, as previously described for 
the lac00 fragment. 
Finally, the I-sceI fragment of pJB15 was cloned into pDOC-C to produce a plasmid capable 
of being used to transfer the donor molecule to the E. coli chromosome through the method of 
gene doctoring (Figure 2.9). The pJB15 and pDOC-C plasmids were both digested with the 
endonuclease I-SceI, however pDOC-C was further treated with CIP to remove terminal 5’ 
phosphate groups, in order to prevent re-ligation of vector DNA. Both vector and insert were 
then purified by extraction from 0.8% agarose gels using the QIAquick Gel Extraction Kit, 
after which I-SceI digested pDOC-C was ligated with the pJB15 I-sceI fragment and used to 
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transform calcium chloride E. coli RLG221 to produce the pJB master donor plasmid (Figure 
2.6). 
 
2.9.3 Selection of target sites for lac28::egfp insertion 
For the lac28::gfp fusion to be inserted at different locations around the E. coli K-12 MG1655 
chromosome, the sites were selected and targeted specifically to minimise disruption to local 
chromosomal processes. The positions targeted are represented on the circular map presented 
in figure 2.10 and detail of each insertion site, including position of genes and relevant 
transcription elements, is represented in figures 2.11-2.24. Intergenic regions between 
convergent genes were targeted where possible and rho-independent transcription terminators 
left undisturbed in order to minimise disruption of local transcriptional activity and 
chromosomal architecture. The exceptions to this were the dkgB locus, which is immediately 
downstream of the rrsHrrlHrrfH and aspU genes, but upstream of the dkgB regulatory region, 
and the eaeH locus, which is situated within the non-expressed eaeH pseudogene. Homology 
regions (HR) for gene doctoring were selected to insert the fusion without replacement of any 
natural E. coli K-12 MG1655 DNA, except in the case of the ΔtsEPOD strains, in which the 
region of high protein binding was intentionally replaced by the lac28::egfp fusion. HRs were 
also selected so as not to include any recognition sites for the MfeI, XmaI, NheI and SacI 
restriction endonucleases. Identification of local sequence elements was enabled by analysis 
of data provided by EcoCyc at www.ecocyc.org (Keseler et al., 2011). 
 
2.9.4 Cloning of regions of homology to the E. coli chromosome into the pJB plasmid 
In order to insert the lac28::egfp fusion at the chromosomal loci described in section 2.9.3, 
the homology regions selected, which are represented in figure 2.11-2.24, were cloned into 
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Figure 2.10: Map of the E. coli MG1655 chromosome and lac28::egfp insertion sites 
The black circle represents the E. coli MG1655 circular chromosome of total size 
4639675 bp. The grey shaded blocks and two white gaps represent the six macrodomains as 
defined by Valens et al. (2004) and are labelled. The position of oriC and the diff, the direct 
opposite locus, are marked with black lines and labelled with their positions in kb relative to 
the co-ordinate system origin. Arrows indicate the position of sites of insertion for the 
lac28::egfp construct and the direction of the arrows indicates the orientation of the promoter. 
Sites of insertion are labelled according to the names of neighbouring genes. 
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Figure 2.11: Schematic diagram of the lac locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the lac locus 
lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the lac locus insertion site, with genes represented by white block 
arrows. The position of homology regions, used for insertion of the lac28::egfp fusion in 
strain BRY40, by gene doctoring, is represented by the grey shaded boxes, labelled HR1 and 
HR2, with the exact positions in bp with respect to the co-ordinate system origin. Due to the 
position of the HRs, gene doctoring will cause replacement of the region 365131-365652 bp, 
which contains the lacZYA regulatory region, with the lac28::egfp fusion. The approximate 
position of oligonucleotide primers used to PCR check/sequence the chromosomal insert is 
represented by black arrows labelled with the primer code (D56613 and D56614). 
Approximately to scale. 
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Figure 2.12: Schematic diagram of the ara locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the ara 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the ara locus insertion site, with genes represented by white block 
arrows. The position of homology regions, used for insertion of the lac28::egfp fusion in 
strains BRY13 and BRY21, by gene doctoring, is represented by the grey shaded boxes, 
labelled HR1 and HR2. The exact position of lac28::egfp insertion (72143 bp) is labelled 
“insertion site” and is given in bp, with respect to the co-ordinate system origin. The position 
of REP elements at the target insertion site is represented by vertical black lines. The 
approximate position of oligonucleotide primers used to PCR check/sequence the 
chromosomal insert is represented by black arrows labelled with the primer code (D69748 and 
D69747). Approximately to scale. 
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Figure 2.13: Schematic diagram of the mel locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the mel 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the mel locus insertion site, with genes represented by white block 
arrows. The position of homology regions, used for insertion of the lac28::egfp fusion in 
strains BRY15 and BRY37, by gene doctoring, is represented by the grey shaded boxes, 
labelled HR1 and HR2. The exact position of lac28::egfp insertion (4342915 bp) is labelled 
“insertion site” and given in bp, with respect to the co-ordinate system origin. The position of 
REP elements at the target insertion site is represented by vertical black lines. The 
approximate position of oligonucleotide primers used to PCR check/sequence the 
chromosomal insert is represented by black arrows labelled with the primer code (D69751 and 
D69752). Approximately to scale. 
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Figure 2.14: Schematic diagram of the asl locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the asl locus 
lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the asl locus insertion site, with genes represented by white block 
arrows. White triangles represent RNA coding genes. The position of homology regions, used 
for insertion of the lac28::egfp fusion in strain BRY35, by gene doctoring, is represented by 
the grey shaded boxes, labelled HR1 and HR2. The exact position of lac28::egfp insertion 
(3982359 bp) is labelled “insertion site” and given in bp, with respect to the co-ordinate 
system origin. The position of REP elements at the target insertion site is represented by 
vertical black lines. The approximate position of oligonucleotide primers used to PCR 
check/sequence the chromosomal insert is represented by black arrows labelled with the 
primer code (D72905 and D72906). Approximately to scale. 
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Figure 2.15: Schematic diagram of the nupG locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the nupG 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the nupG locus insertion site, with genes represented by white block 
arrows. White triangles represent RNA coding genes. The position of homology regions, used 
for insertion of the lac28::egfp fusion in strain BRY34, by gene doctoring, is represented by 
the grey shaded boxes, labelled HR1 and HR2. The exact position of lac28::egfp insertion 
(3104995 bp) is labelled “insertion site” and given in bp, with respect to the co-ordinate 
system origin. The approximate position of oligonucleotide primers used to PCR 
check/sequence the chromosomal insert is represented by black arrows labelled with the 
primer code (D72903 and D72904). Approximately to scale. 
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Figure 2.16: Schematic diagram of the mntH locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the mntH 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the mntH locus insertion site, with genes represented by white block 
arrows. The position of homology regions, used for insertion of the lac28::egfp fusion in 
strain BRY73, by gene doctoring, is represented by the grey shaded boxes, labelled HR1 and 
HR2. The exact position of lac28::egfp insertion (2509358 bp) is labelled “insertion site” and 
given in bp, with respect to the co-ordinate system origin. The position of REP elements at the 
target insertion site is represented by vertical black lines. The approximate position of 
oligonucleotide primers used to PCR check/sequence the chromosomal insert is represented 
by black arrows labelled with the primer code (D76494 and D76493). Approximately to scale. 
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Figure 2.17: Schematic diagram of the tam locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the tam 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the tam locus insertion site, with genes represented by white block 
arrows. The position of homology regions, used for insertion of the lac28::egfp fusionin strain 
BRY33, by gene doctoring, is represented by the grey shaded boxes, labelled HR1 and HR2. 
The exact position of lac28::egfp insertion (1606129 bp) is labelled “insertion site” and given 
in bp, with respect to the co-ordinate system origin. The approximate position of 
oligonucleotide primers used to PCR check/sequence the chromosomal insert is represented 
by black arrows labelled with the primer code (D69751 and D69752). Approximately to scale. 
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Figure 2.18: Schematic diagram and DNA sequence of the dkgB locus lac28::egfp fusion 
insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the dkgB 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the dkgB locus insertion site, with genes represented by white block 
arrows. Genes encoding RNA are indicated by the            symbol. The position of promoters 
is indicated by the black arrows with the promoter type also indicated (σ70 or σ32). The 
position of homology regions, used for insertion of the lac28::egfp fusion in strain BRY58, by 
gene doctoring, is represented by the grey shaded boxes, labelled HR1 and HR2. The exact 
position of lac28::egfp insertion (229046 bp) is labelled “insertion site” and given in bp, with 
respect to the co-ordinate system origin. The position of REP elements at the target insertion 
site is represented by vertical black lines. The approximate position of oligonucleotide 
primers used to PCR check/sequence the chromosomal insert is represented by black arrows 
labelled with the primer code (D75808 and D75809). Approximately to scale. Also shown is 
the DNA base sequence of the dkgB insertion site, with RNA or protein coding regions in 
uppercase. The promoter -10 and -35 regions are underlined and the transcription start site in 
uppercase with an arrow. The aspU Rho-independent transcription terminator is boxed and 
labelled with a stem-loop structure. 
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Figure 2.19: Schematic diagram and DNA sequence of the rcs locus lac28::egfp fusion 
insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the rcs locus 
lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the rcs locus insertion site, with genes represented by white block 
arrows. White triangles represent RNA coding genes. The position of homology regions, used 
for insertion of the lac28::egfp fusion in strain BRY27, by gene doctoring, is represented by 
the grey shaded boxes, labelled HR1 and HR2. The exact position of lac28::egfp insertion 
(2314948 bp) is labelled “insertion site” and given in bp, with respect to the co-ordinate 
system origin. The position of REP elements at the target insertion site is represented by 
vertical black lines. The approximate position of oligonucleotide primers used to PCR 
check/sequence the chromosomal insert is represented by black arrows labelled with the 
primer code (D75808 and D75809). Approximately to scale. Also shown is the DNA base 
sequence of the rcs insertion site, with protein coding regions in uppercase. The promoter -10 
and -35 regions are underlined and the transcription start site in uppercase with an arrow. The 
REP element sequences are underlined and labelled. 
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Figure 2.20: Schematic diagram of the yafT locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the yafT 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the yafT locus insertion site, with genes represented by white block 
arrows. White triangles represent RNA coding genes. Crossed boxes represent pseudogenes. 
The position of transcriptionally silent extended protein occupancy domains (tsEPOD) is 
indicated by the black box. The position of homology regions, used for insertion of the 
lac28::egfp fusion in strain BRY22, by gene doctoring, is represented by the grey shaded 
boxes, labelled HR1 and HR2, with the exact positions in bp with respect to the co-ordinate 
system origin. Use of HR3 and HR4 for gene doctoring will cause replacement of the region 
between the HRs (237530-239300 bp) with the lac28::egfp fusion, creating the ΔtsEPOD 
strain BRY59. The approximate position of oligonucleotide primers used to PCR 
check/sequence the chromosomal insert is represented by black arrows labelled with the 
primer code (DNNNNN). Approximately to scale. 
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Figure 2.21: Schematic diagram of the eaeH locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the eaeH 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the eaeH locus insertion site, with genes represented by white block 
arrows. Crossed arrows represent pseudogenes. The position of transcriptionally silent 
extended protein occupancy domains (tsEPOD) is indicated by the black box. The position of 
homology regions, used for insertion of the lac28::egfp fusion in strain BRY23, by gene 
doctoring, is represented by the grey shaded boxes, labelled HR1 and HR2, with the exact 
positions in bp with respect to the co-ordinate system origin. Use of HR3 and HR4 for gene 
doctoring will cause replacement of the region between the HRs (312940-315678 bp) with the 
lac28::egfp fusion, creating the ΔtsEPOD strain BRY60. The approximate position of 
oligonucleotide primers used to PCR check/sequence the chromosomal insert is represented 
by black arrows labelled with the primer code (DNNNNN). Approximately to scale. 
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Figure 2.22: Schematic diagram of the ycb locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the ycb 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the ycb locus insertion site, with genes represented by white block 
arrows. The position of transcriptionally silent extended protein occupancy domains 
(tsEPOD) is indicated by the black box. The position of homology regions, used for insertion 
of the lac28::egfp fusion in strain BRY32, by gene doctoring, is represented by the grey 
shaded boxes, labelled HR1 and HR2. The exact position of lac28::egfp insertion (1005714 
bp) is labelled “insertion site” and given in bp, with respect to the co-ordinate system origin. 
The approximate position of oligonucleotide primers used to PCR check/sequence the 
chromosomal insert is represented by black arrows labelled with the primer code (D72907 and 
D72908). Approximately to scale. 
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Figure 2.23: Schematic diagram of the yqe locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the yqe 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the yqe locus insertion site, with genes represented by white block 
arrows. The position of transcriptionally silent extended protein occupancy domains 
(tsEPOD) is indicated by the black box. The position of homology regions, used for insertion 
of the lac28::egfp fusion in strain BRY54, by gene doctoring, is represented by the grey 
shaded boxes, labelled HR1 and HR2, with the exact positions in bp with respect to the co-
ordinate system origin. Use of HR3 and HR4 for gene doctoring will cause replacement of the 
region between the HRs (2984331-2995806 bp) with the lac28::egfp fusion, creating the 
ΔtsEPOD strain BRY68. The approximate position of oligonucleotide primers used to PCR 
check/sequence the chromosomal insert is represented by black arrows labelled with the 
primer code (DNNNNN). Approximately to scale. 
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Figure 2.24: Schematic diagram of the pitB locus lac28::egfp fusion insertion site 
The black circle represents the E. coli MG1655 chromosome and the grey shaded blocks and 
two white gaps represent the six macrodomains (see figure 2.10). The position of the pitB 
locus lac28::egfp fusion insertion site is represented by the arrow and label. Also shown is the 
organisation of genes at the pitB locus insertion site, with genes represented by white block 
arrows. The position of transcriptionally silent extended protein occupancy domains 
(tsEPOD) is indicated by the black box. The position of homology regions, used for insertion 
of the lac28::egfp fusion in strain BRY55, by gene doctoring, is represented by the grey 
shaded boxes, labelled HR1 and HR2, with the exact positions in bp with respect to the co-
ordinate system origin. Use of HR3 and HR4 for gene doctoring will cause replacement of the 
region between the HRs (3131588-3133385 bp) with the lac28::egfp fusion, creating the 
ΔtsEPOD strain BRY69. The approximate position of oligonucleotide primers used to PCR 
check/sequence the chromosomal insert is represented by black arrows labelled with the 
primer code (DNNNNN). Approximately to scale. 
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the master donor pJB plasmid to allow the transfer of the lac28::egfp fusion to the 
chromosome of E. coli K-12 MG1655 by the gene doctoring method. The upstream HR of 
each site, referred to as HR1, was amplified from E. coli K-12 MG1655 genomic DNA by 
PCR, using primers that incorporate an upstream MfeI and downstream XmaI target site 
(Table 2.6). The HR1 PCR product was purified using the QIAquick PCR Purification Kit, 
after which it was digested with the restriction endonucleases MfeI and XmaI and further 
purified by use of the QIAquick PCR Purification Kit. The pJB22 gene doctoring plasmid was 
used as stock for all target sites, as excision of the ~ 500 bp HR before cloning of the new HR 
was easily detectable by agarose gel electrophoresis. pJB22 was digested with MfeI and XmaI, 
treated with CIP to prevent re-ligation and purified by excision from a 0.8% agarose gel using 
the QIAquick Gel Extraction Kit. MfeI-XmaI digested pJB22 was then ligated with the MfeI-
XmaI HR1 fragment before being used to transform calcium chloride competent E. coli 
RLG221. The presence of the correct insert was checked by DNA sequencing with the primer 
D58794 (Table 2.4).  
The resulting plasmid was assigned a pJB number and stored at -20˚C, after which a separate 
stock of the plasmid was digested with the restriction endonucleases NheI and SacI, treated 
with CIP and purified by extraction from a 0.8% agarose gel. The downstream HR, HR2, was 
amplified from E. coli K-12 MG1655 genomic DNA by PCR using primers which incorporate 
a target site for NheI upstream and SacI downstream of the fragment (Table 2.6). The 
resulting HR2 PCR fragment was purified and digested with NheI and SacI before further 
purification using the QIAquick PCR Purification Kit. NheI-SacI digested plasmid containing 
HR1 was then ligated with the NheI-SacI HR2 PCR product before being used to transform 
calcium chloride competent E. coli RLG221 to produce the finished donor plasmid. The 
presence of the correct HR2 in the finished gene doctoring donro plasmid was confirmed by 
DNA sequencing using primer D58793 (Table 2.4). 
 102 
Table 2.6: Oligonucleotides used to amplify homology regions 
Name Sequence (5’ – 3’) 1 Use 2 
D69231 GCCGCAATTGCCGGGATT
GAAACTGAACG 
Used to amplify the thiQ homology region and 
introduce an MfeI site. Used with D69232. (ara) 
D69232 GCCGCCCGGGCGACGCTT
GCCGCGTCTTATC 
Used to amplify the thiQ homology region and 
introduce an XmaI site. Used with D69231. (ara) 
D69233 GCCGGAGCTCCTGAACAT
GCGTTGCATCAAC 
Used to amplify the yabI homology region and 
introduce a SacI site. Used with D69234. (ara) 
D69234 GCCGGCTAGCCATCAGGC
AACCCGCAC 
Used to amplify the yabI homology region and 
introduce an NheI site. Used with D69233. (ara) 
D71381 GCCGGAGCTCCCGGGATT
GAAACTGAACG 
Used to amplify the thiQ homology region and 
introduce a SacI site. Used with D71382. (Inverse 
ara) 
D71382 GCCGGCTAGCCGACGCTT
GCCGCGTCTTATC 
Used to amplify the thiQ homology region and 
introduce an NheI site. Used with D71381. 
(Inverse ara) 
D71383 GCCGCCCGGGCATCAGGC
AACCCGCAC 
Used to amplify the yabI homology region and 
introduce an XmaI site. Used with D71384. 
(Inverse ara) 
D71384 GCCGCAATTGCTGAACAT
GCGTTGCATCAAC 
Used to amplify the yabI homology region and 
introduce an MfeI site. Used with D71383. 
(Inverse ara) 
D69239 GCCGCAATTGGATCCAGA
TCCATCTGCTGG 
Used to amplify the melB homology region and 
introduce an MfeI site. Used with D69240. (mel) 
D69240 GCCGCCCGGGTTCCTTATC
CGGTCTACAAAATTTG 
Used to amplify the melB homology region and 
introduce an XmaI site. Used with D69239. (mel) 
D69241 GCCGGAGCTCCGTTAACG
CCGCTGCTCTATACGC 
Used to amplify the yjdF homology region and 
introduce a SacI site. Used with D69242. (mel) 
D69242 GCCGGCTAGCTTCACGCC
GCATCCGGC 
Used to amplify the yjdF homology region and 
introduce an NheI site. Used with D69241. (mel) 
D72989 GCCGGAGCTCGATCCAGA
TCCATCTGCTGG  
Used to amplify the melB homology region and 
introduce a SacI site. Used with D72876. (Inverse 
mel) 
D72876 GCCGGCTAGCTTCCTTATC
CGGTCTACAAAATTTG 
Used to amplify the melB homology region and 
introduce an NheI site. Used with D72989. 
(Inverse mel) 
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Table 2.6: Oligonucleotides used to amplify homology regions (continued) 
Name Sequence (5’ – 3’) 1 Use 2 
D72988 GCCGCAATTGCGTTAACG
CCGCTGCTCTATACGC 
Used to amplify the yjdF homology region and 
introduce an MfeI site. Used with D72878. 
(Inverse mel) 
D72878 GCCGCCCGGGTTCACGCC
GCATCCGGC 
Used to amplify the yjdF homology region and 
introduce an XmaI site. Used with D72988. 
(Inverse mel) 
D71369 GCCGCAATTGATATTATAC
TGTTTCCAC 
Used to amplify the yafT homology region and 
introduce an MfeI site. Used with D71370. (yafT) 
D71370 GCCGCCCGGGTCCTGGCG
GCAGATATAATTTATTATT
G 
Used to amplify the yafT homology region and 
introduce an XmaI site. Used with D71369. (yafT) 
D71371 GCCGGCTAGCATTTCTGGC
GGCAATAATAC 
Used to amplify the ykfM homology region and 
introduce an NheI site. Used with D71372. (yafT) 
D71372 GCCGGAGCTCGAGTTAAA
CCTCTATATTC 
Used to amplify the ykfM homology region and 
introduce a SacI site. Used with D71371. (yafT) 
D71373 GCCGCAATTGATCCATAA
AAAATATATTGG 
Used to amplify the upstream eaeH homology 
region and introduce an MfeI site. Used with 
D71374. (eaeH) 
D71374 GCCGCCCGGGGAAAAAGA
ACCTGAACAGAG 
Used to amplify the upstream eaeH homology 
region and introduce an XmaI site. Used with 
D71373. (eaeH) 
D71375 GCCGGCTAGCCACTCGCT
GTCACCTTTACC 
Used to amplify the downstream eaeH homology 
region and introduce an NheI site. Used with 
D71376. (eaeH) 
D71376 GCCGGAGCTCGCACCAAC
ACCAATGCG 
Used to amplify the downstream eaeH homology 
region and introduce a SacI site. Used with 
D71375. (eaeH) 
D71881 GGACCAATTGATTGTTCTG
ACTATGAACAACAACC 
Used to amplify the rcsB homology region and 
introduce an MfeI site. Used with D71882. (rcs) 
D71882 GGACCCCGGGATGGGAAT
CGTAGGCCG 
Used to amplify the rcsB homology region and 
introduce an XmaI site. Used with D71881. (rcs) 
D71883 GGACGCTAGCTATTTCAA
CAAATTACATTAAAGTAG
G 
Used to amplify the rcsC homology region and 
introduce an NheI site. Used with D71884. (rcs) 
D71884 GGACGAGCTCGCGGTCAG
CGATAATGAC 
Used to amplify the rcsC homology region and 
introduce a SacI site. Used with D71883. (rcs) 
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Table 2.6: Oligonucleotides used to amplify homology regions (continued) 
Name Sequence (5’ – 3’) 1 Use 2 
D72684 CGGCCAATTGAAGAGCAC
GATCGAATGATG 
Used to amplify the ycbW homology region and 
introduce an MfeI site. Used with D72685. (ycb) 
D72685 CGGCCCCGGGTTAGACTG
CCTGTTCGAGG 
Used to amplify the ycbW homology region and 
introduce an XmaI site. Used with D72684. (ycb) 
D72686 CGGCGCTAGCCTAACGCG
CCAACTTAAG 
Used to amplify the ycbX homology region and 
introduce an NheI site. Used with D72687. (ycb) 
D72687 CGGCGAGCTCCTAGCCGC
TGTATTTTCACC 
Used to amplify the ycbX homology region and 
introduce a SacI site. Used with D72686. (ycb) 
D72688 CGGCCAATTGCTGGCAAC
CGGTACAGG 
Used to amplify the tam homology region and 
introduce an MfeI site. Used with D72689. (tam) 
D72689 CGGCCCCGGGTTTACTCCA
TACGCCGGG 
Used to amplify the tam homology region and 
introduce an XmaI site. Used with D72688. (tam) 
D72690 CGGCGCTAGCTATCACGT
CAGCTGGTAATG 
Used to amplify the yneE homology region and 
introduce an NheI site. Used with D72691. (tam) 
D72691 CGGCGAGCTCTATCTCAA
GACTGAAGATCTTCAG 
Used to amplify the yneE homology region and 
introduce a SacI site. Used with D72690. (tam) 
D72692 CGGCCAATTGCAATCATC
ATGTCGATTTC 
Used to amplify the nupG homology region and 
introduce an MfeI site. Used with D72693. 
(nupG) 
D72693 CGGCCCCGGGTAATTAGT
GGCTAACCGTC 
Used to amplify the nupG homology region and 
introduce an XmaI site. Used with D72692. 
(nupG) 
D72694 CGGCGCTAGCCGCAAAGA
AAAACGGGTC 
Used to amplify the speC homology region and 
introduce an NheI site. Used with D72695. 
(nupG) 
D72695 CGGCGAGCTCGTGTTGCC
GAGCGTTTATAAC 
Used to amplify the speC homology region and 
introduce a SacI site. Used with D72694. (nupG) 
D72695 CGGCGAGCTCGTGTTGCC
GAGCGTTTATAAC 
Used to amplify the speC homology region and 
introduce a SacI site. Used with D72694. (nupG) 
D72696 CAAACAATTGCAGAAATG
ATCG 
Used to amplify the aslB homology region and 
introduce an MfeI site. Used with D72697. (asl) 
D72697 CGGCCCCGGGGAGATCTG
CCTTTGCCG 
Used to amplify the aslB homology region and 
introduce an XmaI site. Used with D72696. (asl) 
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Table 2.6: Oligonucleotides used to amplify homology regions (continued) 
Name Sequence (5’ – 3’) 1 Use 2 
D72698 CGGCGCTAGCAGCGATAG
CGCCGGCTTAG 
Used to amplify the aslA homology region and 
introduce an NheI site. Used with D72699. (asl) 
D72699 CGGCGAGCTCGGAAAGGG
ATGATCCAACCG 
Used to amplify the aslA homology region and 
introduce a SacI site. Used with D72698. (asl) 
D72369 GCCGGCTAGCCTGGCTAC
AGGAAGGCC 
Used to amplify the lacZ homology region and 
introduce an NheI site. Used with D72370. (lac) 
D72370 GCCGGAGCTCGTTTCGGG
TTTTCGACG 
Used to amplify the lacZ homology region and 
introduce a SacI site. Used with D72369. (lac) 
D68504 TACGCAATTGCCATGAAG
ACGGTACGCG 
Used to amplify the lacI homology region and 
introduce an MfeI site. Used with D68505. (lac) 
D68505 TACGCCCGGGTCACTGCC
CGCTTTCCAG 
Used to amplify the lacI homology region and 
introduce an XmaI site. Used with D68504. (lac) 
D72371 GGACCAATGGTTTCGGGT
TTTCGACG 
Used to amplify the inverse lacZ homology 
region and introduce an MfeI site. Used with 
D72372. (Inverse lac) 
D72372 GGACCCCGGGCTGGCTAC
AGGAAGGCC 
Used to amplify the inverse lacZ homology 
region and introduce an XmaI site. Used with 
D72371. (Inverse lac) 
D71377 TACGGAGCTCCCATGAAG
ACGGTACGCG 
Used to amplify the inverse lacI homology region 
and introduce a SacI site. Used with D71378. 
(Inverse lac) 
D71378 TACGGCTAGCTCACTGCCC
GCTTTCCAG 
Used to amplify the inverse lacI homology region 
and introduce an NheI site. Used with D71377. 
(Inverse lac) 
D68765 GGACGCTAGCATGACCAT
GATTACGGATTC 
Used to amplify the lacZ (+O2) homology region 
and introduce an NheI site. Used with D68766. 
(lac +O2) 
D68766 GGACGAGCTCCACATATC
CTGATCTTCCAG 
Used to amplify the lacZ (+O2) homology region 
and introduce a SacI site. Used with D68765. (lac 
+O2) 
D75746 GCTCAATTGATGAGGCTT
ATCTGACGC 
Used to amplify the mntH homology region and 
introduce an MfeI site. Used with D75747. 
(mntH) 
D75747 GCTCCCGGGGCCAATGGA
GCACAATGC 
Used to amplify the mntH homology region and 
introduce an XmaI site. Used with D75746. 
(mntH) 
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Table 2.6: Oligonucleotides used to amplify homology regions (continued) 
Name Sequence (5’ – 3’) 1 Use 2 
D75748 GCTGCTAGCGGACGCGTT
TAATGGCG 
Used to amplify the ypeC homology region and 
introduce an NheI site. Used with D75749. 
(mntH) 
D75749 GCTGAGCTCGTGCTGGTG
GTAACACG 
Used to amplify the ypeC homology region and 
introduce a SacI site. Used with D75748. (mntH) 
D74762 CGGCCAATTGCCTGACTCC
TTGAGAGTCC 
Used to amplify the aspU homology region and 
introduce an MfeI site. Used with D74763. (dkgB) 
D74763 CGGCCCCGGGGAAAAAAA
ACCTCGAGCG 
Used to amplify the aspU homology region and 
introduce an XmaI site. Used with D74762. 
(dkgB) 
D74764 CGGCGCTAGCGTCTGTAT
ATCTATTATTGCCAG  
Used to amplify the dkgB homology region and 
introduce an NheI site. Used with D74765. (dkgB) 
D74765 CGGCGAGCTCAAATACCG
ATCTCACGC  
Used to amplify the dkgB homology region and 
introduce a SacI site. Used with D74764. (dkgB) 
D74746 CGGCCAATTGGTGATTGA
TTATAAAAAAAAC 
Used to amplify the yqeJ homology region and 
introduce an MfeI site. Used with D74747. (yqe) 
D74747 CGGCCCCGGGATGTATTTT
AGTTTACCTTGC 
Used to amplify the yqeJ homology region and 
introduce an XmaI site. Used with D74746. (yqe) 
D74748 CGGCGCTAGCAACAAAAA
GATGGAACCTCG 
Used to amplify the yqeL homology region and 
introduce an NheI site. Used with D74749. (yqe) 
D74749 CGGCGAGCTCCACGAAAA
AGAAACCAAGG 
Used to amplify the yqeL homology region and 
introduce a SacI site. Used with D74748. (yqe) 
D74750 CGGCCAATTGCAAAAAAA
TTGCCTGGACCAG 
Used to amplify the yghT homology region and 
introduce an MfeI site. Used with D74751. (pitB) 
D74751 CGGCCCCGGGCTGGCGAT
CGGGCATTTC 
Used to amplify the yghT homology region and 
introduce an XmaI site. Used with D74750. (pitB) 
D74752 CGGCGCTAGCGACCGGGC
ATTTTCAGG 
Used to amplify the pitB homology region and 
introduce an NheI site. Used with D74753. (pitB) 
D74753 CGGCGAGCTCGAAACTGC
CAGGCGTCAG 
Used to amplify the pitB homology region and 
introduce a SacI site. Used with D74752. (pitB) 
D75191 GGACCAATTGGATTTGCT
GTACTTTATTC 
Used to amplify the upstream ΔeaeH homology 
region and introduce an MfeI site. Used with 
D75192. (ΔeaeH) 
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Table 2.6: Oligonucleotides used to amplify homology regions (continued) 
Name Sequence (5’ – 3’) 1 Use 2 
D75192 GGACCCCGGGATATCTAT
TATTCTCCCG 
Used to amplify the upstream ΔeaeH homology 
region and introduce an XmaI site. Used with 
D71373. (ΔeaeH) 
D76797 GCCGGCTAGCGGCCTGTG
TCCATATTACG 
Used to amplify the downstream homology 
ΔeaeH region and introduce an NheI site. Used 
with D71376. (ΔeaeH) 
D76798 GCCGGAGCTCCACCGCGA
AATCTATGC 
Used to amplify the downstream ΔeaeH 
homology region and introduce a SacI site. Used 
with D71375. (ΔeaeH) 
D75195 GGACCAATTGTGAGTTCA
GAGAGCCGC 
Used to amplify the upstream ΔyafT homology 
region and introduce an MfeI site. Used with 
D75196. (ΔyafT) 
D75196 GGACCCCGGGATCCTCTTC
GGATACGG 
Used to amplify the upstream ΔyafT homology 
region and introduce an XmaI site. Used with 
D75195. (ΔyafT) 
D75197 GCCGGCTAGCGTTAAGAC
GTAAGATGCG 
Used to amplify the downstream homology ΔyafT 
region and introduce an NheI site. Used with 
D75198. (ΔyafT) 
D75198 GCCGGAGCTCTGCTACGA
CTTACGTTTTC 
Used to amplify the downstream ΔyafT homology 
region and introduce a SacI site. Used with 
D75197. (ΔyafT) 
D76801 GGACCAATTGAAATATGC
CTGAGCAGC 
Used to amplify the upstream Δyqe homology 
region and introduce an MfeI site. Used with 
D76802. (Δyqe) 
D76802 GGACCCCGGGTTCCGTAA
GTGAGTTGG 
Used to amplify the upstream Δyqe homology 
region and introduce an XmaI site. Used with 
D76801. (Δyqe) 
D76803 GCCGGCTAGCTTGTCTGG
AGATTCAGG 
Used to amplify the downstream homology Δyqe 
region and introduce an NheI site. Used with 
D76804. (Δyqe) 
D76804 GCCGGAGCTCCAAGCAAT
CAACACTGG 
Used to amplify the downstream Δyqe homology 
region and introduce a SacI site. Used with 
D76803. (Δyqe) 
D76805 GGACCAATTGATCGTTTG
ATTTTGTCG 
Used to amplify the upstream ΔpitB homology 
region and introduce an MfeI site. Used with 
D76806. (ΔpitB) 
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Table 2.6: Oligonucleotides used to amplify homology regions (continued) 
Name Sequence (5’ – 3’) 1 Use 2 
D76806 GGACCCCGGGAAAAATGT
TAAGGCAGC 
Used to amplify the upstream ΔpitB homology 
region and introduce an XmaI site. Used with 
D76805. (ΔpitB) 
D76807 GTTTCGCTAGCTTCGCGG Used to amplify the downstream homology ΔpitB 
region and introduce an NheI site. Used with 
D76808. (ΔpitB) 
D76808 GCCGGAGCTCAATGCTGG
TACTGGTGG 
Used to amplify the downstream ΔpitB homology 
region and introduce a SacI site. Used with 
D76807. (ΔpitB) 
 
1
 Target sites for restriction endonucleases are underlined.  
2
 The chromosomal locus for which the homology region and primer are used to target is 
italicised and in brackets. 
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2.9.5 Construction of strains carrying lac28::egfp at different chromosomal positions 
The pJB donor plasmids, described in section 2.9.4, were used to transfer the lac28::egfp 
fusion to the specifically targeted chromosomal loci, described in section 2.9.3, by the gene 
doctoring method. E. coli K-12 MG1655 cells were co-transformed, by the rubidium chloride 
method described in section 2.6.2, with the mutagenesis plasmid pACBSR and the relevant 
pJB donor plasmid. Transformants were selected on nutrient agar supplemented with 
chloramphenicol and ampicillin, and used to transfer the lac28::egfp fusion to the desired 
location on the chromosome of E. coli K-12 MG1655 by the gene doctoring method, 
described in section 2.8. Candidates were screened for the presence of the insert by colony 
PCR, as described in section 2.7.2, using oligonucleotide primers designed to bind to regions 
of the chromosome flanking the homology regions used (Table 2.7). Successful candidates 
were assigned a BRY strain number and stored as glycerol stocks at -80˚C (Table 2.1). The 
kanamycin resistance cassette was then excised from the chromosome using FLP 
recombinase, as described in section 2.8.3. Candidates were then screened for the loss of the 
kan gene by colony PCR, as previously described. The integrity of the lac28 promoter 
fragment on the chromosome was then checked by purifying the PCR product using the 
QIAquick PCR Purification Kit, after which the lac28 promoter region was sequenced using 
primer D68556 (Table 2.4). Successful candidates were assigned a BRY number and stored as 
glycerol stocks at -80˚C (Table 2.1). 
 
2.10 Fluorescence assays 
2.10.1 Exponential growth phase fluorescence assays 
Fluorescence assays were used to measure the level of fluorescence as a function of OD620 
from strains carrying chromosomally encoded lac28::egfp fusions to determine the level of  
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Table 2.7: Oligonucleotides used for sequencing and/or PCR screening of inserts 
Name Sequence (5’ – 3’)  Use 1 
D54890 TGAAGGGCAATCAGCTGT
TG 
Anneals to 3’ end of lacI gene, upstream of 
cloning site in pKH3. Used for sequencing inserts 
in pKH3. 
D55668 GAGCGGCGACGATAGTCA
TG 
Anneals downstream of SalI site in pBR322. 
Used for sequencing inserts in pBR322 during 
construction of pKH3. 
D10520 CCCTGCGGTGCCCCTCAA
G 
Anneals upstream of EcoRI site in pRW50. Used 
for sequencing and amplification of inserts in this 
vector. 
D56613 CTTGATGTCTCTGACCAGA
C 
Anneals within the lacI sequence outside of the 
pKH3 homology. Used for screening gene 
gorging candidates by PCR amplification. 
D56614 TTATGCAGCAACGAGACG
TC 
Anneals within the lacZ sequence outside of the 
pKH3 homology. Used for screening gene 
gorging candidates by PCR amplification. 
D68556 TTTACGTCGCCGTCCAG Anneals downstream of the start codon of gfp. 
Used for sequencing promoter inserts in pJB3 
derivatives and BRY strains. 
D69747 GTCGCACAGAACATCGG Anneals to thiQ gene outside of the homology 
regions used. Used for PCR screening with 
D69748. (ara) 
D69748 TCGCTGGTCATTTCTGAAG Anneals to yabI gene outside of the homology 
regions used. Used for PCR screening with 
D69747. (ara) 
D69751 TATCGCCTCAATGGTGAC
A 
Anneals to melB gene outside of the homology 
regions used. Used for PCR screening with 
D69752. (mel) 
D69752 TTGCCACCGCCAGAC Anneals to yjdF gene outside of the homology 
regions used. Used for PCR screening with 
D69751. (mel) 
D71835 GGAAACCATTATGCAGGA
GG 
Anneals to yafT gene outside of the homology 
regions used. Used for PCR screening with 
D71836. (yafT) 
D71836 TTTCCCTGCATTCAATGC Anneals to ykfM gene outside of the homology 
regions used. Used for PCR screening with 
D71835. (yafT) 
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Table 2.7: Oligonucleotides used for sequencing and/or PCR screening of inserts 
Name Sequence (5’ – 3’)  Use 1 
D71837 AATTTACAGTCCGATGAA
GG 
Anneals to eaeH gene upstream of the homology 
regions used. Used for PCR screening with 
D71838. (eaeH) 
D71838 TTTCAGATAATCGCGCC Anneals to eaeH gene upstream of the homology 
regions used. Used for PCR screening with 
D71837. (eaeH) 
D72064 GCGCCATTTCCCAAGCC Anneals to rcsB gene upstream of the homology 
regions used. Used for PCR screening with 
D72065. (rcs) 
D72065 CGCTCTGCCGTCAACGG Anneals to rcsC gene upstream of the homology 
regions used. Used for PCR screening with 
D72064. (rcs) 
D72901 GTGCTTTGCCAGACTGC Anneals to tam gene outside of the homology 
regions used. Used for PCR screening with 
D72902. (tam) 
D72902 TGACATTACGCAAACAGC
C 
Anneals to yneE gene outside of the homology 
regions used. Used for PCR screening with 
D72901. (tam) 
D72903 ATCCGATGTTTGCCAGC Anneals to nupG gene outside of the homology 
regions used. Used for PCR screening with 
D72904. (nupG) 
D72904 GCATAATGAACAGCATAT
TGAGG 
Anneals to speC gene outside of the homology 
regions used. Used for PCR screening with 
D72903. (nupG) 
D72905 CACTATGTTTATCCGCAAT
ATCG 
Anneals to aslB gene outside of the homology 
regions used. Used for PCR screening with 
D72906. (asl) 
D72906 TCGCGTACCGACTTTCG Anneals to aslC gene outside of the homology 
regions used. Used for PCR screening with 
D72905. (asl) 
D72907 GGCAGATGCGAATTAAAC
C 
Anneals to ycbW gene outside of the homology 
regions used. Used for PCR screening with 
D72908. (ycb) 
D72908 TCGCATTGGTGATGTGG Anneals to ycbX gene outside of the homology 
regions used. Used for PCR screening with 
D72907. (ycb) 
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Table 2.7: Oligonucleotides used for sequencing and/or PCR screening of inserts 
Name Sequence (5’ – 3’)  Use 1 
D76493 GCTACAGCTGCGGCGGC Anneals to mntH gene outside of the homology 
regions used. Used for PCR screening with 
D76494. (mntH) 
D76494 GCGGCAATAACCGTTTCTT
GCG 
Anneals to ypeC gene outside of the homology 
regions used. Used for PCR screening with 
D76493. (mntH) 
D75808 AGTGGACGCATCACTGG Anneals to aspU gene outside of the homology 
regions used. Used for PCR screening with 
D75809. (dkgB) 
D75809 CCTCATCTTTCAGGGCC Anneals to dkgB gene outside of the homology 
regions used. Used for PCR screening with 
D75808. (dkgB) 
D75800 AGCGCATTTGTCATAGG 
 
Anneals to yqeJ gene outside of the homology 
regions used. Used for PCR screening with 
D75801. (yqe) 
D75801 TTTCTCTCATTTGATTAGA
GC 
Anneals to yqeL gene outside of the homology 
regions used. Used for PCR screening with 
D75800. (yqe) 
D75802 ACACCTCCATTAATTGC  Anneals to yghT gene outside of the homology 
regions used. Used for PCR screening with 
D75803. (pitB) 
D75803 ACACTACCTGCAACAGC Anneals to pitB gene outside of the homology 
regions used. Used for PCR screening with 
D75802. (pitB) 
D75810 ACCTGACAGCGTGTATTCC 
 
Check primer for ΔeaeH, which anneals outside 
of the homology regions used. Used for PCR 
screening. (ΔeaeH) 
D75812 CATTACAAACGGAGTCTG
G 
Check primer for ΔyafT, which anneals upstream 
of the homology regions used. Used for PCR 
screening with D75813. (ΔyafT) 
D75813 AAAACCGTTGACGAAGG Check primer for ΔyafT, which anneals 
downstream of the homology regions used. Used 
for PCR screening with D75812. (ΔyafT) 
D77712 GTCTTTCATCACAACCTCG Check primer for Δyqe, which anneals upstream 
of the homology regions used. Used for PCR 
screening with D77713. (Δyqe) 
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Table 2.7: Oligonucleotides used for sequencing and/or PCR screening of inserts 
Name Sequence (5’ – 3’)  Use 1 
D77713 GGTCTTTACCTTGATCTCC Check primer for Δyqe, which anneals 
downstream of the homology regions used. Used 
for PCR screening with D77712. (Δyqe) 
D77714 GGAGATTTGGTTTTCATGC Check primer for ΔpitB, which anneals upstream 
of the homology regions used. Used for PCR 
screening with D77715. (ΔpitB) 
D77715 TTGCGCTGATTGTTTCC Check primer for ΔpitB, which anneals 
downstream of the homology regions used. Used 
for PCR screening with D77714. (ΔpitB) 
 
1
 The chromosomal locus for which the primer was used to amplify is italicised and in 
brackets 
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eGFP expression and lac28 promoter activity. Strains carrying the chromosome-encoded 
lac28::egfp fusion were grown overnight at 37°C with aeration in M9 minimal salts media, 
supplemented with 0.3% fructose. Density of the overnight culture was determined by 
measuring OD620 and then used to sub-culture into 5 ml of the same medium for each 
strain/condition to a final OD620 ~ 0.03. Where required, the inducers IPTG and melibiose 
were added to the growth medium, to the final concentrations stated in the results chapters, 
when subcutured. Cultures were incubated at 37°C with aeration until mid-exponential phase 
(OD620 of 0.3-0.5). 250 µl samples of each culture were aliquoted into a sterile, black, 
optically clear bottomed, 96-well, Corning Costar 3603 plate (Thermo Scientific). 
Fluorescence at excitation wavelength 485 nm and emission wavelength 510 nm was 
measured for an integration time of 1 second using a Thermo Fluoroskan Ascent FL 
fluorometer (Thermo Scientific) after a 10 second shake step at 600 rpm. The OD620 of the 
samples was then measured using a Labsystems Multiskan MS plate reader (Thermo 
Scientific). Each experiment consisted of a minimum of 3 biological replicates for each strain 
tested and experiments were repeated on at least 2 separate occasions. The starting strain, 
E. coli K-12 MG1655, was grown under the same conditions as the test strains to measure 
auto-fluorescence of the cells, however no fluorescence was usually detected at the optical 
density used. The activity of the lac28 fragment promoter was derived as fluorescence/OD620 
to represent specific fluorescence of the culture, with mean and standard deviation calculated 
for each strain/condition. The in vivo half-life of the GFP protein is estimated to be greater 
than 24 hours when expressed in E. coli (Andersen et al., 1998). Hence, expressed eGFP 
protein is expected to accumulate during the time course used in these experiments, therefore 
representing the expression over the whole growth period used. 
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2.10.2 Stationary phase fluorescence assays 
Fluorescence assays were also used to measure the activity of the lac28::egfp fusion during 
stationary phase. Strains carrying the chromosome-encoded lac28::egfp fusion were grown 
overnight at 37°C with aeration in M9 minimal salts media, supplemented with 0.3% fructose. 
The culture was split into two 2.5 ml aliquots and 250 μM IPTG added to one of the cultures 
to induce activity of the lac28 fragment promoter. Cultures were then incubated for a further 5 
hours after the addition of inducer, after which 250 µl samples of each culture were aliquoted 
into a sterile, black, optically clear bottomed, 96-well, Corning Costar 3603 plate (Thermo 
Scientific). Fluorescence at excitation wavelength 485 nm and emission wavelength 510 nm 
was measured for an integration time of 1 second using a Thermo Fluoroskan Ascent FL 
fluorometer (Thermo Scientific) after a 10 second shake step at 600 rpm. Samples were 
diluted 1 in 10 in phosphate buffered saline and the OD620 was measured using a Labsystems 
Multiskan MS plate reader (Thermo Scientific). The activity of the lac28 fragment promoter 
was then derived by fluorescence/OD620 to represent specific fluorescence of the culture. The 
non-induced cultures demonstrated a fluorescence signal at the high optical density used in 
the experiment due to auto-fluorescence of the cells, therefore the fluorescence/OD620 value 
for the un-induced sample was subtracted from that of the induced sample to subtract 
background auto-fluorescence. This background fluorescence did vary slightly, but was 
always less than the starting MG1655 strain. Each experiment consisted of a minimum of 3 
biological replicates for each strain tested and experiments were repeated on at least 2 
separate days, with mean and standard deviation calculated for each strain/condition. 
 
2.11 Measurement of mRNA or gDNA by Quantitative real-time PCR 
Quantitative real-time PCR (qRT-PCR) was used to measure the copy number of the egfp  
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gene and to measure the levels of egfp mRNA in E. coli BRY strains. Total cellular RNA and 
genomic DNA were extracted from the same cultures, which were grown with and without 
inducer, by the methods described in sections 2.5.7. and 2.5.8. Total RNA was used as 
template to synthesise egfp and polA cDNA using the cDNA Synthesis Kit (Bioline), as 
described by the manufacturer’s protocol. The egfp QuantiTect Primer Assay (Qiagen) was 
used as the experimentally validated primer set and the D63693 and D63694 primers, which 
are designed to amplify the polA reference gene mRNA. To verify the absence of 
contaminating DNA in the samples, regular PCR was done with the RNA samples as the 
template. cDNA or gDNA was used as template in qRT-PCR, which was performed using an 
ABI Prism® 7000 Sequence Detection System (Applied Biosystems) and the SensiMix 
SYBR Hi-ROX Kit (Bioline), as described by the manufacturer’s protocol. Relative 
expression levels of the egfp target gene were determined by normalising reaction threshold 
cycle (CT) values to that of the polA reference gene. ΔCT values for un-induced (no IPTG) 
cultures were used as calibrators (ΔΔCT = ΔCTinduced - ΔCTun-induced) for analysis of results by 
the relative quantification method (2
-ΔΔC
T), which was used with standard curves (Livak and 
Scmittgen, 2001). Each reaction was repeated three times for each of three separate biological 
replicates to yield mean and standard deviation for each experiment. gDNA samples were 
analysed by the same method, however the ΔCT values for the BRY33 strain cultures, which 
carry the egfp gene at the tam locus, were used as calibrators for analysis of results by the 
relative quantification method (2
-ΔΔC
T). 
 
2.12 Gene gorging 
The gene gorging method of recombineering was adapted by Hollands (2009) to allow 
replacement of the E. coli chromosomal lacZYA promoter with any promoter of choice. This 
method was used to create a range of chromosome encoded promoter::lacZYA fusions, to 
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allow comparison of promoter activities when encoded by the chromosome or a multi-copy 
plasmid. Hence, a general protocol for replacement of the lacZYA regulatory region with a 
promoter fragment of interest on the E. coli chromosome by gene gorging is described here 
with slight modifications from the original protocol (Hollands, 2009). This method requires 
the use of the pKH3 plasmid which carries ampicillin resistance and the starting strain E. coli 
K-12 KH001, a derivative of MG1655 which carries a deletion in the DNA binding domain of 
lacI, and in which the lac promoter has been knocked out. The KH001 strain was co-
transformed with the mutagenesis plasmid, pACBSR (Cm
R
; Figure 2.3), and the pKH3 donor 
plasmid carrying the promoter of interest (Amp
R
; Figure 2.5), and co-transformants were 
selected on MacConkey lactose agar supplemented with chloramphenicol and ampicillin. A 
single co-transformant colony was suspended in 500 μl LB medium, supplemented with 
ampicillin and chloramphenicol, and incubated at 37˚C with aeration for ~3 h until the culture 
was turbid. Cells were harvested by centrifugation at ~18000 x g, and then washed in 0.1 x 
LB by resuspension. This process was repeated twice to remove any residual antibiotics, as no 
selection is required during induction of the mutagenesis machinery. Cells were then 
suspended in 500 μl 0.1 x LB supplemented with 0.3% L-arabinose to induce expression of 
the I-SceI endonuclease and λ-red homologous recombination proteins, which are encoded by 
the mutagenesis plasmid pACBSR. 0.1 x LB medium was used as no further growth was 
required during the mutagenesis procedure. The culture was incubated at 37˚C with aeration 
for a further ~3 h, after which 100 μl of a 10-6 dilution of the culture was spread onto each of 
10-15 non-selective MacConkey lactose agar plates and incubated overnight at 37˚C. 
Recombinant colonies displayed a Lac
+
 phenotype in a Lac
-
 background. Candidates were 
screened for the presence of the chromosomal insert by colony PCR, as described in section 
2.7.2, and sequencing using primers D56613 and D56614, which anneal to regions flanking 
the lacI and lacZ HRs (Table 2.7). 
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Efficiency of donor plasmid linearisation was tested by spreading 100 μl of a 1/1000 dilution 
of the culture, taken before and after addition of arabinose to the culture medium, on nutrient 
agar and nutrient agar supplemented with ampicillin. Cells in which the donor plasmid has 
been linearised will not be able to grow in the presence of ampicillin, therefore comparison of 
the number of ampicillin resistant colonies pre- and post-induction demonstrates the 
efficiency of donor plasmid linearisation. Candidates were screened for chloramphenicol 
sensitivity to confirm loss of the mutagenesis plasmid, after which a BRY strain number was 
assigned and the strain stored as a glycerol stock at -80˚C. 
 
2.13 Construction of chromosomal promoter::lacZ fusions by gene gorging 
2.13.1 Construction of promoter::lacZ fusions in the donor plasmid pKH3 
The hcp3831NS, CC-41.5 and CC-61.5 promoter fragments were cloned to form transcription 
fusions to lacZ in pKH3 to create donor vectors for gene gorging (Table 2.2). To do this, a 
BamHI recognition site was introduced downstream of the promoter transcription start sites 
(upstream of the translation initiation region), so as not to include the translation initiation 
regions of these promoters. Promoters were amplified by PCR from pRW50 vectors 
containing the relevant promoter, using the relevant primers, as listed in table 2.8. PCR 
products were purified using a QIAquick PCR purification kit then digested using EcoRI and 
BamHI restriction endonucleases. The CC promoter transcription fusions were cloned using 
EcoRI upstream and BglII downstream, due to the promoter containing an internal BamHI 
recognition site, therefore these digests were done using EcoRI and BglII. The digested 
fragments were then purified by electroelution from a 7.5% polyacrylamide gel and cloned 
into EcoRI/BamHI digested pKH3 vector, which had been CIP treated and purified by 
extraction from a 0.8% agarose gel. The promoter fragment inserts were confirmed by  
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Table 2.8: Oligonucleotides used for amplification of promoter fragments 
Name Sequence (5’ – 3’) 1 Use  
D65217 GCCGGGATCCTCCTTAATA
TACATGTTTAAGG 
Anneals to the phcp3831NS fragment to 
incorporate a BamHI site 10 bp downstream of 
the transcription start site. 
D65683 GCCGAGATCTATATCAGA
ATTATGGCAG 
Anneals to the 3’ end of the CC promoter 
fragments to incorporate a BglII site 1 bp 
downstream of the transcription start site. 
D66433 CGAGGAATTCGAACTCGG
TACCC 
Anneals to the 5’ end of the CC promoter 
fragments and introduces a G→A mutation in the 
SacI site immediately downstream of the EcoRI 
site. 
D66948 TATAGAATTCGGGCAGTG
AGCGCAACGC 
Anneals upstream of O
3
 in the lacZYA regulatory 
region and incorporates an EcoRI site. Used to 
create pRW500/plac. 
D69482 GCCGAAGCTTAAGGCGAT
TAAGTTGGG 
Anneals to lacZ to incorporate a HindIII site 
immediately downstream of codon 28 to create 
the lac28 promoter fragment. 
D54890 TGAAGGGCAATCAGCTGT
TG 
Anneals to 3’ end of lacI gene, upstream of 
cloning site in pKH3. Used for sequencing inserts 
in pKH3. 
D66432 CGCCACCATCCAGTGCAG Anneals downstream of the SacI restriction site in 
lacZ. Used in creating pRW500 derivatives. 
 
1
 Target sites for restriction endonucleases are underlined.  
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sequencing using primer D54890 (Table 2.7). Successful candidates were stored at -20˚C. 
 
2.13.2 Construction of chromosomal promoter::lacZ fusion by gene gorging 
The hcp3831NS, CC-41.5 and CC-61.5::lacZ transcription fusions were transferred to the 
chromosome of E. coli strain KH001 co-transformed with the mutagenesis plasmid, pACBSR, 
and the relevant pKH3 derivative by the gene gorging method described in section 2.12. 
Recombinant colonies were identified by a red phenotype (Lac
+
) in a white background (Lac
-
) 
on MacConkey lactose agar. Candidates were screened by colony PCR, as described in 
section 2.7.2, and sequencing using primers D56613 and D56614 (Table 2.7). Successful 
candidates were assigned a BRY strain number and stored as glycerol stocks at -80˚C and on 
MacConkey lactose plates (Table 2.1). 
 
2.14 Construction of promoter::lacZYA fusions in pRW500 
2.14.1 Construction of pRW500 
The lac expression vector pRW50 contains a trpBA fragment fused to lacZYA, creating a 
promoter::trpBA::lacZYA fusion, whereas the chromosomal promoter lacZ fusions created by 
gene gorging, as described in section 2.13.2, do not contain the trpBA fragment. Therefore the 
trpBA fragment of pRW50 was replaced with the pKH3 cloning region, which is present on 
the chromosome of strain KH001, to make promoter::lacZ fusions, encoded by the plasmid, 
comparable with that of the chromosomal copies, described in section 2.13.2 (Figure 2.25). 
The pKH3 promoter cloning region and 5’ end of lacZ were amplified by PCR using E. coli 
K-12 KH001 genomic DNA as template and using primers D54890 and D66432 (Table 2.8). 
Primer D54890 anneals to the 3’ end of the lacI gene, upstream of the promoter cloning site in  
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Figure 2.25: Schematic overview of pRW500 and pRW500 derivative construction 
For details see text (section 2.14). The pKH3 cloning site::lacZ chromosomal fusion was 
amplified from E. coli KH001 genomic DNA. This was then cloned into EcoRI-SacI digested 
pRW50 to replace the trpBA fragment and create plasmid pRW500. The same procedure was 
used to create pRW500 derivatives carrying promoter::lacZ fusions, except E. coli MG1655, 
KH002, BRY01, BRY03 or BRY05 genomic DNA was used as template for the PCR. Black 
circles represent plasmid DNA with the plasmid name in the centre. Genes are represented by 
block arrows with the direction of transcription depicted by the arrow and the gene name 
labelled. The position of restriction endonuclease target sites of interest are represented by 
black lines perpendicular to the plasmid or PCR DNA lines. Oligonucleotides are represented 
by thin arrow lines with the primer code number (D54890 and D66432). Cloning steps are 
represented by thick black arrows with the procedure labelled. 
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KH001, whereas primer D66432 anneals downstream of a unique target site for the restriction 
endonuclease SacI, which is within the lacZ gene. The PCR product was purified using the 
QIAquick PCR Purification Kit then digested with the endonucleases EcoRI and SacI before 
further purification by extraction from a 0.8% agarose gel. The plasmid pRW50 was digested 
with EcoRI and SacI, after which the larger fragment was purified by extraction from a 0.8% 
agarose gel, using the QIAquick Gel Extraction Kit. EcoRI-SacI digested pRW50 was then 
ligated with the EcoRI-SacI PCR fragment before being used to transform calcium chloride 
competent E. coli RLG221 to produce the plasmid pRW500 (Figure 2.2). The presence of the 
correct insert of was screened by DNA sequencing using primer D10520 (Table 2.4).  
 
2.14.2 Construction of promoter::lacZYA fusions in pRW500 
The chromosomal promoter::lacZYA fusions described in section 2.13.2 were amplified by 
PCR to allow direct cloning of each fusion into pRW500 and comparison between 
chromosome-encoded and plasmid-borne promoter activities (Figure 2.25). The lac, melR 
(TB10a), phcp3831NS, CC-41.5 and CC-61.5 promoter::lacZYA fusions were amplified by 
colony PCR from E. coli K-12 MG1655, KH002, BRY01, BRY03 or BRY05 strains using 
primers D54890 and D66432 (Table 2.8). PCR products were purified using the QIAquick 
PCR Purification Kit, after which they were digested with the restriction endonucleases EcoRI 
and SacI before further purification by extraction from a 0.8% agarose gel. Plasmid pRW500 
was prepared by EcoRI-SacI digest, CIP treatment and purification by extraction from a 0.8% 
agarose gel. EcoRI-SacI digested pRW500 was then ligated with the EcoRI-SacI PCR 
fragments, carrying the promoter::lacZ fusions, before being used to transform calcium 
chloride competent E. coli RLG221. Candidates were screened for the presence of the correct 
promoter::lacZ fusion by DNA sequencing using primer D54890 (Table 2.8). Successful 
candidates were stored at -20˚C (Table 2.2). 
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2.15 β-galactosidase assays 
β-galactosidase assays were used to measure the activity of promoter::lacZ fusions encoded 
either by the chromosome or plasmid during a range of growth conditions. Strains carrying 
the relevant promoter::lacZ fusion were grown overnight at 37°C with aeration in either LB 
media, M9 minimal salts media or minimal salts medium, as defined in section 2.2.1 and 
supplemented with the relevant anitbiotics, sugars or inducers. Density of the overnight 
culture was determined by measuring OD650 and then used to sub-culture into 5 ml of the 
relevant medium for each strain/condition to a final OD620 ~ 0.03. Cultures were incubated at 
37°C with aeration until mid-exponential phase (OD620 of 0.3-0.5). Each culture was lysed by 
adding 2 drops each of toluene and 1% sodium deoxycholate, mixing by vortex for 15 s and 
aerating for 30 min at 37 °C. 
The β-galactosidase activity of each culture was assayed by addition of 100 μl of each culture 
lysate to 2.5 ml Z buffer (10 mM KCl, 1 mM MgSO4.7H2O, 60 mM Na2HPO4, 30 mM 
NaH2PO4.2H2O supplemented with 2.7 ml β-mercaptoethanol per litre of distilled water, 
adjusted to pH 7) supplemented with 13 mM 2-Nitrophenyl β-D-galactopyranoside (ONPG). 
The reaction was incubated at 37˚C until a yellow colour developed, after which the reaction 
was stopped by adding 1 ml 1 M sodium carbonate. Absorbance of the reaction at OD420 was 
measured with a “no lysate” control reaction subtracted as background. β-galactosidase 
activity was calculated in Miller units using the following calculation: 
 
1000 x 2.5 x 3.6 x OD420nm 
β-galactosidase activity  =  _________________________________ nmol/min/mg bacterial mass 
          4.5 x OD650nm x t x v                                  
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Where: 
2.5 = factor for conversion of OD650 into bacterial mass, based on OD650 of 1 being 
         equivalent to 0.4 mg/ml bacteria (dry weight).  
            3.6 = final assay volume (ml) 
   1000/4.5 = factor for conversion of OD420 into nmol o-nitrophenyl (ONP), based on 1  
                     nmol ml
-1 
ONP having an OD420 of  0.0045 
    t = incubation time (min) 
               v = volume of lysate added (in ml)   
 
Each experiment consisted of a minimum of 3 biological replicates for each strain tested and 
experiments were repeated on at least 2 separate occasions, with mean and standard deviation 
being calculated for each strain/condition. 
 
2.16 α-galactosidase activity assays 
α-galactosidase assays were used to measure expression of the melAB operon, which encodes 
genes required for transport and utilisation of the sugar melibiose. Strains used were deficient 
in lacY expression, due to the lacY gene product interfering with transport of melibiose, the 
inducer of the melAB operon. The relevant E. coli strains were grown overnight with aeration 
in 5 ml M9 minimal salts media at 30°C, due to the temperature sensitivity of the melibiose 
symporter, MelB. Density of the overnight culture was determined by measuring OD650 and 
then used to sub-culture into 5 ml M9 minimal salts medium, supplemented with 0.2% 
melibiose where stated, to a final OD620 ~ 0.03. Cultures were incubated at 30°C with aeration 
until mid-exponential phase (OD620 of 0.3-0.5). Optical density of the culture at OD650 and 
OD410 was measured and recorded. 50 μg/ml chloramphenicol was added to each culture and 
incubated for 10 mins with aeration to arrest protein production. 60 μl 0.1 M 4-nitrophenyl 
α-D-galactopyranoside was added directly to 2 ml of each culture and incubated at 30˚C with 
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aeration until a yellow colour developed, after which the reaction was stopped by addition of 
160 μl 0.5 M EDTA and 167 μl 3 M sodium carbonate. The final OD410 was recorded and α-
galactosidase activities calculated as follows: 
    2.5 x 2.387 x ΔOD410 
α-galactosidase activity =   _____________________________ 
    t x 0.0045 x 2 x OD650 
 
Where: 2.5 = factor for conversion of OD650 into bacterial mass, based on OD650 of 1 being 
         equivalent to 0.4 mg/ml bacteria (dry weight).  
         2.387 = final assay volume (ml) 
      0.0045 = factor for conversion of OD410 into nmol p-nitrophenyl (PNP), based on 1  
                     nmol ml
-1 
PNP having an OD410 of  0.0045 
    t = incubation time (min) 
               v = volume of culture added (in ml)  
 
Each experiment consisted of a minimum of 3 biological replicates for each strain tested and 
experiments were repeated on at least 2 separate occasions, with mean and standard deviation 
being calculated for each strain/condition. Mean activity for the un-induced cultures was 
subtracted from that of the induced cultures as background. 
 
2.17 Fluorescence microscopy 
Cells were harvested by centrifugation at ~18000 x g from 1.5 ml of the appropriate liquid 
culture. Cells were then washed 3 times with PBS. Cells were harvested by centrifugation and 
all supernatant was removed using a pipette. The cell pellet was resuspended in 5 μl PBS and 
pipetted into the centre of the slide and a cover slip applied. Slides were imaged using a 
Nikon Eclipse 90i microscope using a FITC filter for visualising GFP. 
 126 
 
 
 
 
 
 
 
 
 
 
Chapter 3:  
 
Position-dependent modulation of promoter activity  
in Escherichia coli 
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3.1 Introduction 
3.1.1 Position-based modulation of promoter activity 
The expression level of any bacterial gene is set by modulation of RNAP binding to defined 
target sequences within the upstream regulatory element, in response to specific chemical or 
physical stimuli. This is achieved by transcription factor binding in regulatory regions and 
interacting with the multi-subunit RNAP holoenzyme to regulate transcription initiation 
(reviewed by Lee et al., 2012). However, changes to the physiological status of the cell, such 
as growth phase or nutrient limitation, can also affect the global transcription profile through 
NAP binding (Browning et al., 2010; Dillon and Dorman, 2010) or variations of superhelical 
density (Peter et al., 2004; Blot et al., 2006; Travers and Muskhelishvili, 2007). These global 
effects on gene expression, and the compaction of the genome to form the nucleoid, suggest 
that position within the folded chromosome could also affect the level of transcription, as 
suggested by Schmid and Roth (1987). However, to date, the effect of chromosomal position 
on gene expression has barely been investigated, with previous studies being limited in 
experimental design by technologies and knowledge available at the time (Beckwith et al., 
1966; Schmid and Roth, 1987; Sousa et al., 1997). Therefore, in the work presented in this 
chapter, I aimed to utilise the gene doctoring method of recombineering (Lee et al., 2009) to 
insert one relatively small promoter and reporter gene at different loci throughout the E. coli 
K-12 chromosome. 
 
3.1.2 Gene doctoring: chromosome engineering by homologous recombination 
The gene doctoring method is an enhanced protocol for the incorporation of mutant alleles 
into the bacterial chromosome by λ-Red mediated homologous recombination (Lee et al., 
2009). The Red recombinase system of bacteriophage λ exploits three proteins, encoded by 
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the gam, bet and exo genes, which facilitate the recombination of linear double-stranded DNA 
molecules. In gene doctoring, the Saccharomyces cerevisiae I-SceI endonuclease is used to 
generate a linear DNA fragment (the donor molecule) in vivo. Expression of the Gam protein 
inhibits degradation of this fragment by the host RecBCD complex. The Exo protein is a 3’ to 
5’ exonuclease that acts on the donor molecule to create 3’ single stranded overhangs to allow 
binding by the single stranded DNA binding protein, Bet. The Bet protein then facilitates 
strand invasion and recombination at the site of homology in the host chromosome, with the 
assistance of the host RecA protein (Murphy, 1998).  
The gene doctoring method uses a two-plasmid system based on the gene gorging method of 
Herring et al. (2003) in which the target DNA, containing regions of homology to the 
chromosome, is delivered to the cell on a stable, high copy number plasmid (Figure 3.1). The 
donor DNA, carrying the regions of homology, is flanked by DNA recognition sites for the 
I-SceI endonuclease, of which there are none in the E. coli chromosome. The I-SceI 
endonuclease and the λ-Red genes are under control of an arabinose inducible promoter 
encoded by the mutagenesis plasmid pACBSR, which is co-transformed with the donor 
plasmid. Therefore, upon addition of arabinose to the growth medium, the donor plasmid is 
linearised by the I-SceI endonuclease and the λ-Red machinery facilitates recombination of 
the donor fragment with the E. coli chromosome. Recombination is selected by incorporation 
of a kanamycin resistance cassette on the donor fragment, which is flanked by DNA 
recognition sites for the FLP recombinase. Subsequent expression of the FLP recombinase 
from the pCP20 plasmid allows recombination of the FLP recombinase target sites resulting 
in removal of the kan cassette. Further to this, the sacB sucrose sensitivity gene is included in 
the donor plasmid, outside of the donor fragment, therefore allowing counter-selection against 
retention of the donor plasmid (Figure 3.1). The gene doctoring method was utilised in this 
study to incorporate a promoter and reporter gene at various chromosomal loci. 
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Figure 3.1: Diagram of gene doctoring recombineering 
Figure on page 130. a. Recipient E. coli MG1655 is co-transformed with the pACBSR 
recombineering plasmid and the pJB donor plasmid. Addition of arabinose to the growth 
medium induces expression of I-SceI endonuclease and the λ-Red recombination machinery 
from the pACBSR plasmid. The donor plasmid is linearised by the I-SceI endonuclease to 
allow λ-Red mediated recombination of the donor fragment with the homologous regions of 
the chromosome. Recombinants should have lost the sacB gene and retained the kan cassette, 
therefore are selected by ability to grow on solid media supplemented with kanamycin and 
sucrose. Recombinants are transformed with the temperature sensitive pCP20 plasmid 
encoding FLP-recombinase, which recognises sites flanking the kanamycin resistance cassette 
allowing removal of the cassette. Recombinants are verified by PCR amplification of genomic 
DNA and sequencing. b. Schematic diagram of pACBSR and pJB donor plasmids. Arrows 
represent genes and indicate the direction of transcription. Approximately to scale. 
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Figure 3.1: Diagram of gene doctoring recombineering 
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3.2 Construction of donor plasmids and preliminary experiments 
The green fluorescent protein (GFP) of the jellyfish Aequorea victoria offers an exceptionally 
useful tool for the study of biological systems. Since the discovery of GFP in 1962, this 
protein has been modified to produce an enormous variety in colour, brightness, maturation 
and codon optimisation, making it applicable to a vast number of applications (Shimomura et 
al., 1962; Shaner et al., 2005). The requirement for a small reporter gene, for this experiment, 
led to the selection of the 714 bp egfp gene, which is codon optimised and encodes a brighter 
version of the A. victoria GFP, also demonstrating faster maturation in bacteria than the wild 
type protein (Tsien, 1998).  
The gene doctoring method requires the use of a plasmid to donate the insert and flanking 
homology regions, therefore a master donor plasmid for the fusion of any promoter to the egfp 
gene was created. The donor plasmid was based on the I-SceI flanked donor fragment of the 
pKH5 gene gorging plasmid cloned into the pDOC-C gene doctoring plasmid (Figure 2.5; 
Figure 2.8; Figure 2.9). This resulted in the pJB3 master donor plasmid. The plasmid contains 
the kanamycin resistance cassette and λ oop transcription terminator, of the pKH5 plasmid, to 
allow selection of recombinants and prevent read-through from upstream operons. The lacI 
homology region was replaced with a multiple cloning site and the lacZ homology replaced 
with the egfp gene, followed by a downstream multiple cloning site (Figure 2.8; Figure 2.9). 
For details of plasmid construction and plasmid maps please see section 2.9.2 and figures 2.5 
and 2.6. 
The lac promoter was chosen to drive transcription of egfp because it is a very well 
characterised, strong and natural E. coli promoter. Therefore the lac00 fragment, containing 
the endogenous E. coli lac promoter region from position -93 bp to +41 bp relative to the 
transcription start site, was amplified by PCR. This fragment includes the lacZ ATG and was 
fused to the egfp gene by cloning the fragment into the EcoRI/HindIII site of the gorging 
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vector pJB3, to create plasmid pJB4 (Figure 3.2a). The pJB4 plasmid was used to transform 
the E. coli MG1655 lacI
-
 derivative strain, KH000, which was then visualised by fluorescence 
microscopy (Table 2.1; Figure 3.3b). The fluorescent signal detected from cells, transformed 
with the pJB4 plasmid, was very low and required a long 900 ms exposure for detection. This 
suggested that expression of eGFP by the lac00 fragment was poor. Experiments reported by 
Kudla et al. (2009) demonstrated that expression of a promoter::gfp fusion could be 
significantly increased by addition of a 28 codon leader sequence with weak secondary 
mRNA structure. Therefore, the first 28 codons of the lacZ gene were included in the 
promoter fragment. The lac28 fragment, containing the endogenous E. coli lac promoter 
region from position -93 bp to +122 bp, relative to the transcription start site, was amplified 
by PCR from genomic DNA. This fragment was then fused to the egfp gene, of the pJB3 
plasmid, by cloning into the EcoRI/HindIII site, to create the pJB15 plasmid (Figure 3.2b). 
Visualisation of E. coli KH000, transformed with pJB15, by fluorescence microscopy with a 
10 ms exposure, showed cells with a similar fluorescence intensity to that of pJB4 
transformed cells, visualised with a 900 ms exposure. These results indicated approximately a 
90-fold increase in expression upon addition of the first 28 codons of the lacZ gene to the 
promoter fragment (Figure 3.3). Therefore this fusion was used for insertion into the 
chromosome. 
The pJB15 plasmid carries stop codons in each of the three reading frames and the λ oop 
transcription terminator upstream of the lac28 fragment, to prevent translational and 
transcriptional read-through from neighbouring genes. Upstream of the terminator is the 
kanamycin resistance gene flanked by flippase recognition target (FRT) sites, which when 
removed by FLP recombinase, leaves behind one copy of the 34 bp FRT site. The egfp gene 
also has two stop codons in the next two reading frames after the egfp stop codon to prevent 
any translational read-through (Figure 2.6). Oligonucleotide primers used in the construction 
of these plasmids and fragments are listed in table 2.5 (Materials and Methods). The I-SceI
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a. 
EcoRI .        .lacIO3   .         .crp      .         .         .-35      .         .   -10   .         
gaattcGGGCAGTGAgcgcaacgcaattaatgtgagttagctcactcattaggcaccccaggctttacactttatgcttccggctcgtatgttgtg 
 
  +1     .lacIO1   .         . SD      . lacZ HindIII               
tggAattgtgagcggataacaatttcacacaggaaacagctATGaagctt 
 
b. 
 
EcoRI .        .lacIO3   .         .crp      .         .         .-35      .         .   -10   .         
gaattcGGGCAGTGAgcgcaacgcaattaatgtgagttagctcactcattaggcaccccaggctttacactttatgcttccggctcgtatgttgtg 
 
  +1     .lacIO1   .         . SD      . lacZ    .         .         .         .         .         
tggAattgtgagcggataacaatttcacacaggaaacagctATGACCATGATTACGGATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAA 
 
   .         .         .  HindIII.                            
ACCCTGGCGTTACCCAACTTAATCGCCTTaagctt 
 
 
Figure 3.2: Sequence of the lac00 and lac28 promoter fragments 
a. The base sequence of the lac00 EcoRI-HindIII promoter fragment containing the lacZYA regulatory element from – 93 bp to + 41 bp relative 
to the transcription start site. b. The sequence of the lac28 EcoRI-HindIII promoter fragment containing the lacZYA regulatory element from 
-93 bp to + 122 bp relative to the transcription start site. The lacZ start codon and the lacZ gene are shown in bold capitals with the 
Shine-Dalgarno sequence underlined and bold. The promoter -10, -35 and transcription start sites are in bold and underlined. The lacI operator 
sequences are boxed and labelled and the DNA site for CRP is double underlined. Restriction endonuclease target sites are boxed, italicised and 
labelled. 
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KH000 900 ms KH000 pJB4 (plac) 900 
ms
KH000 pJB15 (plac28) 10 ms
a. b.
c.
KH000 pJB4 (lac00) 900 ms
 lac28) 10 ms
 
Figure 3.3: Expression of eGFP by cells carrying either lac00::egfp or lac28::egfp 
Images were captured using a Nikon Eclipse 90i and eGFP fluorescence visualised using a 
FITC filter. a. The LacI
-
 KH000 strain was visualised by fluorescence microscopy with a 
900 ms exposure and showed no signal. b. The KH000 strain transformed with pJB4 
(lac00::egfp) was visualised by fluorescence microscopy with a 900 ms exposure and showed 
a signal, indicating eGFP expression c. The KH000 strain transformed with pJB15 
(lac28::egfp) was visualised by fluorescence microscopy with a 10 ms exposure and showed a 
similar signal intensity to that of KH000 pJB4 with a 900 ms exposure, therefore indicating a 
~ 90-fold increase in expression. 
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donor fragment of pJB15 was cloned into the gene doctoring plasmid pDOC-C, to allow the 
fragment to be inserted into the E. coli K-12 MG1655 chromosome at target loci (Figure 2.9).  
Insertion of egfp into the E. coli chromosome was targeted to non-coding DNA sites between 
convergent genes to minimise disruption of local chromosomal architecture and gene 
expression. Approximately 500 bp of homology either side of each target locus was amplified 
by PCR from MG1655 genomic DNA, using pairs of primers that incorporate either MfeI and 
XmaI, or NheI and SacI restriction endonuclease target sites at the ends of the PCR products 
(Figure 3.4). Oligonucleotide primers used for homology region amplification are listed with 
a description of usage in table 2.6. The PCR product, encoding the upstream homology 
region, was then digested with MfeI and XmaI before being ligated into MfeI-XmaI digested, 
CIP treated and gel purified pJB22 (Figure 2.9). The resulting plasmid was checked by 
sequencing and used to repeat the procedure for the downstream homology region with NheI 
and SacI restriction endonucleases (Figure 3.4). E. coli K-12 MG1655 was then transformed 
with the resulting plasmid and the mutagenesis plasmid pACBSR, after which the lac28::egfp 
fusion was inserted into the target site by the gene doctoring method as described in section 
2.8 (Figure 3.1). 
 
3.3 Insertion of the lac28::egfp fusion at different chromosomal loci 
To assess the effect of chromosomal location on gene expression, a series of gene doctoring 
donor plasmids, each carrying the lac28::egfp fusion, was created to allow the insertion of the 
fusion at various chromosomal loci. The lac target locus was the first selected in order to find 
the activity of the fusion at the wild-type location for the promoter. The chromosomal lac 
gene regulatory element, including the LacI O
2
 binding site, was replaced with the lac28::egfp 
fusion. Homology regions were selected to allow replacement of the lacZYA gene regulatory 
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Figure 3.4: General protocol for construction of gene doctoring donor plasmids 
Basic protocol used to make all donor plasmids for insertion of the lac28::egfp fusion into the 
E. coli chromosome by gene doctoring. Arrows represent genes, while black lines denote 
intergenic regions (approximately to scale). Direction of transcription of each gene is 
indicated by the arrow heads. DNA modifying enzyme target sites are represented by vertical 
black lines and are labelled. The arrow represents the position and orientation of the lac28 
promoter. The hairpin-loop structure represents the position of the λ oop transcription 
terminator. Step 1. The gene A homology region is amplified by PCR from MG1655 genomic 
DNA, digested with MfeI and XmaI then ligated into MfeI-XmaI digested pJB22. Step 2. The 
downstream gene B homology region is then amplified by PCR to incorporate NheI and SacI 
DNA sites and cloned into the NheI-SacI site of the resulting plasmid. 
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region from position -84 bp to +436 bp, with the lac28::egfp fusion, and cloned into the 
pJB22 gene doctoring donor plasmid as described in section 3.2 (Figure 3.4). Gene doctoring 
was then used to insert the fusion at the lac locus in the genome of E. coli K-12 MG1655. The 
resulting strain was referred to as BRY40 (Table 2.1). 
Homology regions were then selected to target the reporter to non-coding regions between 
convergent genes at different chromosomal positions. Homology regions were amplified by 
PCR then cloned into the pJB22 gene doctoring plasmid, as described in section 3.2 (Figure 
3.4). pJB gene doctoring donor plasmids, listed in table 2.2, were used to place the identical 
lac28::egfp fusion at 13 other chromosomal positions in E. coli K-12 MG1655: ara 
(72143 bp), mel (4342915 bp), yafT (238142 bp), eaeH (313681 bp), rcs (2314948 bp), ycb 
(1005714 bp), tam (1606129 bp), nupG (3104995 bp), asl (3982359 bp), yqe (2987820), pitB 
(3132854 bp), dkgB (229046 bp) and mntH (2509358 bp) (Figures 2.11-2.24; Figure 3.5). 
Target loci were named based on a neighbouring gene and exact positions of insertion within 
the E. coli chromosome are given in bp, with respect to the co-ordinate system origin, as 
defined by EcoCyc (Keseler et al., 2011). Resulting strains were assigned BRY numbers, e.g 
BRY40, see table 2.1. 
The 13 chromosomal positions were targeted to allow incorporation of the fusion at a diverse 
range of chromosomal loci, which represent at least one target site in every macrodomain, as 
defined by Valens et al. (2004). Several loci were targeted to allow investigation of suspected 
position-specific effects. For example, selection of the yafT, eaeH, ycb, yqe and pitB positions 
allowed investigation of promoter activity from within tsEPODs. Also, the asl and tam loci 
were targeted to allow comparison of expression near to the origin of replication with that 
near to the furthest point from the origin of replication on the chromosomal map. Further to 
this, the mel and dkgB loci were chosen to allow the analysis of the effects of neighbouring 
gene expression. The remaining target loci were selected to obtain better coverage of the  
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Figure 3.5: Map of the E. coli MG1655 chromosome and positions of lac28::egfp 
insertion 
The black circle represents the E. coli MG1655 circular chromosome of total size 
4639675 bp. The grey shaded blocks and two white gaps represent the six macrodomain as 
defined by Valens et al. (2004) and are labelled. The position of oriC and the dif, the direct 
opposite locus are marked with black lines and labelled with their positions in kb relative to 
the co-ordinate system origin. Arrows indicate the position of sites of insertion for the 
lac28::egfp construct and the direction of the arrows indicates the orientation of the promoter. 
Sites of insertion are labelled according to the names of neighbouring genes. 
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chromosome. Where possible, no genetic material was removed from the chromosome in 
order to minimise disruption to local chromosomal processes, such as transcription. The target 
site of reporter gene insertion was positioned to avoid disturbance to Rho-independent 
terminators of neighbouring gene transcription, where necessary. Insertion of egfp at the eaeH 
locus was within a pseudogene, as opposed to between convergent genes. However, this 
should have minimum consequences, due to the eaeH pseudogene not being expressed. Also, 
insertion at the dkgB locus was not between convergent genes. The fusion was targeted to a 
position upstream of the dkgB gene regulatory element and downstream of the ribosomal 
RNA coding operon rrsHrrlHrrfH and aspU gene. Orientation of the lac28::egfp fusion on 
the left arm of replication at the tam, rcs, mntH, yqe, nupG and pitB opposes that of 
replication. Insertion of egfp at the ara and lac loci on the right arm of replication also is 
opposed to replication. However, transcription of egfp at all the other loci was co-directional 
with DNA replication, therefore giving a representation of both orientations with respect to 
replication. 
 
3.4 Validation of eGFP fluorescence as a measure of mRNA level 
Regulation of gene expression in E. coli can also occur post-transcriptionally through 
mechanisms such as regulation of translation or mRNA stability. The experiments completed 
in this chapter utilised the lac28::egfp fusion to measure effects of chromosomal position on 
promoter activity by quantification of eGFP fluorescence. Therefore, to check that this is a 
valid measure of egfp mRNA level, with no interference from regulation of translation, the 
mRNA product was measured after expression at 3 different positions and compared to the 
eGFP fluorescence from those same cultures. The BRY33, BRY40 and BRY34 strains, 
carrying egfp at the tam, lac and nupG loci, were selected because they demonstrated a wide 
range of eGFP expression levels (Figure 3.6). 
140 
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
tam  lac  nupG
F
lu
o
r
e
s
c
e
n
c
e
/O
D
6
2
0
ta lac nu
F
lu
o
re
s
c
e
n
c
e
 /
 O
D
6
2
0
a.
0
5
10
15
20
25
tam  lac  nupG
F
o
ld
 c
h
a
n
g
e
 i
n
 e
G
F
P
 m
R
N
A
 e
x
p
r
e
s
s
io
n
ta lac nu
e
g
fp
m
R
N
A
 e
x
p
re
s
s
io
n
b.
0 μM IPTG
100 μM IPTG
 
Figure 3.6: Comparison of eGFP fluorescence and egfp mRNA levels in different 
constructs 
a. Fluorescence/OD620 measured in strains BRY33 (tam), BRY40 (lac) or BRY34 (nupG). 
Cells were grown aerobically at 37°C to mid-exponential phase (OD620 0.3-0.5) in M9 salts 
medium supplemented with the inducer of the lac operon IPTG, where stated. Data shown are 
averages of fluorescence/OD620 measurements from at least three independent experiments, 
and error bars show one standard deviation from the mean. b. egfp mRNA expression upon 
induction of the lac28 promoter::egfp construct from the cultures described in (a.). Data are 
normalised to the un-induced culture. Data show that GFP fluorescence patterns and egfp 
mRNA levels correlate. 
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Expression of the egfp target gene at the tam, lac and nupG loci was assayed by measuring 
fluorescence during mid-late exponential growth on M9 minimal salts medium, supplemented 
with 0.3% fructose as the carbon source. Experiments were performed in the presence or 
absence of 100 μM IPTG, due to the lac promoter being inducible (see later). Total RNA was 
isolated from each of these cultures in parallel. Quantitative real-time PCR (qRT-PCR) was 
used to measure the level of egfp mRNA expressed in strains carrying the fusion at the tam, 
lac and nupG loci. Oligonucleotide primers specific for the target egfp gene (Qiagen) and an 
internal control, polA, were used to amplify cDNA before being used in the qRT-PCR 
reaction. Expression of egfp at the tam locus, which is furthest from the origin of replication, 
was approximately 60% lower than that at the lac locus (Figure 3.6). However, expression of 
egfp at the nupG locus gave more than 2-fold greater expression than that at the lac locus. The 
fluorescence of strains BRY33, BRY40 and BRY34 correlated well with the fold changes in 
egfp mRNA level measured by qRT-PCR upon induction with the inducer IPTG (Figure 3.6). 
These results demonstrate that measurement of eGFP fluorescence is a valid measure of the 
mRNA levels within the cell. Therefore translational efficiency is not altered by change of 
promoter::egfp position within the chromosome. 
 
3.5 Promoter activity during mid-logarithmic growth 
3.5.1 The effect of chromosome position on promoter activity 
To measure the effect of position within the chromosome, and local genetic context, on 
promoter activity, egfp expression was assayed in E. coli strains carrying the lac28::egfp 
fusion at the different chromosomal positions, described in section 3.3 (Table 2.1; Figure 3.5). 
Fluorescence of strains was measured during mid-late exponential growth on M9 minimal 
salts medium supplemented with 100 μM IPTG to induce transcription of egfp, where stated. 
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Expression of the egfp gene was derived from the fluorescence at 510 nm divided by OD620 of 
at least three separate experiments to give the mean and standard deviation. The starting E. 
coli K-12 MG1655 strain was included as a control for auto-fluorescence, however the control 
samples and the un-induced cultures registered no fluorescent signal. Therefore no auto-
fluorescence was detected at the OD620 measured and no fluorescent signal is detected in the 
absence of the inducer, IPTG. These controls suggest that no transcriptional read-through is 
occurring from neighbouring operons. 
The data, summarised in figure 3.7, show that during exponential growth, promoter activity is 
not only dependent on the sequence of the promoter region, but also upon position within the 
chromosome. Position is shown to have an effect on egfp expression, giving up to a 310-fold 
variation in promoter activity across the chromosomal loci tested, regardless of the lac28 
fragment and egfp reporter gene having the same sequences at all loci (Figure 3.7). Positions 
that were uniquely better or worse for promoter activity were found across the entire genome. 
The greatest activity was found at the asl locus, which is closest to the origin of replication 
and gave a signal that was approximately 2.3-fold greater than that of the strain carrying egfp 
at the lac locus. Similar levels of activity to that at the asl locus were found at the nupG locus, 
which is positioned on the left arm of replication, within the NSL macrodomain (Figure 3.7). 
The weakest expression of egfp was at the ara, yafT, tam, mntH and pitB target loci, which 
reside within the NSR, Ter, Left and NSL macrodomains (Figure 3.7). These results suggest 
that position within the E. coli chromosome does affect promoter activity and that these 
effects can be large. 
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Figure 3.7: Expression of egfp at different chromosomal positions during mid-
exponential growth 
Expression of the lac28::egfp fusion during mid-exponential growth (OD620 ~ 0.4) at 37 ˚C in 
M9 minimal medium supplemented with 100 μM IPTG, the inducer of the lac28 promoter. 
Each point represents the fluorescence at 485 nm excitation, 510 nm emission, divided by the 
OD620 of the sample and is the average of at least three independent experiments with the 
error bars showing one standard deviation from the mean. E. coli MG1655 and each of the 
strains in the absence of inducer were also assayed, however no fluorescence signal was 
detected, therefore indicating no auto-fluorescence or un-induced expression. These data are 
not included for the purpose of clarity. The position of each point on the x-axis indicates 
chromosomal position in Mb with respect to the co-ordinate system origin and is to scale. The 
positions of the six macrodomains are represented by the grey shaded boxes with oriC and the 
dif indicated by vertical black lines.  
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3.5.2 Position-dependent modulation of promoter activity does not correlate with 
macrodomains 
The E. coli chromosome is organised into six distinct macrodomains, two of which have 
greater mobility than the rest. These macrodomains occupy distinct positions within the cell 
and this organisation may be an influential factor in position-dependent modulation of 
promoter activity (Valens et al., 2004; Espeli et al., 2008). The rcs and mntH positions are 
both within the Left macrodomain, however egfp expression at rcs was approximately 5-fold 
greater than that of the mntH locus (Figure 3.8). The reporter gene was also targeted to two 
loci within the ORI macrodomain, the asl and mel loci. Activity at the asl locus was 
approximately 4.5-fold greater than that of the promoter activity at the mel locus, regardless 
of the fact that they reside within the same macrodomain (Figure 3.8). Further to this, the ara, 
dkgB and lac target loci are all positioned within the NSR macrodomain, however activity of 
the lac28::egfp fusion at the dkgB locus was undetectable and expression of egfp at the ara 
locus was approximately 6.5-fold weaker than that at the lac locus (Figure 3.8). These results 
indicate that strength of promoter activity is unlikely to correlate with macrodomain location. 
 
3.5.3 Transcription silencing within tsEPODs 
The yafT, eaeH, ycb, yqe and pitB target loci are positioned within regions of the chromosome 
that are highly occupied by protein binding, and have extremely low levels of transcription of 
genes within the domain (Figure 3.5). The work of Vora et al. (2009) defined these regions as 
transcriptionally silent extended protein occupancy domains (tsEPODs) and demonstrated that 
they are distributed across the entire chromosome. Expression of egfp at the eaeH and ycb 
tsEPOD loci was extremely weak, giving a signal that was < 1% of that from the lac locus or 
approximately 310-fold weaker than that seen from the best expressed locus,  
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Figure 3.8: Comparison of promoter activity within different macrodomains 
Fluorescence/OD620 measured in strains BRY13 (ara), BRY58 (dkgB), BRY40 (lac), BRY27 
(rcs), BRY73 (mntH), BRY34 (asl), or BRY15 (mel), carrying lac28::egfp at the designated 
chromosomal locus. Cells were grown aerobically at 37°C to mid-exponential phase (OD620 
0.3-0.5) in M9 salts medium supplemented with the inducer of the lac operon, IPTG, where 
stated. Data shown are averages of fluorescence/OD620 measurements from at least three 
independent experiments, and error bars show one standard deviation from the mean. Loci 
within the NSR, Left and NSL macrodomains are indicated by lines and labels. Data show 
that expression of egfp varies drastically within macrodomains, therefore suggesting no 
correlation between promoter activity and position with respect to macrodomains. 
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asl (Figure 3.7; Figure 3.9). Activity of the lac28 fragment promoter at the yqe locus was 
undetectable, as the strain carrying egfp at this locus gave no fluorescent signal in the 
presence of the inducer IPTG (Figure 3.9). However, lac28 fragment promoter activity at the 
yafT and pitB tsEPOD loci was stronger than that of the other tsEPOD loci, giving activity 
similar to that of the promoter at the tam locus, near to the dif site. The activity at the yafT and 
pitB loci was approximately 20% and 30% as strong as that at the wild-type lac locus, 
respectively (Figure 3.9). These results suggest that the transcriptionally silent profile of 
tsEPODs could be due to the nature of the domain, as opposed to merely containing poor 
promoters. Expression at tsEPODs is analysed in further detail in section 4.5. 
 
3.5.4 The effect of proximity to the origin of replication 
Position within a chromosome has been reported to affect gene expression in several studies, 
which identified proximity to the origin as a key factor (Beckwith et al., 1966; Chandler and 
Pritchard, 1975; Schmid and Roth, 1987; Sousa et al., 1997; Block et al., 2012). Analysis of 
position-dependent variation of promoter activity demonstrates a similar pattern of increased 
activity with proximity to the origin of replication (Figure 3.7; Figure 3.10). Expression of 
egfp at the lac, tam, rcs, nupG  and asl loci showed increasing activity with proximity to the 
origin of replication, with the greatest activity at the asl locus, nearest the origin, and the 
weakest at the tam locus, near the dif site (Figure 3.10). However, activity of the lac28 
fragment promoter did not conform to this expected pattern of gene expression at several of 
the loci tested. 
Activity of the reporter at the mel, ara and dkgB loci was significantly less than at the lac 
locus, in spite of these three loci being positioned closer to the origin of replication than the 
lac locus (Figure 3.11). Also, egfp positioned at the mntH locus was closer to the origin than  
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Figure 3.9: Silencing of promoter activity at tsEPOD loci 
Fluorescence/OD620 measured in strains BRY40 (lac), BRY22 (yafT), BRY23 (eaeH), BRY32 
(ycb), BRY54 (yqe) or BRY55 (pitB), carrying lac28::egfp at the designated chromosomal 
locus. Cells were grown aerobically at 37°C to mid-exponential phase (OD620 0.3-0.5) in M9 
salts medium supplemented with the inducer of the lac operon, IPTG, where stated. Data 
shown are averages of fluorescence/OD620 measurements from at least three independent 
experiments, and error bars show one standard deviation from the mean. Data show that 
promoter activity at tsEPOD loci is exceptionally weak, however expression at the yafT and 
pitB loci is strongest. 
Chromosomal position 
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Figure 3.10: Chromosomal loci with increasing promoter activity with proximity to oriC 
Expression of the lac28 promoter::egfp fusion during mid-exponential growth (OD620 ~ 0.4) at 
37 ˚C in M9 minimal medium supplemented with 100 μM IPTG, the inducer of the lac28 
promoter. Each point represents the fluorescence at 485 nm excitation, 510 nm emission, 
divided by the OD620 of the sample and is the average of at least three independent 
experiments with the error bars showing one standard deviation from the mean. Wild type E. 
coli MG1655 and each of the strains in the absence of inducer were also assayed, however no 
fluorescence signal was detected, therefore indicating no auto-fluorescence or un-induced 
expression. These data are not included for the purpose of clarity. Position of each point on 
the x-axis indicates chromosomal position in Mb with respect to the coordinate systme origin 
and is to scale. The positions of the six macrodomains are represented by the grey shaded 
boxes with oriC and the dif indicated by vertical black lines. Data show the chromosomal 
positions that correlate with the pattern of increasing egfp expression with proximity to the 
origin of replication. 
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Figure 3.11: Chromosomal loci which do not show increasing promoter activity with 
proximity to oriC 
Expression of the lac28 promoter::egfp fusion during mid-exponential growth (OD620 ~ 0.4) at 
37 ˚C in M9 minimal medium supplemented with 100 μM IPTG, the inducer of the lac28 
promoter. Each point represents the fluorescence at 485 nm excitation, 510 nm emission, 
divided by the OD620 of the sample and is the average of at least three independent 
experiments with the error bars showing one standard deviation from the mean. Wild type 
E. coli MG1655 and each of the strains in the absence of inducer were also assayed, however 
no fluorescence signal was detected, therefore indicating no auto-fluorescence or un-induced 
expression. These data are not included for the purpose of clarity. Position of each point on 
the x-axis indicates chromosomal position in Mb with respect to the coordinate system origin 
and is to scale. The positions of the six macrodomains are represented by the grey shaded 
boxes with oriC and the dif indicated by vertical black lines. Data show the chromosomal 
positions that do not correlate with the pattern of increasing egfp expression with proximity to 
the origin of replication. 
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the rcs locus, however promoter activity at the mntH locus was approximately 5-fold weaker 
than that at the rcs locus (Figure 3.11). Further to this, the distance of the nupG locus from the 
origin of replication is similar to that of positions tested on the right arm of replication, 
however promoter activity at the nupG locus was far greater than that of the lac locus. The 
extremely low levels of egfp expression reported at tsEPOD target loci also break the pattern 
of increasing activity with proximity to the origin of replication, due to the target positions 
being spread throughout the NSR, Right and NSL macrodomains (Figure 3.11). 
Insertion of egfp at the asl and tam loci allowed a comparison between promoter activity at 
positions near to the origin of replication or on the opposite side of the chromosome (Figure 
3.5). Activity at the asl locus was approximately 2.3-fold greater than at the wild type lac 
locus, whereas expression at the tam locus was approximately 30% of activity at the lac locus. 
These results revealed an 11-fold increase in promoter activity near to the origin of replication 
compared to that from the tam locus, near to the dif site (Figure 3.12). Activity of the 
promoter at the origin of replication was expected to be stronger due to gene dosage effects, 
as demonstrated by Beckwith et al. (1966), Schmid and Roth (1987) and Sousa et al. (1997). 
However, an 11-fold variation was far greater than expected from copy number differences 
between Ori and Ter (Bremer and Dennis, 1996; Figure 3.12). This variation was investigated 
further in section 3.5.5, section 3.9 and chapter 4. 
 
3.5.5 Gene dosage effects 
Previous work has demonstrated that, in fast growing bacteria, gene expression increases by 
up to ~ 6-fold with increasing proximity to the origin of replication (oriC) due to increased 
copies of this part of the chromosome. This effect is referred to as gene dosage and is reduced 
with slower growth rates (Beckwith et al., 1966; Schmid and Roth, 1987; Sousa et al., 1997;  
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Figure 3.12: Promoter activity at loci near to oriC and the dif site  
Fluorescence/OD620 measured in strains BRY35 (asl) or BRY33 (tam), carrying lac28::egfp 
at the designated chromosomal locus. Cells were grown aerobically at 37°C to 
mid-exponential phase (OD620 0.3-0.5) in M9 salts medium supplemented with the inducer of 
the lac operon IPTG, where stated. Data shown are averages of fluorescence/OD620 
measurements from at least three independent experiments, and error bars show one standard 
deviation from the mean. Data show that promoter activity at the asl locus, near to the origin 
of replication, was approximately 11-fold greater than expression at the tam locus, near to the 
dif site. 
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Block et al., 2012). Similar effects were reported in section 3.5.4, with the difference between 
expression of egfp near to oriC and the dif site being approximately 11-fold, during 
exponential growth (Figure 3.7). These data are in support of gene dosage being the 
contributing factor to this variation. However, the 11-fold difference between expression at 
the asl and tam loci was far greater than the copy number difference expected even, during the 
fastest growth rates (Helmstetter and Cooper, 1968; Bremer and Dennis, 1996). Therefore the 
gene dosage ratio of egfp at the tam, lac, nupG and asl loci, in the BRY33, BRY40, BRY34 
and BRY35 strains, was tested in my experimental conditions by comparing the quantity of 
egfp gene genomic DNA in each of the four strains (Table 2.1; Figure 3.13). 
Genomic DNA was isolated during mid-late exponential growth on M9 minimal salts 
medium. Quantitative real-time PCR was used to measure the copy number of the egfp gene 
in each strain by using the isolated DNA as template, primers for the egfp gene (Qiagen) and 
primers for the internal control polA, the location of which does not change between strains. 
The samples from the BRY33 strain cultures, carrying egfp at the tam locus, are taken as the 
calibrator in the analysis, thus the gene dose ratio of the tam locus is taken as 1. Each data 
point is an average of three separate growth experiments, for which three separate qRT-PCR 
reactions were completed. Errors bars represent one standard deviation from the mean (Figure 
3.13).  
The gene dose ratio of egfp at the asl locus, with respect to the tam locus, was approximately 
1.4, therefore representing approximately 1.4 copies of the origin of replication for every 1 
copy of the dif site (Figure 3.13). The results presented in figure 3.13 demonstrate that the 
copy number of the egfp gene at the lac locus, in the NSR macrodomain, is similar to that of 
the tam locus. However, the nupG locus, which is in the NSL macrodomain, has a copy 
number closer to that of oriC. This result could be due to the position on the left arm of 
replication being slightly over-represented compared to the similar position on the right  
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Figure 3.13: Gene dose ratio of the tam, lac, nupG and asl loci 
a. Circular map of the E. coli MG1655 chromosome with the positions of the six 
macrodomains represented by grey boxes or white spaces and the position of oriC labelled 
and marked with a black line. Position and orientation of the lac28 promoter::egfp fusion in 
strains BRY33 (tam), BRY34 (nupG), BRY 40 (lac) and BRY35 (asl) are represented by the 
black arrows (positions approximately to scale). b. Gene dose ratio of the egfp gene in the 
BRY33, BRY34, BRY40 and BRY35 strains grown aerobically at 37°C to mid-exponential 
phase (OD620 0.3-0.5) in M9 salts medium. Gene dose ratio is a representation of the relative 
quantity of egfp gene in genomic DNA samples, with the tam locus taken as 1, determined 
through the use of quantitative real-time PCR.  
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(Figure 3.13). The doubling time in the growth conditions used for these experiments is 
approximately 54 minutes during exponential growth. This data is in approximate agreement 
with that presented by Bremer and Dennis (1996), which states that there is approximately 1.8 
copies of the origin for every 1 copy of the ter, during growth with a doubling time of 
approximately 60 minutes. Therefore these results clearly demonstrate that the 11-fold 
difference between the activity of the lac28 fragment promoter, at the tam and asl loci, can 
not be explained by the effect of gene dosage, which in this experiment can only account for 
approximately 1.4-fold variations in activity. 
 
3.6 Position-dependent repression of promoter activity by LacI 
3.6.1 The lac operon 
Transcription of the lac operon is driven by the σ70 RNAP holoenzyme and activated by CRP 
binding at position -61.5 bp, relative to the transcription start site, to recruit RNAP by a class I 
mechanism (Gaston et al., 1990; Busby and Ebright, 1999; Figure 1.9). Activity of the lac 
promoter is repressed by the upstream lacI gene product, in the absence of lactose, through 
binding of the repressor to the primary operator site (O
1
), which is situated directly over the 
transcription start site. Two secondary operators, O
2
 and O
3
, are situated one within the lacZ 
gene and the other overlapping the 3’ terminus of lacI gene, respectively. Interaction between 
Lac repressor tetramers, bound at these sites, forms “repression loops” that allow full 
repression of the operon (Reznikoff et al., 1974; Oehler et al., 1990; Wilson et al, 2007; 
Figure 1.9). The action of Lac repressor can be inhibited by the gratuitous inducer IPTG, 
which can enter the cell independently at high concentrations, but requires transport by the 
lacY gene product at low concentrations (Marbach and Bettenbrock, 2012). I have 
investigated the effect of changing lac28::egfp target chromosomal position on repression by 
the LacI protein. 
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3.6.2 The effect of target position on LacI-dependent repression  
All the strains described in section 3.4 carry the lacI gene at the wild type locus under control 
of its natural promoter, whereas the position of the repressible target lac28 fragment was at 
different locations. Therefore, the effect of varying the target position on repression by LacI 
was tested by measuring fluorescence of strains carrying the lac28::egfp fusion at the mel, 
ara, ycb, tam, rcs, nupG and asl positions during mid-late exponential growth on M9 minimal 
salts medium supplemented with varying concentrations of IPTG. The strains carrying the 
fusion at the tsEPOD loci were excluded from this experiment due to the low or undetectable 
levels of promoter activity at these loci during exponential growth. The BRY40 strain, 
carrying egfp at the lac locus, was also excluded from this experiment due to disruption of the 
endogenous lacZYA operon by the lac28::egfp insertion.  
The lac28 fragment promoter was fully induced by the addition of 40 μM IPTG to the growth 
medium when positioned at all the loci tested, except for at the ycb locus. Activity of the 
promoter at the ycb locus was only induced to 40% of maximum expression with 40 μM and 
required 70 μM IPTG for full induction (Figure 3.14; Figure 3.15). Unlike at all other 
positions, activity of the promoter at the ycb locus was not detectable at concentrations lower 
than 40 μM IPTG (Figure 3.14). However, expression at the ycb locus is very low when fully 
induced, therefore this may be explain the lack of detectable activity at low concentrations. 
While the lac28 fragment promoter was fully induced at all other loci with 40 μM, induction 
of the promoter was not the same at all loci in the presence of 10 μM IPTG (Figure 3.14; 
Figure 3.15; Figure 3.16). The positions tested and percentage induction of the lac28 fragment 
promoter, in the presence of 10 μM IPTG, are represented on the circular map of the E. coli 
chromosome in figure 3.16. Activity of the lac28 fragment promoter demonstrated the tightest 
repression at the ycb and ara loci, which are positioned closest to the lacI gene (Figure 3.16). 
Hence, growth in the presence of 10 μM IPTG induced promoter activity at the ara locus to  
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Figure 3.14: Induction of lac28 promoter activity at different chromosomal loci 
Fluorescence/OD620 measured in strains BRY13 (ara), BRY32 (ycb), BRY33 (tam), BRY27 
(rcs), or BRY15 (mel), in which the lac28::egfp fusion is carried at the designated position. 
Cells were grown aerobically at 37°C to mid-exponential phase (OD620 0.3-0.5) in M9 salts 
medium and the inducer of the lac operon, IPTG. Data shown are averages of 
fluorescence/OD620 measurements from at least three independent experiments and means are 
normalised to the maximum level of expression for each locus. Error bars represent one 
standard deviation from the mean. The results demonstrate that repression of egfp expression 
is not equal at all loci. 
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Figure 3.15: Induction of lac28 promoter activity at the nupG and asl chromosomal loci 
Fluorescence/OD620 measured in strains BRY34 (nupG) and BRY35 (asl), in which the 
lac28::egfp fusion is carried at the designated position. Cells were grown aerobically at 37°C 
to mid-exponential phase (OD620 0.3-0.5) in M9 salts medium supplemented with the inducer 
of the lac operon, IPTG. Data shown are averages of fluorescence/OD620 measurements from 
at least three independent experiments and means are normalised to the maximum level of 
expression for each locus. Error bars represent one standard deviation from the mean. The 
results demonstrate that repression of egfp expression is greater at the nupG locus than at the 
asl position. 
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Figure 3.16: Variation in lac promoter level of induction with chromosomal position 
Induction of the lac promoter in the presence of 10 μM IPTG when positioned at different 
chromosomal loci. Cells were grown aerobically at 37°C to mid-exponential phase (OD620 
0.3-0.5) in M9 salts medium supplemented with the inducer of the lac operon, IPTG. Data 
shown are averages of fluorescence/OD620 measurements from at least three independent 
experiments and means are normalised to the maximum level of expression for the promoter 
at each locus. The black circle represents the E. coli MG1655 circular chromosome and the 
grey shaded blocks and two white gaps represent the six macrodomains, as defined by Valens 
et al. (2004). The position of oriC and the dif, the direct opposite locus are marked with black 
lines and labelled with their positions in kb relative to the co-ordinate system origin. Arrows 
indicate the position of sites of insertion for the lac28::egfp construct and the direction of the 
arrows indicates the orientation of the promoter. The lacI gene is at the wild type position in 
all strains and is marked by the grey line. Results demonstrate that repression of lac promoter 
activity is affected by position of the promoter within the chromosome. 
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approximately 30% of the maximum achievable activity at that position (Figure 3.14; Figure 
3.16). These results show that repression of the lac28 fragment promoter is not equal at all 
loci. 
Repression of the promoter was weakest at the mel locus, with activity reaching 
approximately 50% of maximum in the presence of 5 μM IPTG, whereas, the addition of 
10 μM IPTG to the growth medium achieved greater than 90% induction of the promoter at 
the mel locus (Figure 3.15). The promoter at the asl locus, like the mel locus, is positioned 
within the Ori macrodomain and is also poorly repressed by LacI (Figure 3.15; Figure 3.16). 
Growth in the presence of 5 μM IPTG induced activity of the promoter at the asl locus by 
approximately 20%, whereas 10 μM IPTG induced activity of the promoter to approximately 
79% of the maximum (Figure 3.15). These results demonstrate that some positions within the 
genome are less conducive to repression by LacI and suggest that access to the Ori 
macrodomain by the Lac repressor could be limited. 
Fully induced promoter activity at the nupG and asl positions was similar, therefore allowing 
comparison between induction of the promoter when maximum activity is similar. However, 
regardless of the fact that maximum activity is similar, activity at these two loci in the 
presence of low IPTG concentrations differed. Growth in the presence of 5 μM IPTG induced 
activity of the promoter at the asl locus by approximately 20%, whereas expression at the 
nupG locus was undetectable (Figure 3.15). Expression of the reporter gene was also induced 
to a greater level at the asl locus in the presence of 10 μM IPTG, giving approximately 75% 
of maximum activity, whereas promoter activity at the nupG locus reached approximately 
55% of its maximum (Figure 3.15). This result suggests that the repressive action of the LacI 
protein is greater at the nupG locus, which is located in the NSL macrodomain, than at the asl 
locus, which is located in the Ori macrodomain, regardless of the fact that maximum promoter 
activity is similar at the two loci. These results all suggest that location of the target promoter 
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within the cell can affect the efficiency of repression by the LacI repressor protein, which is in 
disagreement with the results obtained by Block et al. (2012). This differential repression 
could be due to unique features of the specific loci targeted, such as variations in 
superhelicity, however this would require further investigation. 
 
3.6.3 The effect of Lac permease on induction of the lac28 fragment promoter 
Insertion of the lac28::egfp fusion at the lac locus, in strain BRY40, causes disruption of 
lacZYA expression due to replacement of the wild-type lac promoter (Figure 2.11). 
Consequently, expression of the lacY gene product, Lac permease, is depleted in the BRY40 
strain, therefore potentially having an effect on IPTG transport (Marbach and Bettenbrock, 
2012). Hence, this strain was not used in the experiments described in section 3.6.2., as 
induction of the lac28 promoter at the lac locus is not comparable to the other loci tested. To 
test the effect of LacY depletion on induction of the lac28 fragment promoter, activity of the 
promoter at the rcs locus was assayed with and without lacY expression and compared to that 
at the lac locus. To do this, the lacZYA regulatory region in strain BRY27 was replaced with 
the pKH3 empty cloning site, using the gene gorging method described in section 2.12, to 
stop expression of the lacY gene. The resulting LacY
-
 strain, carrying the lac28::egfp fusion at 
the rcs locus, is referred to as BRY44. 
Induction of lac28::egfp activity was assayed by measuring fluorescence in the presence of 
varying concentrations of IPTG during mid-late exponential growth of the lac (BRY40), rcs 
(BRY27) and rcsΔlacY (BRY44) strains. Induction of the lac28 fragment promoter, at the lac 
locus, required addition of at least 40 μM IPTG to the growth medium and required 100 μM 
IPTG for full induction (Figure 3.17). In contrast, activity of the promoter at the rcs locus, in 
the presence of LacY, was induced at 5 μM IPTG and reached maximum induction in the  
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Figure 3.17: Effect of LacY on lac28 fragment promoter induction at the rcs locus 
Fluorescence/OD620 measured in strains BRY27 (rcs), BRY44 (rcs Δ lacY) or BRY40 (lac), 
in which BRY27 and BRY44 carry the lac28 promoter::egfp at the rcs locus and the BRY40 
strain at the lac locus. The wild type lac promoter has been replaced with the pKH3 cloning 
site by the gene gorging method, in strain BRY44, in order to knock out lacZYA expression. 
Cells were grown aerobically at 37°C to mid-exponential phase (OD620 0.3-0.5) in M9 salts 
medium supplemented with IPTG. Data shown are averages of fluorescence / OD620 
measurements from at least three independent experiments, and error bars show one standard 
deviation from the mean. The results demonstrate that the Δ plac mutation causes induction of 
the promoter at the rcs locus to behave as that at the lac locus, however repression was still 
greater at the lac locus. 
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presence of 40 μM IPTG (Figure 3.17). These results demonstrate that repression of the lac28 
promoter is relieved by lower concentrations of inducer when positioned at the rcs locus 
compared to that at the lac locus. Deletion of the lacZYA regulatory region abolished 
induction of the promoter at the rcs locus at low IPTG concentrations and caused the 
promoter to behave in a similar way to that at the lac locus. Induction of lac28 fragment 
promoter activity, at the rcs locus in the absence of LacY, required at least 40 μM IPTG and 
full induction was achieved by the presence of 100 μM IPTG, as at the lac locus (Figure 
3.17). These data suggest that IPTG is transported into the cell at lower concentrations by the 
lacY gene product, however depleting lacY expression has no effect in the presence of higher 
IPTG concentrations.  
While the pattern of induction was similar at the rcs and lac loci in the absece of Lac 
permease, repression of egfp expression was stronger at the lac locus, which is immediately 
downstream of the lacI gene (Figure 3.17). Addition of 40 μM IPTG induced the activity of 
the lac28 fragment promoter, at the rcs (ΔlacY) locus, to approximately 58% of its maximum, 
whereas the promoter at the lac locus only reached 32% of maximum (Figure 3.17). These 
results demonstrate that repression of the lac promoter, by LacI, is tighter at the lac locus, 
which is immediately downstream of the lacI gene, than at the rcs locus. This provides further 
evidence to suggest that the chromosomal position of a target promoter can affect 
LacI-dependent repression (Figure 3.17). 
 
3.6.4 The effect of lacI O
2
 on egfp expression at the lac locus 
The lac promoter is repressed, by the lacI gene product, through steric hindrance and looping 
between Lac repressor dimers bound at 2 of three possible operator sites (Reznikoff et al., 
1974; Oehler et al., 1990; Wilson et al., 2007: Figure 1.9). The lac operator O
2
 is located 
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401 bp downstream of the primary operator O
1
 and was not included in the lac28 fragment, in 
order to keep the size of the fragment to a minimum (Figure 3.2b). Creation of the BRY40 
strain, carrying egfp at the lac locus, used a homology region cloned from position 399 bp to 
898 bp, relative to the lacZ start codon, therefore lacI O
2
 was not present on the chromosome 
of this strain (Figure 3.18a).  
In a complementary experiments, the long-range effects of lacI O
2
 on lac28::egfp activity 
were tested by insertion of the lac28::egfp fusion at the lac locus while maintaining the O
2
 
operator on the chromosome. This was achieved by using a homology region from position 1 
bp to 611 bp of the lacZ gene, therefore maintaining lacI O
2
 on the chromosome (Figure 
3.18b). The lac operator O
2 
on the chromosome of the resulting strain, referred to as BRY12, 
is centred 1245 bp downstream from the O
1
 binding site of the lac28 fragment, due to 
insertion of the lac28::egfp fusion. Note that this differs from the situation at the endogenous 
lac promoter in E. coli K-12 MG1655, where lac O
1
 and O
2
 are 401 bp apart.  
The effect of O
2 
on repression of the lac28 fragment promoter, at the lac locus, was assayed 
by comparing fluorescence of the BRY12 (lac +O
2
) and BRY40 (lac) strains during mid-late 
exponential growth on M9 minimal salts, supplemented with varying concentrations of the 
inducer IPTG. The presence of O
2 
on the chromosome causes the fluorescence to be 
decreased, therefore indicating an increased level of repression (Figure 3.19). The absence of 
O
2
 increased expression by approximately 40% at the two higher concentrations of 70 μM and 
100 μM IPTG. However the threshold of inducer required to give a signal appeared to be 
unaffected by the presence of the lac operator O
2
, as no signal was achieved at IPTG 
concentrations lower than 40 μM (Figure 3.19). These data suggest that the lac operator O2 
binding site has an effect on the repression of egfp expression at the lac locus, however the 
majority of the repression remains. This data is in agreement with results presented by Oehler 
et al. (1994). Cooperation of operator sites has previously been shown to have smaller effects  
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Figure 3.18: Schematic diagram of gene organisation at the lac locus in the BRY40 and 
BRY12 strains 
White arrows represent genes, while black lines denote intergenic regions and the thick black 
line represents the insert (approximately to scale). Direction of transcription of each gene is 
indicated by the arrow heads. Direction of replication is from left to right. Thick black vertical 
lines represent the position of lac operator sites and are labelled. The arrow represents the 
position and orientation of the lac promoter. The hairpin-loop structure represents the position 
of the λ oop transcription terminator. a. organisation of genes at the lac locus in strain BRY40 
b. BRY12 
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Figure 3.19: Effect of lac operator O
2
 on lac28 promoter activity at the lac locus 
Fluorescence/OD620 measured in strains BRY12 (lac +O
2
) and BRY40 (lac), each carrying 
egfp at the chromosomal lac locus. The lac operator O
2
 is present where stated (BRY12). 
Cells were grown aerobically at 37°C to mid-exponential phase (OD620 0.3-0.5) in M9 salts 
medium supplemented with the inducer of the lac operon IPTG. Data shown are averages of 
fluorescence/OD620 measurements from at least three independent experiments, and error bars 
show one standard deviation from the mean. 
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at longer distances, therefore the minimal effect of O
2
 on the induction of lac28 fragment 
promoter in strain BRY12 could be due to the extra 844 bp that separate O
1
 and O
2
 compared 
to the 401 bp in the starting strain (Oehler et al., 1994). These data suggest that local 
chromosomal context and the positioning of transcription factor binding sites in the vicinity of 
a promoter can have an effect on its total output. 
 
3.7 Promoter activity during stationary phase 
3.7.1 Effects of chromosome position on promoter activity 
The results presented up to this point have only been concerned with expression in relatively 
fast-growing cultures. Therefore, the effect of position within the chromosome on promoter 
activity was also analysed during stationary phase, by measuring increase in fluorescence on 
induction in E. coli strains carrying the lac28::egfp fusion at the different chromosomal 
locations shown in figure 3.5. Promoter activity was measured during the stationary phase of 
growth on M9 minimal salts medium supplemented with 250 μM IPTG. The higher 
concentration of IPTG was found to be required for induction during stationary phase, 
potentially due to the increased cell density of the cultures compared to that of mid-late 
exponential growth. Overnight cultures were split in two and the inducer added to one half of 
the culture to allow a direct comparison between culture with and without inducer after 
5 hours induction. As in section 3.5, expression of egfp was derived from the fluorescence at 
510 nm divided by OD620 of at least three separate experiments to give the mean and standard 
deviation. The starting E. coli K-12 MG1655 strain was found to auto-fluoresce at the higher 
cell densities required by this experiment, as shown in figure 3.20, therefore activity of 
un-induced cultures were subtracted from that of induced cultures for each separate 
experiment, to give induction of reporter expression, before calculation of mean and standard  
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Figure 3.20: Promoter activity at the mntH and asl loci during stationary phase 
Fluorescence/OD620 measured in strains BRY73 (mntH), BRY35 (asl), carrying lac28::egfp at 
the designated chromosomal locus, or the starting strain MG1655. Samples were taken during 
stationary phase (OD620 ~ 1.5) at 37 ˚C in M9 minimal medium supplemented with 250 μM 
IPTG, where stated. Overnight cultures were split into two aliquots prior to induction of one 
of these to allow direct comparison between induced and un-induced cultures. Data shown are 
averages of fluorescence/OD620 measurements from at least three independent experiments, 
and error bars show one standard deviation from the mean. Data show that fluorescence of the 
mntH and asl strains does vary slightly in the absence of inducer, but this is always lower than 
the starting MG1655 strain and is representative of all other strains used in this work. Data 
also show that fluorescence of the mntH and asl strains increased on addition of IPTG, 
however fluorescence of MG1655 decreased. 
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deviation. The autofluorescence of un-induced cultures did vary between strains, however this 
was always less than the starting MG1655 strain. Further to this, the fluorescence of strains 
carrying the lac28::egfp fusion always increased on average, whereas the fluorescence of the 
starting strain (MG1655) decreased on addition of IPTG (Figure 3.20). This suggests that 
variation of fluorescence in the un-induced culture was not due to leakage of the promoter 
(Figure 3.20). Subtraction of the background auto-fluorescence is the reason for the absolute 
level of fluorescence reported on the y-axis, of figure 3.21, being so much lower than that in 
figure 3.7 (exponential growth). 
Expression of egfp during stationary phase was not only dependent upon regulation by the 
promoter region, but also upon position within the chromosome, as reported for exponential 
growth. Position-dependent modulation of promoter activity during stationary phase caused 
large variation of egfp expression by the lac28 fragment promoter across the chromosomal 
positions tested (Figure 3.21). The total variation of promoter activity was much less than the 
310-fold differences found during exponential growth or even the 11-fold variation between 
non-tsEPOD loci. Also, the level of expression at all loci was very low compared to that 
during exponential growth, which was most likely due to the promoter being σ70-dependent 
(Figure 3.21; Figure 3.7). 
The largest induction of fluorescence during stationary phase was at the mntH locus, which is 
positioned within the Left macrodomain. When positioned at the mntH locus, increase of 
fluorescence on inductrion was approximately 8-fold greater than that at the tam locus, at 
which the promoter activity was weakest (Figure 3.21; Figure 3.22). These results suggest that 
position within the E. coli chromosome does affect promoter activity during stationary phase, 
however the pattern of expression is significantly different compared to that during 
exponential growth and activity is generally much weaker. 
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Figure 3.21: Promoter activity at different chromosomal positions during stationary 
phase 
Expression of the lac28::egfp fusion during stationary phase (OD620 ~ 1) at 37 ˚C in M9 
minimal medium supplemented with 250 μM IPTG. Each point represents the fluorescence at 
485 nm excitation, 510 nm emission, divided by the OD620, of the un-induced sample 
subtracted from the fluorescence/OD620 of the induced culture. Each point is the average of at 
least three independent experiments with the error bars showing one standard deviation from 
the mean. Position of each point on the x-axis indicates chromosomal position in Mb with 
respect to co-ordinate system origin and is to scale. The positions of the six macrodomains are 
represented by the grey shaded boxes with oriC and the dif indicated by vertical black lines. 
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Figure 3.22: Promoter activity at the tam, rcs and mntH loci during stationary phase 
Expression of egfp in the BRY33 (tam), BRY27 (rcs) and BRY73 (mntH) strains during 
stationary phase (OD620 ~ 1) at 37 ˚C in M9 minimal medium supplemented with 250 μM 
IPTG. Each point represents the fluorescence at 485 nm excitation, 510 nm emission, divided 
by OD620, of the un-induced sample subtracted from the fluorescence/OD620 of the induced 
culture. Each point is the average of at least three independent experiments with the error bars 
showing one standard deviation from the mean. Data show that promoter activity was 
strongest at the mntH locus, which was approximately 8-fold greater than the weakest activity 
at the tam locus. Expression of egfp at the mntH locus was also 2-fold stronger than that of the 
rcs locus, which also resides within the Left macrodomain  
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3.7.2 Promoter activity at the asl and nupG loci during stationary phase 
Activity of the lac28 fragment promoter at the nupG locus during stationary phase was one of 
the most highly expressed, giving approximately 75% of the activity reported for the mntH 
locus (Figure 3.23). Activity of the promoter at the nupG locus was approximately 6-fold 
greater than that at the tam locus, whereas, during exponential growth, the difference between 
activity at the two loci was approximately 10-fold (Figure 3.23; Figure 3.7). Therefore this 
result suggests that while the nupG locus is one of the most highly expressed loci during 
stationary phase, some difference in the nature of the nupG locus between the two growth 
phases may have caused a decrease in promoter activity. While expression of egfp at the nupG 
and asl loci was similar during exponential growth, increase in fluorescence on induction at 
the asl locus was significantly weaker than at the nupG locus during stationary phase (Figure 
3.23; Figure 3.7). Induction of the lac28 fragment promoter at the asl position, which is 
located near to the origin of replication, was similar to that at the tam locus, located near to 
the dif site (Figure 3.23). This suggests that the reasons for differences in lac28::egfp 
expression at the tam and asl loci during exponential phase, which caused an 11-fold variation 
in promoter activity between the two loci, are negated during stationary phase. 
 
3.7.3 The effect of proximity to the origin or terminus of replication 
The general pattern of expression during stationary phase was very different to that during 
exponential growth, in which the strongest promoter activity was seen with increasing 
proximity to the origin of replication (Figure 3.7; Figure 3.24). During stationary phase, 
increase in fluorescence on induction was smallest when positioned in the Ori and Ter 
macrodomains. Strength of promoter activity increased as proximity to these regions 
decreased. Thus, the lac28 fragment promoter was strongest when positioned at the mntH  
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Figure 3.23: Promoter activity at the tam, nupG and asl loci during stationary phase 
Expression of egfp in the BRY33 (tam), BRY34 (nupG) and BRY35 (asl) strains during 
stationary phase (OD620 ~ 1) at 37 ˚C in M9 minimal medium supplemented with 250 μM 
IPTG. Each point represents the fluorescence at 485 nm excitation, 510 nm emission, divided 
by the OD620 of the un-induced sample, subtracted from the fluorescence/OD620 of the 
induced culture. Each point is the average of at least three independent experiments with the 
error bars showing one standard deviation from the mean. Data show that activity of the 
promoter at the nupG locus was approximately 6-fold greater than at the tam locus. 
Expression of egfp at the asl locus, which was positioned near to the origin of replication was 
the same as that of the tam locus, which was positioned near to the dif site.  
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Figure 3.24: The effect of chromosomal position with respect to oriC and dif on 
promoter activity during stationary phase 
Expression of the lac28::egfp fusion during stationary phase (OD620 ~ 1) at 37 ˚C in M9 
minimal medium supplemented with 250 μM IPTG. Each point represents the fluorescence at 
485 nm excitation, 510 nm emission, divided by the OD620 of the un-induced sample 
subtracted from the fluorescence/OD620 of the induced culture. Each point is the average of at 
least three independent experiments with the error bars showing one standard deviation from 
the mean. Position of each point on the x-axis indicates chromosomal position in Mb with 
respect to the coordinate system origin and is to scale. The positions of the six macrodomains 
are represented by the grey shaded boxes with oriC and the dif indicated by vertical black 
lines.   
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locus in the Left macrodomain, with the other well expressed loci being in a mid-replichore 
position, as opposed to being in the terminal macrodomains (Figure 3.24). This result suggests 
that the characteristics of the Ori macrodomain are conducive to strong lac promoter activity 
during exponential growth, but become poor for promoter activity during stationary phase. 
 
3.8 Discussion 
3.8.1 5’ mRNA secondary structure improves lac28::egfp expression  
The work described in this chapter sought to analyse the effects of position within the E. coli 
chromosome on promoter activity. This was achieved through use of the improved 
recombineering system, gene doctoring, and detailed knowledge of the sequence and 
annotation of the E. coli genome, allowing targeting of specific loci within the chromosome. 
Design of the lac promoter::egfp fusion revealed that direct fusion of the promoter region and 
ATG start codon to egfp, via a HindIII target site, produced very weak expression of the 
reporter gene (Figure 3.2). Data collected by Kudla et al. (2009) demonstrated that addition of 
a 28 codon leader sequence, with weak secondary mRNA structure, to a promoter::GFP 
fusion increased the fluorescent output of cells carrying the fusion. This result was shown to 
be due to improved translational efficiency. Hence, the first 28 codons of the lacZ gene were 
included in the lac28 promoter::egfp fusion, improving the expression of egfp approximately 
90-fold (Kudla et al., 2009; Figure 3.2; Figure 3.3).  
Scharff et al. (2011) found that mRNAs lacking a Shine-Dalgarno sequence also lack mRNA 
secondary structure at or around the start codon. The lack of mRNA secondary structure was 
found to promote faithful translation initiation at the correct AUG in the absence of a Shine-
Dalgarno sequence. Recent work has also suggested that evolution of weak mRNA secondary 
structure near the start codon is selected only in functional genes, whereas this pressure is not 
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observed in pseudogenes, which are not expressed, or poorly expressed genes of unknown 
function (Keller et al., 2012). The evidence presented by Keller et al. (2012) and Scharff et al. 
(2011) suggests that improved expression of the lac28::egfp fusion was most likely caused by 
changes in mRNA secondary structure near to the AUG start codon, therefore improving 
translational efficiency. 
3.8.2 Experimental approach improves sensitivity to position-dependent effects  
The large effects of chromosome position on promoter activity reported here are in 
disagreement with the results of previous studies and this could be due to differences in 
experimental approaches (Beckwith et al., 1966; Chandler and Pritchard, 1975; Schmid and 
Roth, 1987; Sousa et al., 1997; Block et al., 2012). As highlighted by Schmid and Roth, 
(1987) the experimental approaches of previous studies were similar in that they utilised a 
transposition vehicle of some variety to move the promoter::reporter probe to different loci. 
Beckwith et al. (1966) utilised a temperature sensitive FTSlac
+
 episome to insert the lacZYA 
operon at various chromosomal locations within E. coli to create 11 different Hfr strains. This 
also means that the lac promoter was contained within the large FTSlac
+
 episome, therefore 
separating the promoter from the genomic DNA (Beckwith et al., 1966). The work of Schmid 
and Roth, (1987) utilised two Tn10 insertion sequences flanking the hisGDBCH’ operon, 
which is approximately 5 kb. Therefore the promoter could have been separated from local 
sequence by the ~ 5 kb hisGDBCH’ genes and Tn10 sequence on the downstream side or the 
Tn10 insertion sequence upstream. As illustrated by Schmid and Roth, the large amount of 
flanking sequence could serve to shield, or insulate, the promoter from the effects of local 
genetic elements. This is also true of the probe used by Sousa et al. (1997) in which the 
Pseudomonas putida sal promoter is flanked by a 19-bp Tn5 insertion terminus, an ~1.4 kb 
kanamycin resistance determinant and the ~800 bp nahR regulator upstream, and the ~3 kb 
lacZ reporter gene downstream.  
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The lac28::egfp probe used in this study was designed to keep the insert size to a minimum, 
therefore the kanamycin resistance gene was removed from the chromosome by FLP 
recombinase. This left only 157 bp of foreign DNA upstream of the promoter fragment, which 
included the single FRT site and the λ oop terminator to prevent read-through from 
neighbouring operons. Also, only 875 bp of foreign DNA was incorporated downstream of 
the transcription start site, which includes the egfp coding region (Figure 2.6). The minimal 
size of the lac28::egfp construct, compared to the promoter::reporter probes used in other 
studies, should leave the promoter better exposed to the local genetic context and leave the 
local chromosomal architecture relatively undisturbed. These differences in strain 
construction could explain why larger variation in gene expression levels were found in this 
work and different conclusions were made. 
 
3.8.3 Insertion target site may improve sensitivity to position-dependent effects  
Another major variation between this work and that of the previous studies is the target site of 
insertion. The work of Sousa et al. (1997) does not define the exact locus of insertion for the 
psal::lacZ insertion, however Beckwith et al. (1966) utilised the FTSlac
+
 episome to insert the 
lacZYA operon into the chromosome. Use of the episome leads to insertion within gene 
coding regions, due to integration of the episome being non-random and targeted to disrupt 
specific genes and phage integration sites (Beckwith et al., 1966; Scaife, 1967). Schmid and 
Roth, (1987) utilised the Tn10 transposon to create gene knockouts, which could then be 
targeted for homologous recombination by the Tn10 flanked hispGDCB operons, therefore 
being inserted into the non-functional gene coding region. The work of Block et al. (2012) 
also inserted a promoter::reporter fusion within gene coding regions, however this was 
through choice as opposed to limitations of cloning technology. The promoter was inserted in 
the opposite orientation to that of the target gene regulatory element. In contrast, the work 
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presented in this chapter targeted non-coding regions between convergent genes, upstream of 
promoter regions, or, in the case of the eaeH locus, within pseudogenes. Intergenic regions 
between convergent genes were targeted because this would allow minimal disruption of the 
neighbouring genomic processes, such as transcription, translation and the local chromosomal 
architecture. The targeting of gene coding regions would cause premature termination of local 
transcription, therefore potentially having an effect on expression of the promoter::reporter 
probe through changes in local chromosomal architecture and structure, or cell physiology. 
The other difference was in the selection of the tsEPODs as target sites, which were 
demonstrated to be uniquely poor regions for promoter activity, potentially due to the large 
quantities of protein bound to the region. The silencing of transcription within tsEPODs was 
investigated further in section 4.5 of chapter 4. 
 
3.8.4 Proximity to the origin of replication improves promoter activity through a 
mechanism other than gene dosage 
Analysis of egfp expression during exponential growth, revealed that promoter activity varies 
by approximately 310-fold, dependent upon position of the promoter within the chromosome. 
Measurement of egfp mRNA levels showed a correlation with eGFP fluorescence, measured 
from three loci, suggesting that the variation was not due to changes in regulation of 
translation. The strongest promoter activities were found at the asl and nupG loci, which are 
in the Ori and NSL macrodomains, respectively. The lac28::egfp fusion at the asl locus 
resides between the aslB and aslA genes, the former of which is regulated by a σ54 promoter 
with a large σ70 common antigen biosynthesis pathway operon and some tRNA genes 
immediately upstream of the aslB gene (Figure 2.14). The generally low level of promoter 
activity in the neighbouring area could mean less competition for σ70 RNAP, therefore 
possibly explaining the elevated levels of expression during exponential growth. However, the 
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poorly expressed tam locus also had two stationary phase transcription units upstream of the 
lac28 fragment promoter along with many operons dependent on alternative σ subunits in the 
vicinity. Therefore, if neighbouring gene transcription is a factor in position-dependent 
modulation of promoter activity, then it appears not to be a factor at these loci. The proximity 
of these two highly expressed loci to the origin of replication was the most apparent common 
feature. 
The general pattern of increasing strength in activity, with proximity to the origin of 
replication, was found in the dataset presented in figure 3.10. and this type of pattern has been 
previously suggested to be due to gene dosage (Beckwith et al., 1966; Chandler and Pritchard, 
1975; Schmid and Roth, 1987; Sousa et al., 1997; Block et al., 2012). The difference between 
promoter activity near oriC compared to the dif site was approximately 11-fold, therefore 
greatly exceeding the maximum 3-fold variation reported by Schmid and Roth (1987), the 
~ 6-fold variation reported by Block et al. (2012) or the ~ 1.8 fold difference in gene copy 
number at the ori compared to the ter presented by Bremer and Dennis (1996).  
Growth of E. coli in this study used M9 minimal salts medium supplemented with 0.3% 
fructose as the carbon source, which yields a slow doubling time of ~ 60 minutes and is much 
slower than that used by the previously mentioned studies. Hence, the gene dose ratio 
between the origin of replication and the terminus was expected to be small and this was 
confirmed, through the use of quantitative real-time PCR of genomic DNA, to be 
approximately 1.4 to 1.5 (Figure 3.13).  This is in agreement with that presented by Bremer 
and Dennis (1996). Hence, the results presented in this chapter show that transcriptional 
activity, during exponential growth, does increase with proximity to the origin of replication. 
However, in contrast to previous work, this relationship is not solely dependent upon gene 
dosage, and alternative mechanisms are discussed in chapter 4. 
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3.8.5 Anomalies to the expected pattern of increasing activity with proximity to oriC 
The results presented in section 3.6 also demonstrated that, while there was a general 
relationship between proximity of the promoter to the origin of replication and strength of 
activity, not all loci tested conformed to this general pattern. Previous studies have also 
detected “anomalies” from the pattern of gene expression expected from the gene dosage 
effect, such as the two presented by Beckwith et al. (1966). One of these “anomalies” was the 
EC-7 Hfr strain, which has the FTSlac
+
 episome inserted between argB and thr, and is one of 
the closest sites to oriC. The other anomaly was the EC-28 strain containing the FTSlac
+
 
episome at the most distal position from oriC. The expression of lacZ from the EC-7 strain 
was shown to be ~ 80% of that from a similar position on the left replichore. The EC-28 strain 
contained the FTSlac
+
 episome at the most distal position from oriC, however lacZ expression 
in this strain was far greater than most others carrying the episome at positions proximal to 
oriC. The work of Block et al. (2012) reports that all sites tested follow the expected pattern 
of gene dosage-dependent expression, provided that transcription terminators flanking the 
insert are present. Three sites are found to fall dramatically outside of the predicted pattern in 
the absence of flanking terminators. However, due to the target sites being within coding 
regions, these effects are attributed to “local sequence effects”, such as clashing of elongation 
complexes, reduced translation or increased mRNA degradation. 
In this study, activity of the lac28 fragment promoter at the ara and mel loci was shown to be 
less than expected from the general pattern. Activity of the promoter at the mntH and dkgB 
loci was also very low, considering the activity of the promoter at other loci in these areas and 
the location with respect to the origin of replication (Figure 3.11). The weak promoter activity 
demonstrated at the dkgB locus could potentially be due to the activity of neighbouring 
operons and this is discussed further in chapter 4. However the weak activity at the mntH 
locus was not expected, since this locus did not reside within a tsEPOD, and the neighbouring 
180 
operons did not show particularly strong expression. Strikingly, expression of egfp at the 
mntH locus did increase upon entry into stationary phase to become the best expressed locus 
(Figure 3.11; Figure 3.21). Data published by Grainger et al. (2006) shows that there is a 
small peak of FIS binding at the downstream neighbouring promoter region. Each cell 
contains approximately 60,000 molecules of the FIS protein during exponential growth, 
however upon entry into stationary phase the concentration drops to undetectable levels. 
Therefore binding in the neighbouring region could be having a negative effect on lac28 
promoter activity, which is relieved upon entry into stationary phase when quantities of FIS 
are reduced (Azam et al., 1999). 
 
3.8.6 Hierarchies of promoter activity change dramatically upon entry into stationary 
phase  
The effect of chromosomal position on promoter activity during stationary phase was 
analysed and demonstrates an 8-fold variation in activity across the positions tested (Figure 
3.21). The general pattern of increasing activity with proximity to the origin of replication 
was not observed during stationary phase. Promoter activity was strongest when positioned 
within the NSL, NSR, Left and Right macrodomains, while expression from the Ori and Ter 
was relatively weak. The exceptionally high activity of the lac28 fragment promoter at the asl 
locus, during exponential growth, was greatly reduced during stationary phase, as was that at 
the nupG locus, however not to the same degree (Figure 3.7; Figure 3.21). Due to the high 
activity not being associated with gene dosage, this change must be due to another factor, 
which could potentially be superhelical density. DNA superhelicity is more relaxed during 
stationary phase, which could have large effects on lac28 fragment promoter activity, due to 
the sensitivity of the lac promoter to superhelical density (Sanzey, 1979; Balke and Gralla, 
1987). This global change in superhelical density could explain levelling out of gene 
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expression patterns during stationary phase and the effect of superhelicity was investigated 
further in section 4.4 of chapter 4. The transition to stationary phase also appeared to have an 
effect on expression of the lac28::egfp construct at tsEPOD loci, which would be expected, 
due to the large changes seen in NAP concentrations within the cell and general restructuring 
of the nucleoid (Azam, 1999; Figure 3.21). These effects were analysed further in section 4.5 
of chapter 4. 
 
3.8.7 Position of target DNA sites affects repression by LacI 
The efficiency of LacI-dependent repression was found to be sensitive to the position of the 
target lac28 fragment promoter (Section 3.6.2). Montero Llopis et al. (2010) demonstrated 
that chromosomally expressed mRNA shows limited dispersion from the site of transcription. 
These data lead to the hypothesis that the Lac repressor protein has a higher probability of 
localising to the same region as the lacI gene, due to the coupling of transcription and 
translation. The increased local concentration of LacI repressor around the site of production 
would function in a similar way to the pseudo-operators of the lac operon, increasing 
repression of the promoter through increased LacI local concentration in proximity of the 
target (Oehler et al., 1994). Evidence for this hypothesis has recently been supplied by the 
work of Kuhlman and Cox, (2012) in which fluorescently labelled LacI shows limited 
dispersion and localises with the position of the lacI gene. Further evidence demonstrates that 
repression of the target promoter is increased with proximity to the lacI gene, however this 
effect is quite small (Kuhlman and Cox, 2012). This is expected, as the LacI repressor protein 
is found at low levels with 8-12 tetramers per cell, therefore cannot be present at all loci 
(Gilbert and Müller-Hill, 1966). Interestingly, genes encoding transcription factors are often 
found closer to the target binding site than would be expected if located at random (Kolesov 
et al., 2007; Janga et al., 2009). 
182 
The strains used in the experiments presented here carry the lacI gene at the wild type 
location under control of the wild type promoter, whilst the position of the target lac28 
fragment was varied. Repression of the lac28 fragment promoter was analysed in each strain, 
by measuring induction of the promoter in the presence of varying IPTG concentrations, and 
was found to be affected by the chromosomal position of the target. The lac28 fragment 
promoter was most tightly repressed at the ycb locus, which suggests that this locus is highly 
accessible to LacI. However, when positioned at this location, the promoter is very weak, so 
this result may be an artefact of the low levels of promoter activity. Other than the ycb locus 
promoter activity was most tightly repressed at the ara locus, which is the closest to the lacI 
gene on the circular map and resides in the same macrodomain (Figure 3.16). This result 
provides evidence that the repressive action of LacI is dependent upon proximity to the lacI 
gene, as suggested by Kuhlman and Cox (2012).  
Repression of the lac28 fragment promoter at the mel and asl locations was the weakest but 
these positions both reside within the Ori macrodomain (3.14; 3.15). This macrodomain is the 
neighbour of the NSR macrodomain on the circular map, in which the lacI gene resides, 
however this does not mean that these loci are proximal within the folded nucleoid. These 
data suggest that the Ori macrodomain may not reside in a similar location to the site of Lac 
repressor production. Alternatively, access to target promoters within the Ori macrodomain 
may be limited, potentially due to structuring, architecture or some topological characteristic 
of the domain. 
Activity of the promoter is similar when fully induced at the asl and nupG loci, however at 
lower concentrations of IPTG, expression at the asl locus is greater, suggesting a difference in 
repression by LacI (Figure 3.16). The nupG locus is on the opposite side of the circular map 
to the lacI gene, however this would not be the case in the folded nucleoid as the 
non-structured macrodomains reside within similar home positions in the cell and exhibit 
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more freedom of movement than the other domains (Espeli et al., 2008). Therefore the lac28 
promoter at the nupG position would be expected to locate to a position that is relatively close 
to the lacI gene within the cell, compared to that of the asl locus in the Ori macrodomain. 
This could allow tighter repression if the Lac repressor demonstrates limited dispersion from 
the site of production, the lacI gene, as suggested by Kuhlman and Cox, (2012). These results 
demonstrate that the circular chromosome map may be of little use in attempting to predict 
position-dependent effects on transcription factor activity. These data also suggest that some 
loci may be more or less accessible to certain proteins, potentially affecting the regulation of 
gene expression.  
 
3.8.8 Lac permease is involved in transport of IPTG at low concentrations 
Expression of the lacY gene product was shown to play a role in the induction of lac28 
activity by IPTG at low concentrations. Elimination of lacY expression, in the strain carrying 
the lac28 fragment promoter at the rcs locus, showed that induction of egfp expression by 
IPTG became similar to that at the lac locus, where lacY expression is already disrupted. The 
concentration of IPTG required to induce expression of egfp at the rcs locus was increased, as 
was the concentration required for full induction. This result suggests that Lac permease is 
involved in transport of IPTG into the cell at low concentrations, however diffusion across the 
membrane is sufficient at higher concentrations. These data are in agreement with that of 
Marbach and Bettenbrook (2012). Repression of lac28 activity, by LacI, at the rcs locus was 
also shown to be weaker than at the lac locus. However, further work, in which the 
experiments performed in section 3.6.2 are repeated in LacY depleted cells, would allow 
direct comparison of lac promoter repression at all loci tested with that at the lac locus, the 
closest to the lacI gene. 
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Chapter 4: 
 
Mechanisms of position-dependent modulation of  
promoter activity 
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4.1 Introduction 
The effect of position within the bacterial chromosome on promoter activity has been 
investigated by several groups, including in this study (Chapter 3). To date, the effects of 
chromosomal position on expression have been attributed to gene dosage, which is the 
increase in gene expression correlating with proximity to the origin of replication. However, 
this study has demonstrated position-based modulation of promoter activity, which does not 
correlate with that expected from gene dosage alone (Beckwith et al., 1966; Schmid and Roth; 
1987; Sousa et al., 1997; Block et al., 2012; Chapter 3.). Therefore the mechanisms behind 
position-based modulation of promoter activity required further investigation.  
 
4.1.1 Orientation 
There are many factors that could affect the activity of a promoter in different chromosomal 
contexts, one of which is orientation, and this issue was addressed by previous studies 
(Beckwith et al., 1966; Schmid and Roth; 1987; Block et al., 2012). Collisions between the 
DNA polymerase and RNAP are bound to occur due to the two highly processive enzyme 
complexes sharing the same template. Also, the DNA polymerase proceeds much faster along 
the template than the RNAP. Head-on-collisions between RNAP and the replisome cause 
inhibition of replication fork progress to a greater extent than co-directional collisions (French 
1992; reviewed in Merrikh et al., 2012). Therefore, this leads to evolutionary selection of 
highly expressed and essential genes locating to the leading-strand of DNA replication, to 
allow the two processes to occur in the same direction (French, 1992; Price et al., 2005; 
Mirkin and Mirkin, 2005). Transcription is disrupted by collisions with the replisome, 
however the degree to which it is disrupted is greater in head-on-collisions. Therefore, the 
orientation of a gene is predicted to have an effect on its level of expression (French, 1992; 
Price et al., 2005).  
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4.1.2 Neighbouring gene expression 
When moved to a different chromosomal position, promoters will have different neighbouring 
operons with varying levels of transcriptional activity. Based on the transcription factory 
hypothesis, put forward by Cook (2010) and described in section 1.4.3, or if local pools of 
RNA polymerase exist, then strong neighbouring transcription could subtract from the locally 
available pool of RNAP (Jin et al., 2006). Activity of transcription units can also have an 
effect on the distribution of superhelicity due to the fact that an actively transcribing RNAP 
elongation complex increases negative supercoiling behind the complex and decreases 
negative supercoiling, or introduces positive supercoils, ahead (Wu et al., 1988; Tsao et al., 
1989). These changes can affect the activity of promoters, especially those which are sensitive 
to changes in negative superhelicity, such as the lac promoter (Sanzey, 1979; Brahms et al., 
1985). Therefore the degree of neighbouring transcription could have an effect on target gene 
transcription through changes in local chromosomal architecture. These effects were analysed 
by assessment of the interaction between neighbouring inducible operons, or promoter 
activity in the vicinity of highly transcribed regions. 
 
4.1.3 Distribution of superhelicity 
The transition from exponential growth to stationary phase causes a large number of changes 
to the E. coli cell, one of which is the relaxation of the chromosomal superhelical density to 
produce a less negatively supercoiled molecule (Balke and Gralla, 1987). This change in the 
global superhelical density was suggested to be the mechanism behind shifts in transcription 
patterns presented in section 3.5. The superhelical density of the chromosome is not only 
changed during growth phase transitions, but is also changed and adapts in response to 
processes such as replication and transcription (Postow, 2004; Nöllmann, 2007). Further to 
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this, the chromosome is organised into many dynamic supercoiled domains, so the local 
superhelical density can vary across the genome (Postow, 2004). Variations in negative 
superhelicity across the genome are predicted to be one of the contributing factors to 
position-dependent modulation of lac28 fragment promoter activity, due to the sensitivity of 
the lac promoter to superhelical density (Sanzey, 1979). These effects were tested by 
measuring promoter activity at different positions during perturbation of chromosomal 
superhelical density, by inhibition of DNA gyrase. 
 
4.1.4 Transcriptionally silent extended protein occupancy domains 
The work of Vora et al. (2009) sought to identify the protein occupancy landscape of the 
E. coli genome and identified tsEPODs, as discussed in section 1.4.2. The operons contained 
within tsEPODs could be transcriptionally silent due to the sequence of the promoter, or due 
to some silencing effect produced by the domain in which they reside. This has not been 
tested, hence the effect of tsEPODs, on activity of the lac28 fragment promoter, was analysed 
by insertion of the reporter within tsEPODs and replacement of tsEPODs with the reporter.  
 
4.2 Effects of orientation on promoter activity 
4.2.1 Effects of orientation on promoter activity at the lac, ara and mel positions 
The effect of orientation on expression of the lac28 promoter::egfp construct was assessed by 
inserting the construct in the opposite orientation, to previously,  at the lac, ara and mel loci 
to create the inverse lac, inverse ara and inverse mel strains, BRY41, BRY21 and BRY37, 
respectively (Figure 4.1). This was achieved by utilising PCR to amplify the homology 
regions used to create the lac, ara and mel gene doctoring donor plasmids; however, the MfeI  
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Figure 4.1: Schematic diagram of gene organisation at the lac, ara and mel loci in the 
BRY40, BRY41, BRY13, BRY21, BRY15 and BRY37 strains 
White arrows represent genes and grey arrows represent target convergent genes, while black 
lines denote intergenic regions and the thick black line represents the insert (approximately to 
scale). Direction of transcription of each gene is indicated by the arrow heads. Direction of 
replication is from left to right in each panel. The arrow represents the position and 
orientation of the lac promoter. The hairpin-loop structure represents the position of the λ oop 
transcription terminator. a. organisation of genes at the lac locus in strain BRY40 (lac) and 
BRY41 (Inverse lac) b. organisation of genes at the ara locus in strain BRY13 (ara) and 
BRY21 (Inverse ara)  c. organisation of genes at the mel locus in strain BRY15 (mel) and 
BRY37 (Inverse mel). 
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and XmaI target sites in the oligonucleotide primers were replaced with SacI and NheI target 
sites, respectively, and vice versa (Figure 3.4). Homology regions were cloned into the gene 
doctoring donor plasmid pJB22, then resulting plasmids were used to insert the lac28::egfp 
fusion into the chromosome using the gene doctoring method, as described in section 2.8. The 
name “Inverse” has no bearing on the relationship between the direction of transcription and 
replication, but instead merely refers to the order in which the strains were made.  
The effect of orientation on egfp expression was assayed by measuring fluorescence of 
strains, carrying the lac28::egfp fusion at the lac, ara and mel positions, in both orientations, 
during mid-late exponential growth on M9 minimal salts medium. As in section 3.5, activity 
of the promoter was derived from fluorescence at 510 nm divided by OD620 of at least three 
separate experiments to give the mean and standard deviation. The starting E. coli K-12 
MG1655 strain was included as a control for auto-fluorescence, however the control samples 
and the un-induced (no IPTG) cultures registered no fluorescent signal, therefore indicating 
no auto-fluorescence of the culture at the OD620 measured and no un-induced expression of 
the construct. Therefore, orientation had no measurable effect on the un-induced basal activity 
of the promoter and no read-through from neighbouring operons was detected in either 
orientation at any of the loci. 
Expression of egfp at the lac locus was weakly affected by orientation of the insert. Thus, 
activity of the promoter in the BRY41 inverse lac strain was approximately 80% of that in the 
BRY40 lac strain, indicating that activity of the promoter was weakly affected by orientation 
at the lac locus (Figure 4.2). The activity of the lac28 fragment promoter at the ara locus was 
low, giving approximately 9% of that at the lac locus. However, upon inversion to the 
opposite orientation, in the BRY21 strain, activity was increased 10-fold, having similar 
activity to that of the promoter in the inverse lac strain (Figure 4.2). Expression of the 
lac28::egfp construct at the mel locus was approximately 4.8-fold stronger than that of  
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Figure 4.2: Effect of orientation on lac28::egfp activity at the lac, ara and mel loci 
Fluorescence/OD620 measured in strains BRY40 (lac), BRY41 (Inverse lac), BRY13 (ara), 
BRY21 (Inverse ara), BRY15 (mel) or BRY37 (Inverse mel). Cells were grown aerobically at 
37°C to mid-exponential phase (OD620 0.3-0.5) in M9 salts medium supplemented with the 
inducer of the lac operon IPTG, where stated. Data shown are averages of fluorescence/OD620 
measurements from at least three independent experiments, and error bars show one standard 
deviation from the mean. Arrows indicate whether replication and transcription are head to 
head (→←) or co-directional (→→). Orientation has a minimal effect at the lac locus, 
whereas the Inverse ara locus demonstrates a 10-fold increase in expression and the Inverse 
mel locus a 2.3-fold increase in expression compared to that of the original ara and mel locus 
strains. 
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the promoter at the ara locus. Inversion of the construct, like at the ara locus, increased 
expression levels, giving an activity that was approximately 2.3-fold greater than the promoter 
in the opposite orientation (Figure 4.2). Expression of the lac28::egfp construct was similar in 
the lac, inverse lac, inverse ara and inverse mel strains, whereas the promoter in the ara and 
mel strains demonstrated less activity (Figure 4.2). 
The lac, ara and mel loci are all located on the right arm of replication. The lac28 fragment 
promoter in the lac and ara strains was oriented in the opposite direction to that of replication, 
whereas the promoter in the mel strain was oriented co-directionally with replication (Figure 
4.1). Insertion of the fusion in the opposite orientation at the ara locus caused the egfp gene to 
be transcribed co-directionally with replication, which significantly increased expression 
(Figure 4.1; Figure 4.2). However, the lac28 fragment promoter in the mel strain was already 
oriented co-directionally with replication and insertion in the head to head orientation caused 
an increase in promoter activity (Figure 4.1; Figure 4.2). Therefore the effects of orientation at 
these three positions did not correlate with that expected due to collisions with replication. 
This could be due to the slow growth rate in minimal medium and reduced rounds of 
replication per cell cycle. 
 
4.2.2 Analysis of local sequence context 
Analysis of ChIP and microarray data presented by Grainger et al. (2006) demonstrates that 
there is no significant amount of transcription occuring in the vicinity of the ara and mel loci 
in the conditions of this experiment. These data also demonstrate that there is no significant 
enrichment in FIS, IHF or H-NS binding within 10 kb of the ara and mel loci. This suggests 
that the difference in expression is not due to the promoter being positioned closer to a 
repressive site due to any of these proteins. 
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The ara and mel insertion sites are between the convergent genes yabI and thiQ, and melB and 
yjdF, respectively. Analysis of these intergenic regions between these two sets of convergent 
genes revealed that they each contain two repetitive extragenic palindromic (REP) sequences 
each (Figure 4.3). The function of REP elements is not entirely understood, however these 
sites are thought to play a role as mRNA stabilisers at the 3’ end of transcripts (Higgins et al., 
1988; Khemici and Carpousls, 2004). Further to this, these elements are also known to be 
target binding sites for DNA polymerase I, DNA gyrase and the NAP IHF, all of which are 
known to modify DNA structure (Gilson et al., 1990; Espeli and Boccard, 1997; Engelhorn et 
al., 1995).  
The ara and mel loci insertion sites are both situated within one of the two REP sites between 
the respective convergent genes, therefore disrupting one of the REP elements and leaving the 
other intact (Figure 4.3). This situation meant that in the ara and mel strains, BRY13 and 
BRY15, there was an intact REP element upstream of the lac28 fragment promoter. However, 
the inverse orientation strains, BRY21 and BRY37, have the intact REP element downstream 
of the egfp transcript (Figure 4.3). Expression of the lac28::egfp construct was greater in the 
inverse orientation strains, in which the intact REP element is downstream of the transcript. 
These data suggest that the increased expression could be due to greater mRNA stability, 
created by REP element-dependent protection of the 3’ transcript end (Newbury et al., 
1987a, b; Higgins et al., 1988; Khemici and Carpousls, 2004). Contrary to the fact that REP 
elements are known to act as binding sites for IHF (Engelhorn et al., 1995), data presented by 
Grainger et al. (2006) confirms that these REP elements are not bound by IHF during 
exponential growth. The effect of DNA polymerase I and DNA gyrase at these sites has yet to 
be determined, however further study on the action of DNA gyrase at these sites is presented 
in section 4.4. These data suggest that REP element position may be a contributing factor to 
orientation-based effects on promoter activity at these loci. However this effect could be due 
either to the action of DNA gyrase at these target sites, or stabilisation of mRNA transcripts.
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Figure 4.3: Schematic diagram of REP element disruption at the ara and mel loci 
White arrows represent genes and grey boxes represent repetitive extragenic palindromic 
(REP) elements, while black lines denote intergenic regions and the thick black line 
represents the insert (approximately to scale). Direction of transcription of each gene is 
indicated by the arrow heads. Direction of replication is from left to right in each panel. The 
arrow represents the position and orientation of the lac promoter. The hairpin-loop structure 
represents the position of the λ oop transcription terminator. a. organisation of genes at the 
ara locus in strain BRY13 (ara) and BRY21 (Inverse ara)  b. organisation of genes at the mel 
locus in strain BRY15 (mel) and BRY37 (Inverse mel). Insertion of the lac28::egfp fusion 
caused disruption of the REP7Aa element at the ara locus (a) and the REP327b element at the 
mel locus (b) 
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4.2.3 Effects of orientation on promoter activity during stationary phase 
Expression of the lac28::egfp fusion in both orientations at the ara and mel loci was assayed 
during stationary phase, as described in section 3.7. In stationary phase, activity of the 
promoter originally inserted at the ara and mel loci, in strains BRY13 and BRY15, was 
stronger than that of the promoter in the inverse orientation (Figure 4.1; Figure 4.4). This 
result was the opposite of that during exponential growth, during which the construct in the 
inverse ara and inverse mel strains were more highly expressed (Figure 4.2).  
Expression of egfp was similar at the ara and mel loci, in strains BRY13 and BRY15, 
however the inverse ara strain, BRY21, gave a signal that was approximately 2.5-fold weaker 
(Figure 4.4). This result suggests that the previously mentioned difference in REP 
element-dependent transcript stability does not entirely explain the differences in expression 
caused by orientation. This is due to the fact that the proposed difference in transcript stability 
should have been maintained during stationary phase, as mRNA stability is known to be 
unaffected by growth transition (Kuzj et al., 1998). REP elements are also known to be targets 
for DNA gyrase, which is active during exponential growth but inhibited by GyrI on entry 
into stationary phase, as discussed in section 1.2.2 (Nakanishi et al., 1998; Baquero et al., 
1995; Oh et al., 2001). Therefore these effects may be partially due to the action of DNA 
gyrase and this is investigated further in section 4.4. 
 
4.3 Effects of neighbouring promoter activity 
4.3.1 Effects of neighbour operon induction 
Transcription of neighbouring operons is a potential factor affecting the expression of the 
lac28::egfp construct in the experiments presented in chapter 3. The insertion of egfp at the  
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Figure 4.4: Effect of orientation on lac28::egfp activity at the ara and mel loci during 
stationary phase 
Expression of the lac28::egfp fusion in the BRY13 (ara), BRY21 (Inverse ara), BRY15 (mel) 
and BRY37 (Inverse mel) strains during stationary phase (OD620 ~ 1) at 37 ˚C in M9 minimal 
medium supplemented with 250 μM IPTG. Each point represents the fluorescence at 485 nm 
excitation, 510 nm emission, divided by the OD620 of the un-induced sample, subtracted from 
the fluorescence/OD620 of the induced culture. Each point is the average of at least three 
independent experiments with the error bars showing one standard deviation from the mean. 
The signal obtained from the induced inverse mel strain (BRY37) was unchanged that of the 
un-induced culture, therefore is represented as zero. The activity of the construct at the ara 
and mel loci was similar and both were greater than in the opposite orientation. 
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mel position, in the BRY15 and BRY37 strains, allows the effect of neighbouring gene 
expression on lac28::egfp activity to be investigated. The mel insertion locus is situated 
immediately downstream of the melibiose inducible operon melAB, of which the melA gene 
encodes the α-galactosidase enzyme (Figure 4.5). The activity of α-galactosidase can be 
measured in vivo by quantifying the release of o-nitrophenyl during hydrolysis of 
o-nitrophenyl-α-D-galactopyranoside by the enzyme. At 37˚C, transport of the inducer, 
melibiose, into the cell requires the lacY gene product, due to the temperature sensitive nature 
of the melibiose transporter. However, at 30˚C, transport can be facilitated by either the melB 
or lacY gene products (Prestidge and Pardee, 1965; Kennedy, 1970; Tamai et al., 1998). 
Hence, the pKH3 gene gorging plasmid was used to knock out the wild type lac promoter to 
abolish any interference from the transport of melibiose into the cell by the lacY encoded Lac 
permease, as in section 3.6.3. The wild-type lacZYA regulatory region of the BRY15, BRY37 
and BRY35 strains was knocked out to create the BRY75, BRY79 and BRY78 strains, 
carrying egfp at the mel locus in both orientations and at the asl locus. Therefore this system 
allowed the effect of melAB transcription on that of the egfp gene and the effect of egfp 
transcription on that of the melAB operon, to be analysed.   
The effect of neighbouring melAB expression on lac28::egfp activity at the mel locus was 
assayed by measuring fluorescence of the BRY75, BRY79 and BRY78 strains during 
exponential growth at 30˚C on M9 minimal salts medium supplemented with 100 μM IPTG 
or 0.2% melibiose, where stated. The addition of 0.2% melibiose to M9 minimal salts medium 
is known to induce expression of the melAB operon (Webster et al., 1987) The starting E. coli 
K-12 MG1655 strain was included as a control for auto-fluorescence, however the control 
samples and the un-induced cultures (- IPTG) registered no fluorescent signal. This 
demonstrated that no read-through from the neighbouring melAB operon was occuring. The 
BRY78 strain, containing the lac28::egfp fusion at the asl position, which is completely un-
connected to the melAB locus, was included as a control to ensure the addition of 
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Figure 4.5: Schematic diagram of gene organisation in the BRY75 and BRY79 mel locus 
strains 
White arrows represent genes and grey arrows represent reporter genes, while black lines 
denote intergenic regions and the thick black line represents the insert (approximately to 
scale). Direction of transcription of each gene is indicated by the arrow heads. The grey ovals 
indicate reporter gene products. Direction of replication is from left to right. The arrow 
represents the position and orientation of the lac promoter. The hairpin-loop structure 
represents the position of the λ oop transcription terminator. Induction of the melAB operon 
promoter by melibiose, or induction of the lac28 promoter by IPTG is indicated by a + 
symbol. The mel orientation is present in the BRY75 strain and the inverse mel orientation is 
present in the BRY79 strain. Both of these strains are lacY
-
 due to disruption of the lacZYA 
regulatory region. 
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melibiose to the growth medium had no direct effect on the lac28 fragment promoter activity. 
The activity of the melA gene product, α-galactosidase, was also assayed, as described in 
section 2.16, in the same cultures used for the fluorescence measurements, therefore making 
these results directly comparable.  
The expression of egfp at the asl locus, in the BRY78 strain, was unaffected by the addition of 
melibiose to the growth medium, therefore indicating that the lac28 fragment promoter was 
not directly affected by the presence of melibiose in the growth medium (Figure 4.6b). The 
α-galactosidase activity of the BRY78 strain culture was induced by the presence of 0.2% 
melibiose, however was unaffected by the presence of IPTG. These data show that the 
expression of the melAB operon was not directly affected by the presence of IPTG in the 
growth medium (Figure 4.6a). These results confirm that each promoter is only responsive to 
the respective inducer molecules with no cross-talk between the systems. 
Activity of the lac28 fragment promoter at the mel locus, in both orientations, was depressed 
by the induction of the upstream melAB operon (Figure 4.6b). Expression of egfp in the 
BRY75 mel strain, was reduced approximately 4-fold by the presence of melibiose in the 
growth medium, which induced expression of the melAB operon. Expression of the lac28 
promoter::egfp construct was also repressed in the BRY79 strain, which contains the fusion in 
the inverse mel orientation, and gave approximately 3-fold reduced activity in the presence of 
melibiose. This suggests that induction of upstream transcription represses lac28 fragment 
promoter activity, regardless of orientation of the fusion (Figure 4.6b). Repression of lac28 
activity by active upstream transcription could possibly be due to positive supercoiled 
domains created ahead of the elongating transcription complex, to which the lac promoter is 
sensitive (Wu et al., 1988; Sanzey, 1979).  
The α-galactosidase activity in the BRY75 mel strain, and BRY79 inverse mel strain, was 
significantly increased above that in the BRY78 strain, in which the lac28::egfp fusion is 
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Figure 4.6: Effect of neighbouring transcription on lac28::egfp and the melAB operon 
Strains BRY75 (mel), BRY79 (Inverse mel) and BRY78 (asl) were grown aerobically at 30°C 
to mid-exponential phase (OD620 0.3-0.5) in M9 salts medium supplemented with IPTG or the 
inducer of the melAB operon, melibiose, where stated. Data shown are average measurements 
from at least three independent experiments, and error bars show one standard deviation from 
the mean. a. α-galactosidase activity was measured in vivo and represented as a function of 
optical density as described in section 2.16. Data demonstrate that induction of the lac28 
fragment promoter is only detrimental to melAB activity in the BRY79 inverse mel strain. b. 
Fluorescence/OD620 was used to measure the lac28 fragment promoter activity. Data 
demonstrate that induction of the upstream melAB operon is detrimental to lac28 fragment 
activity regardless of orientation. 
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absent from the mel locus (Figure 4.6a). This increased expression could be due to the 
presence of the lac28 fragment promoter causing a change to local chromosomal architecture. 
Alternatively, both the lac and mel promoters are activated by CRP, therefore the presence of 
an additional CRP binding site could serve to increase the local concentration of CRP. 
The α-galactosidase activity in the BRY75 mel strain was not affected by induction of the 
co-oriented lac28 fragment promoter (Figure 4.6a). However, α-galactosidase activity in the 
BRY79 inverse mel strain was reduced by 50% upon induction of the downstream, 
convergently oriented, lac28 fragment promoter (Figure 4.6a). These results demonstrate that 
expression of the melAB operon is only negatively affected by activity of the lac28::egfp 
fusion when positioned downstream of the lac28 fragment promoter. The data presented in 
this section shows that active transcription can have a significant negative effect on 
downstream promoter activity. 
 
4.3.2 Effects of highly transcribed neighbouring genes 
The dkgB locus is located immediately downstream of the rrsHileValaVrrlHrrfH and aspU 
highly expressed, ribosomal and tRNA operons, thereby allowing further analysis of the 
effects of neighbouring gene transcription (Figure 4.7). The high levels of transcription in the 
upstream region of the dkgB locus are shown by the abundant RNAP binding demonstrated by 
the ChIP-microarray data presented by Grainger et al. (2006) and re-interpreted in figure 4.7. 
However the large amount of rRNA transcription is known to be inhibited and maintained at 
low levels on entry into stationary phase (Jacobson and Gillespie, 1968; Paul, et al., 2004). 
Therefore the switch from very high activity during exponential growth to very low activity 
during stationary phase allowed the effect of highly expressed neighbouring transcription, on 
lac28 fragment promoter activity at the dkgB locus, to be analysed.  
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Figure 4.7: Schematic diagram of gene organisation in the BRY58 dkgB strain and 
enrichment of RNAP binding 
White box arrows represent genes and the grey arrow illustrates the dkgB gene, while black 
lines denote intergenic regions and the thick black line represents the insert (approximately to 
scale). Direction of transcription of each gene is indicated by the arrow heads. Direction of 
replication is from left to right. The arrow represents the position and orientation of the lac 
promoter. The hairpin-loop structure represents the position of the λ oop transcription 
terminator. Enrichment ratio of RNAP is shown on the y-axis, as measured by chromatin 
immunoprecipitation and microarray analysis. Data gathered from E. coli MG1655 during 
mid-exponential growth (OD650 0.3-0.4) on M9 minimal salts medium supplemented with 
fructose. Data adapted from Grainger et al., (2006). 
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Expression of egfp at the dkgB position during exponential growth was analysed in section 3.5 
and no measureable level of eGFP fluorescence could be detected (Figure 4.8). Therefore this 
result indicates that during exponential growth, when transcription of the 
rrsHileValaVrrlHrrfH and aspU operons is highly active, lac28 fragment promoter activity 
was suppressed. However, when the activity of the lac28 fragment promoter was measured 
during stationary phase it was shown to be 4-fold greater than that of the promoter at the tam 
locus, which was more active during exponential growth (Figure 3.21; Figure 4.8). Therefore 
this result suggests that high transcriptional activity of the upstream rrsHileValaVrrlHrrfH 
and aspU operons causes suppression of the lac28 fragment promoter during exponential 
growth, but this is relieved upon entry into stationary phase (Jacobson and Gillespie, 1968; 
Paul, et al., 2004; Grainger et al., 2006). These results are in agreement with those presented 
in section 4.3.1. and suggest that active transcription can have a repressive effect on 
downstream promoters. 
 
4.4 Effects of local superhelical density 
4.4.1 Inhibition of DNA gyrase activity by novobiocin 
The DNA gyrase of E. coli is solely responsible for introducing negative supercoils into the 
genome and contains two subunits, GyrA and GyrB, the latter of which is inhibited by the 
coumarin drug novobiocin (Nöllmann et al, 2007; Sugino et al, 1978). Therefore this allowed 
the general disruption of global chromosomal supercoiling, in all strains tested in section 3.5., 
by the addition of novobiocin to the growth medium. This enables analysis of effects due to 
changes in local superhelical density, by the action of DNA gyrase, on the activity of the 
lac28 fragment promoter at the different locations. 
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Figure 4.8: Effect of growth phase on promoter activity at the dkgB locus 
Fluorescence/OD620 measured in the BRY58 (dkgB) strain. Cells were grown aerobically at 
37°C to mid-exponential phase (OD620 0.3-0.5) or stationary phase (OD620 ~ 1) in M9 salts 
medium supplemented with 100 μM IPTG during exponential growth or 250 μM IPTG during 
stationary phase, where stated.  Data shown are averages of fluorescence/OD620 measurements 
from at least three independent experiments, and error bars show one standard deviation from 
the mean. Fluorescence/OD620 measurements for un-induced (- IPTG) cultures are subtracted 
from that for induced cultures. Data show that the lac28 promoter::egfp construct at the dkgB 
locus is not inducible during exponential growth, however during stationary phase an increase 
in fluorescence is seen. 
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Plasmid pBR322 was used as a control to ensure that the addition of increasing concentrations 
of novobiocin affects the superhelical density of DNA within the cell. Plasmid was harvested 
from transformed BRY35 cells during mid-late exponential growth at 37˚C on M9 minimal 
salts medium supplemented with 80 μg/ml ampicillin and varying concentrations of 
novobiocin. Plasmid DNA was then visualised by 1% agarose gel electrophoresis 
supplemented with 2.5 μg/ml chloroquine, to separate the different supercoiled plasmid 
topoisomers, and stained with ethidium bromide to allow UV visualisation (Section 2.4.2). 
The addition of chloroquine causes DNA molecules to become more positively supercoiled, 
therefore increasing the migration speed. This accentuates differences in the supercoiled 
forms, aiding in separation. The intensity of fluorescence for each lane was plotted against the 
distance travelled through the gel as illustrated in Figure 4.9. The change in migration of 
pBR322 through the gel demonstrates that superhelical density is shifted to a more positively 
supercoiled state with increasing concentrations of novobiocin in the growth medium. This 
confirms that, in these conditions, the addition of novobiocin to the growth medium did cause 
a change to the global superhelical density of DNA within the cell, through the inhibition of 
GyrB (Figure 4.9). 
 
4.4.2 Effects of DNA gyrase inhibition on promoter activity 
The effect of novobiocin on lac28::egfp expression was investigated by measuring 
fluorescence of the BRY13, BRY15, BRY21, BRY22, BRY23, BRY27, BRY32, BRY33, 
BRY34, BRY35, BRY37 and BRY40 strains during mid-late exponential growth on M9 
minimal salts medium supplemented with 100 μM IPTG to induce expression of the lac28 
fragment promoter. Novobiocin was added to the growth medium at 50 μg/ml, which is 
sub-inhibitory to growth. The starting E. coli K-12 MG1655 strain was included as a control 
for auto-fluorescence, however the control samples and the un-induced (no IPTG) cultures 
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Figure 4.9: Effect of novobiocin inhibition of gyrB on pBR322 plasmid supercoiling  
pBR322 plasmid DNA was harvested from BRY35 cells during mid-late exponential growth 
at 37˚C on M9 minimal salts medium supplemented with 80 μg/ml ampicillin and varying 
concentrations of novobiocin, where stated. Plasmid DNA was visualised by 1% agarose gel 
electrophoresis supplemented with 2.5 μg/ml chloroquine to separate the varying supercoiled 
plasmid topoisomers and stained with ethidium bromide to allow UV visualisation. The 
intensity of fluorescence for each lane was plotted against the distance travelled through the 
gel (relative front). a. Separation of supercoiled pBR322 in cells grown with no novobiocin or 
25 μg/ml novobiocin. b. Separation of supercoiled pBR322 in cells grown with no novobiocin 
or 50 μg/ml novobiocin. c. Separation of supercoiled pBR322 in cells grown with no 
novobiocin or 75 μg/ml novobiocin. d. Separation of supercoiled pBR322 in cells grown with 
no novobiocin or 100 μg/ml novobiocin. Data presented demonstrate a shift in pBR322 
supercoiling to a more positively supercoiled state in the presence of increasing 
concentrations of novobiocin, indicated by increased migration speed through the gel 
(increased relative front). 
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registered no fluorescent signal in the presence of novobiocin. Therefore this indicated no 
measurable effect of novobiocin on the un-induced, basal level, activity of the construct. 
Results demonstrated that egfp expression was unaffected by the addition of novobiocin to the 
growth medium in most of the strains tested. However, fluorescence of the BRY21 (inverse 
ara), BRY27 (rcs), BRY34 (nupG), BRY35 (asl) and BRY37 (inverse mel) strains was 
affected by GyrB inhibition at concentrations of novobiocin sub-inhibitory to growth. 
The effect of GyrB inhibition, by novobiocin, on activity of the lac28 fragment promoter in 
the inverse ara, rcs, nupG, asl and inverse mel strains was further characterised by the 
addition of increasing concentrations of novobiocin to the growth medium. The expression of 
egfp in the inverse ara strain was approximately 10-fold greater than that of the fusion in the 
opposite orientation in the BRY13 strain, as reported in section 4.2. However, upon addition 
of increasing concentrations of novobiocin the activity of the promoter was reduced 
incrementally by up to 3.4-fold (Figure 4.10). This argues that a large part of the increased 
activity in the inverse ara strain may be due to the effects of DNA gyrase on local 
superhelical density. This is in agreement with the reduction in activity in the inverse ara 
strain during stationary phase, during which DNA gyrase is inhibited and the chromosome 
becomes relaxed, as reported in section 4.2.3. (Figure 4.4). 
The expression of the lac28::egfp construct at the rcs and inverse mel loci, in the BRY27 and 
BRY37 strains respectively, was only significantly affected by the presence of novobiocin at 
growth inhibitory concentrations of 75 μg/ml and 100 μg/ml (Figure 4.10). This suggests that 
DNA gyrase plays only a small part in the regulation of superhelical density at these 
locations. This implies that the increased expression in the BRY37 inverse mel strain, 
compared to that of the BRY15 strain reported in section 4.2, was not strongly affected by the 
action of DNA gyrase. 
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Figure 4.10: Effects of GyrB inhibition by novobiocin on promoter activity in the inverse 
ara, rcs, nupG, asl and inverse mel strains 
Fluorescence/OD620 measured in strains BRY21 (Inverse ara), BRY27 (rcs), BRY34 (nupG), 
BRY35 (asl) or BRY37 (Inverse mel), each encoding the lac28::egfp fusion at the designated 
chromosomal position. Cells were grown aerobically at 37°C to mid-exponential phase 
(OD620 0.3-0.5) in M9 salts medium supplemented with IPTG and the GyrB inhibitor 
novobiocin, where stated. Data shown are averages of fluorescence/OD620 measurements from 
at least three independent experiments, and error bars show one standard deviation from the 
mean. Minimal effects were seen at the rcs and Inverse mel loci, at growth sub-inhibitory 
concentrations of novobiocin. The greatest effects of novobiocin on the lac28 promoter::egfp 
construct were at the nupG and asl loci. 
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The expression of egfp was most affected by DNA gyrase inhibition in the BRY34 and 
BRY35 strains, which carry egfp at the nupG and asl loci respectively. During exponential 
growth, the lac28::egfp fusion was most strongly expressed at the nupG and asl positions, 
giving approximately 10 and 11-fold greater levels of expression than that at the tam locus, 
near to the dif site, as reported in section 3.5 (Figure 3.7; Figure 3.10). The inhibition of GyrB 
during exponential growth was shown to reduce the activity of the lac28 fragment promoter at 
the nupG locus incrementally by up to 17-fold (Figure 4.10). However, activity of the lac28 
fragment promoter at the nupG locus in the presence of the sub-inhibitory concentration of 
50 μg/ml was approximately 2-fold reduced to a level similar to that of the promoter at the lac 
locus (Figure 4.10). The high promoter activity at the asl locus was also shown to be reduced 
incrementally by up to 4-fold upon the addition of increasing concentrations of novobiocin 
(Figure 4.10). The addition of novobiocin at the sub-inhibitory to growth concentration of 
50 μg/ml was also shown to reduce the expression of egfp at the asl locus by approximately 
2-fold. This reduction made the activity similar to that at the nupG locus in the presence of 
50 μg/ml novobiocin, or to that at the inverse mel or lac loci in the absence of novobiocin 
(Figure 4.10). These results demonstrate that the exceptionally strong lac28 fragment 
promoter activity at the nupG and asl loci is due to the local action of DNA gyrase in 
maintaining locally available negative superhelicity, to which the lac promoter is known to be 
sensitive (Nöllmann et al, 2007; Sanzey, 1979). 
 
4.5 Promoter activity within extended protein occupancy domains 
4.5.1 Effects of tsEPOD replacement on promoter activity during exponential growth 
The supercoiled domains of the E. coli chromosome are expected to contribute to the variation 
in lac28 promoter::egfp expression, which could be due to variations in local superhelical 
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density, as presented in section 4.4 (Postow et al., 2004). The issue of how supercoils are 
constrained in these different domains is addressed by the work of Vora et al. (2009), who 
sought to identify the protein occupancy landscape of the E. coli genome. This work 
identified EPODs, which are large regions of the chromosome, between 1 and ~ 14 kb, bound 
by higher than average amounts of protein. The EPODs were classified as either highly 
transcribed (heEPODs) or transcriptionally silent (tsEPODs). Hence, the lac28::egfp fusion 
was inserted within a number of tsEPODs to ascertain whether the silent profile is due to the 
domain containing poor or repressed promoters, or due to intrinsic properties of the domain 
(Vora et al., 2009). 
As described in section 3.3, the lac28::egfp fusion was, where possible, targeted to 
non-coding regions between convergent genes within tsEPODs. However, the non-expressed 
pseudogene eaeH was interrupted in one of the contructions. Firstly the yafT, eaeH, yqe, pitB 
and ycb loci were targeted to create the BRY22, BRY23, BRY54, BRY55 and BRY32 strains, 
respectively, as described in section 3.3. Homology regions were used that did not replace any 
of the existing chromosomal DNA of the starting E. coli K-12 MG1655 strain, as in section 
3.3, therefore only disrupting the contiguous nature of the tsEPODs (Figures 2.20-2.24; 
Figure 4.11b). Homology regions were then designed to flank each of the tsEPODs, thereby 
replacing the tsEPOD with the lac28::egfp fusion, allowing expression from the locus to be 
analysed without the presence of EPOD DNA (Figures 2.20-2.24; Figure 4.11c). The strains 
in which the tsEPODs have been replaced were assigned BRY numbers and the locus referred 
to as ΔtsEPOD (e.g. ΔyafT). The ΔyafT strain, BRY59, was created to leave the 3’ end of 
dnaQ and the downstream tRNA gene, which reside within the flank of the tsEPOD, present 
in order to minimise disruption to cell growth (Figure 2.20). Construction of the ΔeaeH strain, 
BRY60, was designed to replace the tsEPOD and the neighbouring insF-1 insertion element, 
due to the requirement of a homology region that is unique within the chromosome (Figure 
2.21). The Δyqe and ΔpitB strains, BRY68 and BRY69 respectively, were created as  
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Figure 4.11: Schematic diagram of lac28::egfp insertion in the pitB and ΔpitB strains 
White box arrows represent genes, whereas black lines denote intergenic regions and the thick 
black line represents the insert (approximately to scale). Direction of transcription of each 
gene is indicated by the arrow heads. Disrupted genes are represented by crossed boxes. 
Direction of replication is from left to right. The bent arrow represents the position and 
orientation of the lac promoter. The hairpin-loop structure represents the position of the λ oop 
transcription terminator. The position of tsEPODs is represented by the black box on the 
lower line and the positions of homology regions used to insert the lac28 promoter::egfp 
fusion are indicated by labelled shaded boxes. a. Organisation of genes at the pitB locus in 
E. coli MG1655 with the homology regions to insert the lac28 promoter::egfp fusion, and the 
position of the tsEPOD, indicated. b. Organisation of genes at the pitB locus in the BRY55 
strain. The lac28 promoter::egfp fusion was inserted using the HR1 and HR2 homology 
regions shown. c. Organisation of genes in the ΔpitB BRY69 strain. The tsEPOD region was 
replaced with the lac28 promoter::egfp fusion using the HR3 and HR4 homology regions 
shown. 
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described in section 2.9 (Figures 2.23-2.24), however a Δycb locus recombinant was never 
successfully obtained. 
Activity of the lac28 fragment promoter at positions within tsEPODs was assayed by 
measuring fluorescence of the BRY22, BRY23, BRY32, BRY54, BRY55, BRY59, BRY60, 
BRY68 and BRY69 strains during mid-late exponential growth on M9 minimal salts medium. 
The starting E. coli K-12 MG1655 strain was included as a control for auto-fluorescence, 
however the control samples and the un-induced (no IPTG) cultures registered no fluorescent 
signal. The BRY22, BRY23 and BRY54 strains, carrying the lac28::egfp fusion at the yafT, 
eaeH and yqe tsEPOD loci, gave no measureable fluorescence signal upon addition of the 
inducer IPTG to the growth medium (Figure 4.12). This result suggests that the promoter was 
silenced at these positions. Also, very low levels of fluorescence were detected in some of the  
induced BRY32 strain cultures, in which the promoter was positioned at the ycb locus, 
therefore indicating that this locus is also repressive to lac28 fragment promoter activity 
(Figure 4.12). However, activity of the lac28 fragment promoter at the pitB tsEPOD locus, in 
strain BRY55, was stronger, giving approximately the same weak level of activity as the 
promoter at the tam locus, reported in section 3.5 (Figure 4.12; Figure 3.7). 
Results presented in figure 4.12 show that deletion of the tsEPOD encoding DNA led to 
increased activity of the lac28 fragment promoter. Expression of the fusion in the ΔyafT strain 
was greater than that of the promoter in the yafT strain, giving a signal that was approximately 
80% of that seen from the pitB and tam loci (Figure 4.12). Promoter activity in the ΔeaeH 
strain was also greater than that of the tsEPOD version. However, the promoter activity was 
weaker than in the ΔyafT strain, giving an activity that was approximately 2-fold lower than 
that of the tam locus (Figure 4.12). Further to this, activity of the lac28 fragment promoter in 
the Δyqe strain was also increased, compared to that in the yqe tsEPOD strain, and had an 
activity comparable to that in the pitB or tam strains (Figure 4.12). The activity of the lac28 
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Figure 4.12: Effect of deletion of tsEPODs on lac28 promoter activity during exponential 
growth 
Fluorescence/OD620 measured in strains BRY22 (yafT), BRY59 (ΔyafT), BRY23 (eaeH), 
BRY60 (ΔeaeH), BRY54 (yqe), BRY68 (Δyqe), BRY55 (pitB), BRY69 (ΔpitB) or BRY32 
(ycb). Cells were grown aerobically at 37°C to mid-exponential phase (OD620 0.3-0.5) in M9 
salts medium supplemented with IPTG, where stated. Data shown are averages of 
fluorescence/OD620 measurements from at least three independent experiments, and error bars 
show one standard deviation from the mean. Activity of the lac28 fragment promoter is 
silenced at the tsEPOD loci, however upon replacement of the tsEPOD regions, repression is 
lifted. Silencing is weaker at the pitB locus. 
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fragment promoter was also increased approximately 2.3-fold by deletion of the tsEPOD 
encoding region at the pitB locus (Figure 4.12). Therefore these results suggest that the 
tsEPODs analysed in this study silenced promoter activity. However, the degree of silencing 
was less at the pitB tsEPOD locus, indicating that silencing by tsEPODs is not equal. 
 
4.5.2 Effects of tsEPOD replacement on promoter activity during stationary phase 
Promoter activity at tsEPOD loci was analysed during stationary phase, as described in 
section 3.7 and 2.10.2. (Balke and Gralla, 1987; Azam et al., 1999). Activity of the lac28 
promoter when positioned at the yafT tsEPOD locus was increased during stationary phase, 
giving a similar signal to that in the ΔyafT strain and at the nupG locus (Figure 3.21; Figure 
4.13). This indicates that the silencing created by the yafT tsEPOD during exponential growth 
is relieved upon entry into stationary phase. The activity of the lac28 promoter at the pitB 
locus was also unchanged by deletion of the tsEPOD encoding region, therefore indicating 
that either the silencing element of the tsEPOD was absent or that the expression of the ΔpitB 
locus was not improved (Figure 4.13). However, the activity of the lac28 fragment promoter 
at the eaeH and yqe tsEPOD loci was approximately 3-fold less than that of the construct in 
the ΔeaeH and Δyqe strains, which was similar to that in the ΔyafT strain (Figure 4.13). These 
results indicate that the repressive element responsible for promoter silencing at the eaeH and 
yqe tsEPOD loci was reduced, however still present during stationary phase. The expression 
of egfp at the ycb locus was also similar to that of the other ΔtsEPOD strains, indicating that 
tsEPOD silencing at the ycb locus may also be absent during stationary phase (Figure 4.13). 
These results suggest that the tsEPOD landscape does have a silencing effect on promoter 
activity and that this landscape is dynamic and changes with growth phase. 
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Figure 4.13: Effect of tsEPODs on lac28 promoter activity during stationary phase 
Activity of the lac28 fragment promoter in the BRY22 (yafT), BRY59 (ΔyafT), BRY23 
(eaeH), BRY60 (ΔeaeH), BRY54 (yqe), BRY68 (Δyqe), BRY55 (pitB), BRY69 (ΔpitB) or 
BRY32 (ycb) strains during stationary phase (OD620 ~ 1) at 37 ˚C in M9 minimal medium 
supplemented with 250 μM IPTG. Each point represents the fluorescence at 485 nm 
excitation, 510 nm emission, divided by the OD620 of the un-induced sample subtracted from 
the fluorescence/OD620 of the induced culture. Each point is the average of at least three 
independent experiments with the error bars showing one standard deviation from the mean. 
All loci give a signal above that of background. Activity of the lac28 fragment promoter is the 
same in the yaft, ΔyafT, ΔeaeH, Δyqe, pitB, ΔpitB and ycb strains. Some silencing occurs at 
the eaeH and yqe tsEPOD loci indicating that some repressive element remains. 
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4.5.3 Analysis of nucleoid-associated protein binding of tsEPODs  
The organising centres of the E. coli nucleoid are expected to be formed and maintained by 
the cooperative binding of NAPs, due to their high abundance, ability to increase further NAP 
binding, low sequence specificity and the bending, wrapping, bridging and clustering that can 
result upon binding to DNA (Azam and Ishihama, 1999; Luijsterbeurg et al., 2008; Browning 
et al., 2010). The work of Vora et al. (2009) showed that tsEPODs are enriched for NAP 
binding by position-weight matrix prediction and comparison with the Chip-chip data sets for 
the IHF, FIS and H-NS proteins presented by Grainger et al. (2006). Therefore the IHF, FIS 
and H-NS ChIP-chip data sets, presented by Grainger et al. (2006), were analysed at the 
tsEPOD loci used in this study to gain further insight into the observed promoter silencing. 
Further work from our lab identified one of the tsEPODs used in this study as a target for 
SeqA protein binding. SeqA is a regulator of DNA replication initiation that binds 
hemi-methylated GATC sequences after passage of the replication machinery 
(Sánchez-Romero et al., 2010). Therefore the data presented by Sánchez-Romero et al. (2010) 
were also analysed for the tsEPOD loci used in this study. 
Analysis of SeqA ChIP-chip data for the yafT insertion site during exponential growth 
demonstrated that SeqA binding was not significantly enriched at that site (Sánchez-Romero 
et al., 2010). Further to this, no significant quantities of IHF binding could be detected, 
however enrichment ratios of approximately 12 for FIS and H-NS were found for the yafT 
locus (Grainger et al., 2006; Figure 4.14). Binding of FIS and H-NS in the vicinity of the yafT 
locus, correlates with silencing of expression of the lac28::egfp fusion during exponential 
growth. Therefore during stationary growth, when levels of FIS decrease to un-detectable 
levels and H-NS levels are reduced by approximately 60% (Azam et al., 1999), these proteins 
will be less likely to bind to the yafT target site and so less likely to interfere with egfp 
expression, as reported in Figure 4.13. 
216 
dnaQ yafT ykfM yafU
small 
RNA
tRNA
tsEPOD
yafV
IH
F
 E
n
ri
c
h
m
e
n
t
0
5
10
15
20
25
30
35
40
236067 236567 237067 237567 238067 238567 239067 239567 240067
F
IS
 E
n
ri
c
h
m
e
n
t
F
IS
 E
n
ri
c
h
m
e
n
t
0
5
10
15
20
25
30
35
40
45
236067 236567 237067 237567 238067 238567 239067 239567 240067
IH
F
 E
n
ri
c
h
m
e
n
t
0
5
10
15
20
25
30
35
40
236067 236567 237067 237567 238067 238567 239067 239567 240067
H
-N
S
 E
n
ri
c
h
m
e
n
t
H
-N
S
 E
n
ri
c
h
m
e
n
t
IH
F
 E
n
ri
c
h
m
e
n
t
F
IS
 E
n
ri
c
h
m
e
n
t
F
IS
 E
n
ri
c
h
m
e
n
t
IH
F
 E
n
ri
c
h
m
e
n
t
H
-N
S
 E
n
ri
c
h
m
e
n
t
H
-N
S
 E
n
ri
c
h
m
e
n
t
 
Figure 4.14: Association of IHF, FIS and H-NS with the yafT tsEPOD locus  
Enrichment ratio of IHF, FIS and H-NS protein at the yafT tsEPOD locus, measured by 
chromatin immunoprecipitation and microarray analysis. Data gathered from E. coli MG1655 
during mid-exponential growth (OD650 0.3-0.4) on M9 minimal salts medium supplemented 
with fructose. Data adapted from Grainger et al. (2006). Data demonstrate enriched binding of 
FIS and H-NS at the yafT tsEPOD locus. 
217 
The pitB target tsEPOD was also found to be bound by IHF, FIS and H-NS, however in 
smaller quantities than that of the yafT tsEPOD. The enrichment ratio was approximately 6 for 
IHF, FIS and H-NS, which was approximately 50% as strong as the FIS and H-NS signals at 
the yafT tsEPOD (Grainger et al., 2006; Figure 4.14; Figure 4.15). Analysis of the SeqA 
Chip-chip data demonstrated that the pitB tsEPOD was not bound by SeqA protein 
(Sánchez-Romero et al., 2010). These results suggest that relatively weak promoter activity at 
the pitB tsEPOD position, during exponential growth, could also be due to NAP binding in 
the local area. 
The yqe tsEPOD locus was found to be the most bound by NAPs and was also the largest 
tsEPOD which I targeted with the lac28::egfp fusion. Analysis of the ChIP-chip data 
demonstrated that the yqe locus tsEPOD contained one of the largest enrichment ratio peaks 
in the genome for FIS or H-NS, approximately 70 and 76, respectively (Figure 4.16). The IHF 
peak signal for the yqe tsEPOD had an enrichment ratio of approximately 6, which was 
similar to that of the pitB locus (Figure 4.16). These results demonstrate that the yqe tsEPOD 
region was strongly bound by FIS and H-NS, however silencing of the lac28 fragment 
promoter, by the tsEPOD region, seemed at least partially functional during stationary phase, 
indicating the existence of further silencing mechanisms (Figure 4.13). 
In contrast to the protein binding detected at the yafT, pitB and yqe loci, no FIS, IHF, H-NS or 
SeqA binding was detected at the eaeH tsEPOD (Grainger et al., 2006). This result suggests 
that silencing of lac28 fragment promoter activity, at the eaeH tsEPOD locus, was not due to 
binding of FIS, IHF, H-NS or SeqA, therefore the tsEPOD must be formed of some other 
protein binding. Analysis of the ChIP-chip data for the ycb tsEPOD locus also confirmed that 
there was no significant FIS or H-NS binding to the tsEPOD and only weak levels of IHF 
with an enrichment ratio of 5 (Grainger et al., 2006). However, SeqA ChIP-chip data from 
Sánchez-Romero et al. (2010), confirmed that the ycb locus tsEPOD was formed of the SeqA 
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Figure 4.15: Association of IHF, FIS and H-NS with the pitB tsEPOD locus 
Enrichment ratio of IHF, FIS and H-NS protein at the pitB tsEPOD locus, measured by 
chromatin immunoprecipitation and microarray analysis. Data gathered from E. coli MG1655 
during mid-exponential growth (OD650 0.3-0.4) on M9 minimal salts medium supplemented 
with fructose. Data adapted from Grainger et al. (2006). Data demonstrate a small signal, 
indicating low levels of IHF, FIS and H-NS binding to the pitB tsEPOD region. 
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Figure 4.16: Association of IHF, FIS and H-NS with the yqe tsEPOD locus 
Enrichment ratio of IHF, FIS and H-NS protein at the yqe tsEPOD locus, measured by 
chromatin immunoprecipitation and microarray analysis. Data gathered from E. coli MG1655 
during mid-exponential growth (OD650 0.3-0.4) on M9 minimal salts medium supplemented 
with fructose. Data adapted from Grainger et al. (2006). Data demonstrate a small IHF signal, 
however extremely large signals of FIS and H-NS binding are detected within the yqe 
tsEPOD. 
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Figure 4.17: Association of SeqA with the ycb tsEPOD locus 
Enrichment ratio of SeqA protein at the ycb tsEPOD locus, measured by chromatin 
immunoprecipitation and microarray analysis. Data gathered from E. coli CMT940 during 
mid-exponential growth (OD650 0.3-0.4) on LB. Data adapted from Sánchez-Romero et al. 
(2010). Data demonstrate a SeqA binding peak that correlates with the ycb tsEPOD locus, 
indicating that this tsEPOD consists of bound SeqA. 
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protein. Therefore these results suggest that silencing of the lac28 fragment promoter, 
reported during exponential growth, could be due to upstream SeqA binding (Figure 4.12; 
Figure 4.17). In summary, these results and data show that the protein content of the tsEPODs 
is not uniform and, whilst the observed silencing of the lac28 promoter is likely due to 
tsEPOD-bound protein, there is probably no single mechanism operating. 
 
4.6 Discussion 
The work presented in chapter 3 demonstrates that position within the chromosome can affect 
gene expression levels and that this variation does not always correlate with the changes 
expected due to proximity to the chromosome replication origin. Previous studies have 
demonstrated position-mediated variation in gene expression, however this was always 
attributed to gene dosage or, more recently, “local sequence effects” created by local DNA 
processes (Beckwith et al., 1966; Schmid and Roth; 1987; Sousa et al., 1997; Block et al., 
2012). Therefore the work of this chapter sought to investigate and evaluate the mechanisms 
behind the position-based effects on promoter activity described in chapter 3. 
 
4.6.1 Orientation effects are unrelated to replication 
The orientation of a promoter with respect to the direction of DNA replication is expected to 
affect gene expression due to disruptive collisions between DNA polymerase and RNAP. 
Collisions are bound to occur due to DNA polymerase moving much faster than RNAP and 
the two highly processive enzymes sharing the same template (McGlynn et al, 2012). The 
effect of collisions between elongation complexes and the replisome is dependent upon 
whether the collision is head-on or co-directional, and the former is far more disruptive to 
both complexes than the latter (French, 1992; Mirkin and Mirkin, 2005). Due to this 
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inequality, highly expressed and essential genes mostly locate to the leading strand of DNA 
replication to keep the majority of transcription co-directional with replication (Price et al., 
2005; Merrikh et al., 2011; McGlynn et al., 2012). The effect of orientation on promoter 
activity was assessed at three loci, lac ara and mel, that are all on the right arm of replication. 
Orientation had little to no effect at the lac locus, however a 10-fold difference in activity was 
found at the ara locus and a 2.3-fold difference at the mel locus. There was no correlation 
between increased expression and direction of replication at these two loci. The lack of 
correlation between gene expression level and orientation relative to replication, is probably 
because of the slow growth rate used in these experiments, in which one doubling takes 
approximately 60 minutes and only one round of replication is expected to be initiated per cell 
cycle (Cooper and Helmstetter, 1968). 
It was expected that the effects of orientation on expression at the ara and mel loci would be 
abolished during stationary phase if they were due to replication-transcription clashes (Chang 
et al., 2002). Surprisingly, analysis of egfp expression at the ara and mel loci, revealed that 
the expression patterns were reversed. Activity in the “inverse” orientation strains was 
stronger during exponential growth, but weaker during stationary phase (Figure 4.4). This 
underscores that the effects of orientation on egfp expression at the ara and mel loci are 
unrelated to DNA replication and highlights our ignorance of what is really going on. 
 
4.6.2 Repetitive extragenic palindromic sequences play a role in orientation effects 
Insertion of the lac28::egfp fusion at the ara and mel loci causes disruption of REP sites 
between the convergent target genes (Figure 4.3). REP elements are 35-40 nucleotide 
stem-loop structures, which are known to be binding targets for DNA polymerase I, and  the 
NAP IHF, and provide cleavage sites for DNA gyrase (Gilson et al., 1990; Espeli and 
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Boccard, 1997; Engelhorn et al., 1995; Messing et al., 2012). REPs are also known to 
increase mRNA stability and terminate transcription when positioned at the 3’ end of a 
transcript (Gilson et al., 1986; Higgins et al., 1988; Khemici and Carpousls, 2004). Insertion 
of the lac28::egfp fusion at the ara and mel loci caused disruption of one of two REP 
elements between each set of convergent genes. The resulting ara and mel strains both have 
one intact REP element upstream of the lac28 fragment promoter, whereas inversion of the 
fusion positioned the intact REP element downstream of the egfp transcript (Figure 4.3). The 
REP element at the 3’ end of the egfp mRNA transcript could improve expression in the 
“inverse” orientation strains. 
Data presented by Grainger et al. (2006), confirmed that the REP elements at the ara and mel 
target loci were not bound by IHF during exponential growth, contrary to the fact that they are 
known IHF binding sites (Engelhorn et al., 1995). Therefore IHF had no role in the 
orientation effects at these loci. However, inhibition of DNA gyrase, for which the REP 
elements are known targets, caused a dramatic reduction in the orientation-dependent 
difference in expression at the ara locus (Figure 4.10). Data presented in section 4.2.3 showed 
that the increased expression in the “inverse” orientation strain is lost. The action of DNA 
gyrase is inhibited upon entry into stationary phase and the chromosome becomes more 
relaxed, therefore creating a similar effect at the ara locus to that of DNA gyrase inhibition 
(Nakanishi et al., 1998; Baquero et al., 1995; Oh et al., 2001). Therefore, increased 
expression in the inverse ara strain, compared to that in the opposite orientation, was due 
partly to the action of DNA gyrase at the downstream REP element. Unlike the ara position, 
inhibition of DNA gyrase had little effect on egfp expression at the mel locus. Therefore 
orientation-dependent differences in expression at the mel locus are most likely due to 
enhanced egfp transcript stability, due to REP element-dependent protection of the 3’ 
transcript end (Figure 4.3; Figure 4.10; Newbury et al., 1987a, b; Higgins et al., 1988; 
Khemici and Carpousls, 2004). These data show that position and nature of local sequence 
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elements, such as REPs, can have significant effects on promoter activity and gene 
expression.  
 
4.6.3 DNA gyrase-dependent enhanced expression at the asl and nupG positions 
The transition from exponential growth to stationary phase causes many changes to E. coli 
cells, one of which is the relaxation of chromosomal superhelical density to produce a less 
negatively supercoiled molecule (Balke and Gralla, 1987). This change was suggested to be 
the mechanism behind the shift in transcription patterns presented in section 3.7. The 
superhelical density of the chromosome is not only changed during growth phase transitions, 
but also changes in response to processes such as replication and transcription (Postow, 2004; 
Nöllmann et al, 2007). Sanzey (1979) showed that expression of the lac operon is negatively 
affected, by up to 75%, upon inhibition of DNA gyrase. Therefore, variations in negative 
superhelicity across the genome were predicted to be one of the contributing factors to the 
large variation in lac28 fragment promoter activity reported in section 3.5. 
Inhibition of GyrB by novobiocin had little to no effect on lac28::egfp expression at the 
majority of positions tested, however the exceptionally high activity at the asl and nupG 
positions was greatly reduced (Figure 4.10). In the presence of novobiocin concentrations 
sub-inhibitory to growth the expression was reduced to a similar level to that at the wild-type 
lac position, therefore proving that the exceptionally strong activity was due to negative 
superhelicity, maintained by the action of DNA gyrase. Analysis of the local sequence at the 
asl and nupG loci reveals that there are no REP elements present, therefore DNA gyrase is not 
acting at these sites as at the ara locus. However, DNA gyrase binding sites are found at a 5 to 
10-fold higher average density near to the origin compared to the Ter proximal region, 
therefore suggesting a gradient of negative superhelicity from Ori to Ter (Sobetzko et al., 
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2012). The density of gyrase binding sites also appears to be greater in the NSL macrodomain 
than in the NSR macrodomain, therefore potentially explaining the difference in expression at 
the nupG locus compared to similar positions on the right arm of replication (Sobetzko et al., 
2012).  
 
4.6.4 Transcription can have a negative effect on downstream promoter activity 
Activity of the lac28 fragment promoter at the mel position was found to be depressed by 
active transcription of the upstream melAB operon, regardless of lac28::egfp orientation 
(Figure 4.6). Also, activity of melAB was unaffected by induction of lac28 when the 
promoters were oriented co-directionally, however melAB expression was reduced when 
downstream of the lac28 fragment promoter (Figure 4.6). Further to this, when positioned at 
the dkgB locus, the lac promoter was only active during stationary phase, during which 
expression of the upstream rRNA operon is inhibited (Jacobson and Gillespie, 1968; Paul, et 
al., 2004; Grainger et al., 2006; Figure 4.8). These results could be due to the fact that an 
actively transcribing RNAP elongation complex increases negative superhelicity behind the 
complex and decreases it ahead (Wu et al., 1988; Tsao et al., 1989). Under-winding (negative 
supercoiling), but not over-winding (positive supercoiling), should assist in local DNA strand 
separation required at promoter transcription start sites for open complex formation and the 
completion of transcription initiation (Browning and Busby, 2004; Travers and 
Muskhelishvili, 2007). Also if the transcription factory hypothesis, as discussed in section 
1.4.3., is correct or if local pools of RNA polymerase exist, then strong neighbouring 
transcription could subtract from the locally available pool of RNAP (Cook, 2010; Jin et al., 
2006). However this is unlikely to be the case, as the lac28 fragment promoter is closer in the 
co-directional orientation, yet has no negative effect on melAB expression upon induction 
(Figure 4.6).  
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4.6.5 tsEPODs silence transcription 
Recent research by Vora et al. (2009), demonstrated that there are regions of the chromosome 
that are both transcriptionally silent and highly occupied by protein. Activity of the lac28 
fragment promoter from within a small subset of tsEPODs was analysed by insertion into the 
tsEPOD without replacement of any genetic material, therefore potentially leaving the protein 
binding as in the starting strain. Promoter activity at tsEPOD locations was suppressed, 
however replacement of the entire tsEPOD region with the lac28::egfp fusion caused 
increased levels of lac28 fragment promoter activity at loci tested during exponential growth 
(Figure 4.12). Therefore, promoters in these regions were not necessarily transcriptionally 
silent due to the sequence of the promoter, but due to a silencing effect produced by the 
domain in which they reside.  
Silencing of promoter activity was not maintained at all tsEPOD loci tested on entry into 
stationary phase. Analysis of ChIP-chip data for the tsEPOD loci revealed FIS, H-NS and IHF 
binding during exponential growth, however this binding was unequal at the different tsEPOD 
loci. During stationary phase, when levels of FIS decrease to un-detectable levels and H-NS 
levels are reduced by approximately 60% (Azam et al., 1999), tsEPODs may be less likely to 
form and interfere with promoter activity. Suppression of egfp expression at the yqe tsEPOD 
position was not relieved upon entry into stationary phase, however ChIP-chip data for this 
locus shows extremely large signals for FIS and H-NS binding during exponential growth 
(Grainger et al., 2006). Thus, as H-NS levels are only reduced by approximately 60% upon 
entry into stationary phase, some residual H-NS binding may still occur at this highly 
preferential binding site (Azam et al., 1999). The repression of the lac28 fragment promoter 
was also maintained at the eaeH tsEPOD locus during stationary phase, however no NAP 
binding could be detected. Therefore the suppression of egfp expression at this locus occurred 
by some other mechanism and the constituents of the eaeH tsEPOD remain unknown. 
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Analysis of ChIP-chip data for the ycb tsEPOD locus revealed that this locus was bound by 
the SeqA protein, which is a regulator of DNA replication that binds hemi-methylated GATC 
sequences after passage of the replication machinery (Sánchez-Romero et al., 2010). 
Therefore the lac28::egfp fusion was silenced during exponential growth when the 
chromosome was being replicated, however was active during stationary phase when 
replication of the chromosome is inhibited (Chang et al., 2002).  
In summary these results demonstrated that tsEPODs are capable of repressing the activity of 
a strong promoter, therefore showing that position within the chromosome and local 
chromosomal architecture can play a major role in the regulation of transcription. However, 
the tsEPODs are dynamic and unequal in their protein constituent parts, with other protein 
components left unidentified. Therefore, further work is required to characterise the pattern of 
tsEPODs during other growth phases and to identify the core proteins involved in their 
formation and the exact mechanism behind repression of transcription initiation. 
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Chapter 5: 
 
Comparison of plasmid-located and chromosome-located 
promoters in Escherichia coli 
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5.1 Introduction 
5.1.1 Plasmid-based gene expression systems 
Work reported in chapters 3 and 4 shows that bacterial gene expression is not only dependent 
upon promoter sequence, but also on position within the folded chromosome. However, many 
studies into promoter function utilise mobile extra-chromosomal plasmid-encoded reporter 
gene expression systems, such as the low copy number lac expression vector pRW50 (Lodge 
et al., 1992). While multi-copy plasmids have long been assumed to diffuse freely throughout 
the cell, they have also been shown to localise to positions that are on the periphery of the 
nucleoid at various positions, including the cell poles (Pogliano et al., 2001). Further to this, 
the work of Sánchez-Romero et al. (2012), demonstrated that the congregation of several 
partition-system deficient plasmids in one location was driven by high transcriptional activity. 
This suggested the presence of favoured locations for transcription, and that promoters may 
be moved to these specific locations as transcription occurs (Sánchez-Romero et al., 2012). 
Localisation to the space surrounding the ribosome-free nucleoid would facilitate coupled 
transcription and translation, therefore being positioned within a plasmid could affect the 
accessibility of the promoter to RNAP and ultimately the level of gene expression (Robinow 
and Kellenberger, 1994; Azam et al., 2000; Woldringh, 2002). Therefore the activity of 
several promoters, with a range of activities, was compared when the promoters were located 
either on the bacterial chromosome or a multi-copy, RK2-based, lac expression vector. 
 
5.1.2 Construction of single copy promoter::lacZ fusions by gene gorging 
The “gene gorging” method (Herring et al., 2003) was exploited by Hollands (2009) to allow 
the endogenous lac promoter, of the E. coli K-12 chromosome, to be replaced with any 
promoter of interest (Figure 5.1). The pKH3 master donor plasmid was developed to allow 
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any promoter to be cloned between regions of homology to the lacI and lacZ genes, which are 
flanked by recognition sites for the I-SceI yeast endonuclease in the plasmid (Figure 5.1b). 
The recipient strain is co-transformed with the donor plasmid and the pACBSR mutagenesis 
plasmid, which encodes the I-SceI endonuclease and the λ-Red homologous recombination 
machinery under control of an arabinose-inducible promoter (Figure 5.1b). Addition of 
arabinose to the growth medium allows the donor plasmid to be linearised by the I-SceI 
endonuclease to provide a linear donor molecule for λ-Red-mediated recombination of the 
homologous regions with the chromosome, therefore replacing the endogenous lac promoter 
with the promoter of interest (Figure 5.1).  
To allow simple Lac
+
 or Lac
-
, red-white, screening, Hollands created two starting strains to be 
used as recipients for the gene gorging system. The region of the lacI gene encoding the DNA 
binding domain of the Lac repressor was deleted in E. coli K-12 MG1655, to create the 
constitutively Lac
+
 KH000 strain. Gene gorging of weak promoters into this strain allows 
recombinants to be selected as white or pink in a red background by selection on MacConkey 
lactose agar. The starting strain used in this study was E. coli K-12 MG1655 KH001, in which 
gene gorging method was used to replace the lacZYA regulatory region with the empty pKH3 
cloning site in strain KH000 (Hollands, 2009). Therefore KH001 has a lac
-
 phenotype, 
allowing recombinants carrying the promoter of interest on the chromosome, fused to lacZ, to 
be identified by red/white selection on MacConkey lactose agar.  
 
5.1.3 The hcp, lac, melR and CC promoters 
Previous chapters of this study utilised one promoter at many different positions to study the 
effects of location on gene expression. Hence a range of promoters, with varying activities 
was selected to compare gene expression in single copy on the E. coli chromosome compared  
231 
pACBSR Donor
CmR
AmpR
lacI lacZ
pACBSR Donor
CmR
AmpR
lacI lacZ
lacI lacZ
promoter
Co-transformation of E. coli KH001 
with pACBSR and Donor plasmid
Arabinose 
induction of I-SceI 
and λ-Red 
expression, from 
pACBSR
Donor plasmid is linearised 
by I-SceI to produce linear 
donor DNA fragment
λ-Red proteins 
mediate 
recombination 
with homologous 
regions of the 
chromosome
lacZ + recombinants selected by red/white 
screening and confirmed by PCR and 
sequencing
a.
I-SceI
CmR
pACBSR
λ-Red
paraBAD
araC
ori
b.
pKH3
Donor plasmid
I-sceI
ampR
lacI homology 
region 
lacZ TIR
λ oop 
terminator
I-sceI
lacZ homology 
region 
Promoter 
cloning site
Figure 5.1: Diagram of chromosomal promoter::lacZYA fusion construction by gene 
gorging 
a. Recipient E. coli MG1655 KH001 is co-transformed with the pACBSR recombineering 
plasmid and the pKH3 donor plasmid. Addition of arabinose to the growth medium induces 
expression of I-SceI endonuclease and the λ-Red recombination machinery from the pACBSR 
plasmid. The donor plasmid is linearised by the I-SceI endonuclease to allow λ-Red mediated 
recombination of the donor fragment with the homologous regions of the chromosome. 
Recombinants, carrying the promoter of interest fused to lacZYA on the chromosome, are 
identified by red/white selection on MacConkey lactose agar and verified by PCR 
amplification of genomic DNA and sequencing. b. Schematic diagram of pACBSR and pKH3 
donor plasmids. Arrows represent genes and indicate the direction of transcription. 
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to that on a multi-copy plasmid. The hcp gene of E. coli encodes the Hybrid Cluster Protein 
(HCP), which is a cytoplasmic iron-sulphur protein that is thought to be involved in protection 
against reactive nitrogen species created as intermediates of nitrate metabolism (Filenko et al., 
2005; Constantinidou et al., 2006; Filenko et al., 2007). The hcp promoter (phcp) is positively 
regulated, via a class I mechanism, by the FNR protein, which is a global transcription 
regulator of genes required for anaerobiosis. The promoter is also activated by the NarL and 
NarP proteins, which are the response regulators for the two-component regulatory systems 
required for response to nitrate and nitrite. The promoter is negatively regulated by the 
transcription factor NsrR, which is a nitrite sensing repressor that is also thought to respond to 
nitric oxide. Promoter LacZ fusion assays show that phcp has very high activity, therefore this 
promoter was used as one of the stronger promoters in this study and also to determine effects 
during anaerobic growth conditions (Rabin and Stewart, 1993; Filenko et al., 2005; Filenko et 
al., 2007; Chismon et al., 2011). The class I CRP-activated lac promoter also shows strong 
activity and is constitutively active in the lacI
-
 E. coli MG1655 KH000 strain, therefore this 
promoter was also used in this study (Hollands, 2009). 
The CC promoters are synthetic derivatives of the E. coli melR gene promoter. Recall that 
melR encodes the MelR transcription factor responsible for regulation of the melibiose 
utilisation genes. The promoters are activated by CRP, acting at consensus binding sites 
located at positions -41.5 bp or -61.5 bp relative to the transcription start site. These 
promoters were chosen for this study because they are well charaterised, give a middle range 
of activity, were available in our lab, and allow direct comparison between effects on class I 
and class II activated promoters (Gaston et al., 1990).  The wild-type melR promoter has 
much lower activity than the synthetically modified CC constructs and was also available 
from previous studies within our lab, therefore this was used to measure effects with weak 
promoters (Hollands, 2009). These promoters were inserted into the E. coli K-12 
chromosome, at the lac site, in single copy to create promoter lacZ fusions by the gene 
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gorging method. Activities were then compared to that of the same fusions carried by a lac 
expression vector. 
  
5.2 Construction of chromosome and plasmid-encoded promoter::lacZ 
fusions 
5.2.1 Construction of chromosomal promoter::lacZYA fusions by gene gorging 
To compare the activity of several promoters at two separate loci, a set of promoters with a 
range of activities, were first fused to lacZYA in single copy on the E. coli K-12 MG1655 
KH001 chromosome by gene gorging (Figure 5.1). The promoters of interest can be fused to 
the lacZ homology region, encoded by the pKH3 plasmid, as a translation fusion, using the 
translation initiation region (TIR) of the promoter of interest. Alternatively fusions can be 
made as transcription fusions, using only the transcription initiation region of the promoter of 
interest and the TIR of the lacZ gene. All promoter fragments used were fused to lacZYA as 
transcription fusions to eliminate any potential complication due to variation in translation 
efficiency, except the melR promoter, which was used as a translation fusion due to the 
inactivity of the transcription fusion (Hollands, 2009).  
The phcp3831NS fragment, carrying the regulatory region of the hcp gene, from position 
-125 bp to +11 bp relative to the transcription start site, was cloned into the EcoRI/BamHI site 
of the pKH3 gene gorging vector as a transcription fusion (Figure 5.2). The NsrR DNA 
binding target site was inactivated in this promoter fragment, therefore abolishing repression 
by the NsrR transcriptional regulator (Chismon et al, 2011). A DNA fragment carrying the 
model class II CRP-activated CC-41.5 promoter, from position -76 bp to +2 bp relative to the 
transcription start site, was cloned into the EcoRI/BamHI site of pKH3, however the fragment 
was amplified to incorporate an upstream EcoRI target site and a downstream BglII target site,  
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EcoRI      NarL/P    NarL/P        FNR 
         .         .         .         .         .         . 
GAATTCTTTCTCTGCGTAATACCTCTCTGGCGGTAGATCCCTGCCGCCAAAATTGCGCTAAA 
 
       .         .         .         .         .         . 
TCAATCTCCCTTAAAGTTGCATGAAAAATCCCTTTTATCCCCGCGTTAAGCGTCTTAACCTT 
 
NsrR(inactive) BamHI 
     .         . 
AAACATGtATATTAAGGAGGATCC 
    
 
 
Figure 5.2: Sequence of the phcp3831NS promoter fragment 
The phcp3831NS promoter fragment is an EcoRI-BamHI fragment carrying the regulatory 
region of the hcp gene from position -125 bp to +11 bp relative to the transcription start site. 
Target sites for the restriction endonucleases EcoRI and HindIII are highlighted with borders 
and transcription factor DNA binding sites (NarL/P, FNR and inactivated NsrR) are 
underlined. The transcription start is indicated with a bold lower case t and an arrow. 
Mutations inactivating the NsrR site are bold. 
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which is compatible with BamHI sticky ends. This approach had to be used due to the CC 
promoter fragments containing a BamHI site downstream of the CRP target binding site 
(Figure 5.3). The same cloning procedure was utilised to insert the model class I 
CRP-activated CC-61.5 promoter fragment into the EcoRI/BamHI site of pKH3 as a 
transcription fusion (Figure 5.4). Finally the TB10a fragment, carrying the regulatory region 
for the melR gene from position -106 bp to +52 bp relative to the transcription start site, had 
already been cloned into the EcoRI/HindIII site of pKH3 as a translation fusion and used for 
gene gorging to produce the KH002 strain by Hollands (2009) (Figure 5.5). The translation 
fusion was used in place of the transcription fusion due to the transcription fusion having 
exceptionally weak activity, which was similar to that of the KH001 lac
-
 starting strain 
(Hollands, 2009). 
The pKH3 donor plasmids carrying the promoter::lacZ fusions were then used to insert the 
desired promoter into the chromosome of E. coli K-12 MG1655 KH001, to create single copy 
chromosome-encoded promoter::lacZYA fusions, by the gene gorging method (Figure 5.1; 
Section 2.12). Resulting strains were verified by PCR of genomic DNA and sequencing of the 
promoter region. Strains carrying the phcp3831NS, CC-41.5, CC-61.5 and TB10a promoter 
fragments as transcription fusions to the lacZYA genes were named BRY01, BRY03, BRY05 
and KH002 respectively (Table 2.1). 
 
5.2.2 Construction of promoter::lacZYA fusions in the lac expression vector pRW500 
To allow comparison between expression at the chromosomal lac locus and expression on a 
multi-copy plasmid, the chromosomally encoded promoter::lacZYA fusions were cloned into 
the pRW50 plasmid. However, the pRW50 lac expression vector encodes a trpBA::lacZYA 
fusion, therefore direct cloning of the amplified promoter fragments into this vector would not 
be a direct comparison, due to the trpBA fragment (Figure 2.1; Figure 5.6). The lacZ gene  
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EcoRI       Crp    BamHI 
         .         .         .         .         .         . 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGTGATGTACATCACATGGATCCCCCCTC 
 
         -10     BglII 
       .         .         . 
ACTCCTGCCATAATTCTGATaTAGATCT 
 
 
 
Figure 5.3: Sequence of the CC-41.5 promoter fragment 
The CC-41.5 promoter fragment is an EcoRI-BglII fragment carrying the CC-41.5 promoter, a 
synthetic model CRP regulated promoter based on the regulatory region of the melR gene. 
The CRP DNA binding site is underlined and centred at -41.5 bp relative to the transcription 
start site, which is indicated by a bold lower case a and an arrow. Restriction enzyme 
recognition sites are highlighted with borders. 
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EcoRI       Crp       BamHI 
         .         .         .         .         .         . 
GAATTCGAGCTCGGTACCCGGGGATCAGGTAAATGTGATGTACATCACATGGATCCAGATCG 
 
          -10     BglII 
       .         .         .         .         . 
ATGTTTAAAGATCCCCCCTCACTCCTGCCATAATTCTGATaTAGATCT 
 
 
 
 
Figure 5.4: Sequence of the CC-61.5 promoter fragment 
The CC-61.5 promoter fragment is an EcoRI-BglII fragment carrying the CC-61.5 promoter, a 
synthetic model CRP regulated promoter based on the regulatory region of the melR gene. 
The CRP DNA binding site is underlined and centred at -61.5 bp relative to the transcription 
start site, which is indicated by a bold lower case a and an arrow. Restriction enzyme 
recognition sites are highlighted with borders. 
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EcoRI 
GAATTCCCTCATGATACTCGGAGAGTCCCCTCGCCCCTCTGGGAAGAGGGTGAAAACCGTGC 
 
CRP         -10    MelR 
TCCCACTCGCAGTCATCCTCCCTCACTCCTGCCATAATTCTGATaTTCCAGGAAAGAGAGCC 
 
                                  HindIII 
ATCCATGAATACAGATACGTTTATGTGCAGCAGCAAGCTT 
 
 
 
Figure 5.5: Sequence of the TB10a promoter fragment 
The TB10a promoter fragment is an EcoRI-HindIII fragment carrying the regulatory region of 
the melR gene and was designed to create a translational fusion in pKH3. The CRP activator 
binding site is underlined and the MelR repressor binding site is double underlined. The 
promoter -10 is underlined and labelled, with the transcription start indicated by a lower case 
bold a and an arrow. The ATG start codon is in bold and underlined. Restriction enzyme 
recognition sites are highlighted by borders and are labelled. 
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Figure 5.6: Schematic diagram of pRW500 plasmid and promoter::lacZYA fusion 
construction 
Schematic diagram representing basic protocol for construction of the pRW500 plasmid or 
pRW500/promoter of interest fusions. Arrows represent genes, while black lines denote 
intergenic regions (approximately to scale). Direction of transcription of each gene is 
indicated by the arrow heads. DNA modifying enzyme target sites are represented by vertical 
black lines and are labelled. The EcoRI-SacI fragment at the lac locus on the chromosomes of 
strains MG1655, BRY01, BRY03, BRY05, KH002, and KH001 were amplified by PCR and 
cloned into the pRW50 plasmid. This cloning procedure removes the trpBA fragment of the 
pRW50 plasmid to create promoter::lacZYA fusions. 
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encodes a target site for the SacI restriction endonuclease, which is unique in the pRW50 
plasmid. Therefore promoter fragments were amplified by PCR from BRY01, BRY03, 
BRY05 and KH002 genomic DNA with primers designed to incorporate the upstream EcoRI 
site and the SacI site within the lacZ gene. The resulting EcoRI-SacI promoter fragments were 
cloned into the pRW50 lac expression vector to create plasmid encoded versions of the 
promoter::lacZYA fusions described in section 5.2.1 (Figure 5.6).The same procedure was 
used to clone the empty pKH3 cloning site of the KH001 strain or the wild-type lacZYA 
regulatory region into the pRW50 vector to create the empty pRW500 plasmid, to be used as a 
control, and pRW500 carrying the lacZYA operon (Table 2.2; Figure 5.6). 
 
5.3 Comparison of activities of chromosome or plasmid-located promoters 
The effect of position on gene expression was tested by comparison of promoter activities 
encoded on the E. coli K-12 MG1655 chromosome with that on the multi-copy lac expression 
vector pRW500. The E. coli KH001, KH002, BRY01, BRY03 and BRY05 strains, carrying 
the pKH3 empty cloning site, TB10a, phcp3831NS, CC-41.5 or CC-61.5 promoter fragments 
fused to the lacZYA operon were transformed with the empty pRW500 plasmid as a control. 
The E. coli KH001 strain was also transformed with pRW500 carrying the TB10a, 
phcp3831NS, CC-41.5 or CC-61.5 promoter fragments fused to the lacZYA operon encoded 
by the plasmid. Cells were then grown to mid-late exponential growth phase in LB broth 
supplemented with tetracycline for plasmid maintenance and promoter activities were derived 
from measured β-galactosidase activities, as outlined in section 2.15.  
Expression of lacZ by the phcp3831NS fragment promoter was approximately 9-fold greater 
when encoded by the pRW500 plasmid when compared to the chromosomally encoded copy 
of the fusion (Figure 5.7; Table 5.1). Activity of the class I, CRP activated, CC-61.5 fragment  
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Figure 5.7: Measured expression driven by different promoters at the chromosomal lac 
locus and on the pRW500 plasmid 
The figure shows β-galactosidase activities measured in (a.) strain KH001 carrying different 
promoter::lacZ fusions cloned in pRW500 or (b.) the KH002 (pmelR), BRY01 (phcp3831NS), 
BRY03 (CC-41.5) and BRY05 (CC-61.5) strains encoding the same promoter::lacZYA 
fusions on the chromosome and carrying the empty pRW500 plasmid as a control. Cells were 
grown aerobically at 37°C to mid-exponential phase (OD650 0.3-0.5) in LB broth 
supplemented with tetracycline. Data shown are averages of β-galactosidase activity 
measurements from at least three independent experiments, and error bars show one standard 
deviation from the mean. The KH001 strain (no promoter at the chromosomal lac locus) 
transformed with the empty pRW500 plasmid was included as a control (“none”). 
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Table 5.1: Summary of promoter activities at the chromosomal lac locus or the pRW500 
plasmid 
The table lists β-galactosidase activities (in Miller units) measured in strain KH001 carrying 
different promoter::lacZ fusions cloned in pRW500 or the KH002 (pmelR), BRY01 
(phcp3831NS), BRY03 (CC-41.5) and BRY05 (CC-61.5) strains encoding the same 
promoter::lacZYA fusions on the chromosome and carrying the empty pRW500 plasmid as a 
control.  Cells were grown aerobically in LB medium at 37°C to mid-exponential phase 
(OD650 0.3-0.5).  Data listed are averages from at least three independent experiments, shown 
± one standard deviation. The KH001 strain (no promoter at the lac locus on the 
chromosome) transformed with the empty pRW500 plasmid was included as a control 
(“none”). 
 
 
  β-galactosidase activity  
(Miller units ± one standard deviation) 
 
  
Growth 
media 
Promoter Chromosome Plasmid Ratio Promoter Class 
LB None 
 
 
20 ± 0.8 20 ± 0.8 - - 
 phcp 
(phcp3831NS) 
 
360 ± 40 3187 ± 290 8.9 ± 0.02 I 
 CC-61.5tx 
 
 
685 ± 105 6410 ± 93 9.4 ± 0.02 I 
 CC-41.5tx 
 
511 ± 75 2999 ± 128 5.9 ± 0.03 II 
 pmelR 
(TB10a) 
115 ± 22 570 ± 89 5 ± 0.05 II 
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promoter was also approximately 9-fold greater when the fusion was encoded by the pRW500 
multi-copy plasmid compared to that at the lac locus on the chromosome (Figure 5.7 Table 
5.1). However, activity of the class II CRP-activated CC-41.5 fragment promoter encoded by 
the pRW500 plasmid was approximately 6-fold greater than at the lac locus on the 
chromosome.  
Activity of the CC-41.5 promoter was approximately 1.5-fold greater than the phcp3831NS 
promoter fragment when positioned on the chromosome, however activities of the two 
promoters were similar when encoded by the plasmid (Figure 5.7 Table 5.1). Expression of 
lacZ by the class II, CRP-activated, TB10a fragment melR promoter was approximately 5-fold 
increased compared to that of the chromosomally encoded TB10a::lacZYA fusion. Activity of 
chromosomally encoded TB10a was approximately 3-fold weaker than that of the 
phcp3831NS promoter fragment, whereas the plasmid-encoded TB10a promoter was 
approximately 6-fold weaker than the phcp3831NS promoter (Figure 5.7; Table 5.1). 
Comparison of the chromosomally encoded class II CC-41.5 and the class I CC-61.5 promoters 
revealed that the class I activated promoter was approximately 34% stronger than the class II, 
whereas the plasmid encoded class I promoter was approximately twice as strong as the class II 
activated promoter (Figure 5.7; Table 5.1). The pRW500 plasmid is derived from the broad host 
range RK2 plasmid and is expected to be present at approximately six to eight copies per cell 
(Figurski et al., 1979; Kues and Stahl, 1989; Lodge et al., 1992). Therefore these results suggest 
that activity of the class I activated phcp3831NS and CC-61.5 promoter fragments increased by 
the expected fold change. In contrast, the fold increase in expression between chromosomally 
encoded class II CRP-activated TB10a and CC-41.5 promoter fragments, compared with that 
encoded by the pRW500 plasmid, was slightly less than expected (Figure 5.7; Table 5.1). This 
suggests that the class II CRP-activated promoters either have improved expression when 
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encoded by the chromosome at the lac locus or decreased expression when encoded by the 
multi-copy pRW500 plasmid.  
 
5.4 Effect of position of phcp activity under optimal conditions 
The phcp3831NS promoter is activated by the FNR transcription factor, consequently activity 
of the promoter is enhanced in response to anaerobiosis, allowing comparison of the 
chromosome and plasmid-located promoter at different levels of induction (Chismon et al., 
2011). Therefore activity of the phcp3831NS fragment promoter, encoded either by the 
BRY01 strain chromosome or the pRW500 plasmid, was tested during aerobic or anaerobic 
growth. The BRY01 strain was transformed with the empty pRW500 plasmid and the KH001 
strain transformed with pRW500 carrying the phcp3831NS fragment fused to the lacZYA 
operon. Cells were grown to mid-late exponential phase (OD650 0.3-0.5) in minimal salts 
medium supplemented with 10% LB, glycerol, sodium fumarate and tetracycline under 
aerobic or anaerobic conditions at 37˚C. 
Activity of the phcp3831NS fragment promoter was induced approximately 4.7-fold under 
anaerobic conditions, compared to the promoter activity during aerobic growth, when encoded 
on the chromosome and approximately 4.3-fold when carried by the pRW500 multi-copy 
plasmid (Figure 5.8; Table 5.2). This result suggests that activation of the promoter by FNR is 
unaffected by the change in location between chromosome and plasmid. Expression of lacZ 
by the phcp3831NS fragment promoter, carried by the pRW500 plasmid, was approximately 
8.2-fold greater than that of the chromosomally encoded fusion during aerobic growth and 
approximately 7.5-fold greater during anaerobic growth (Figure 5.8; Table 5.2). The ratio 
between chromosomally encoded lacZ expression and that of the plasmid was similar to that 
of the promoter::lacZ fusion during aerobic growth in LB and was within the expected change  
245 
0
2000
4000
6000
8000
10000
12000
14000
none  Chromosome  pRW500 plasmid
phcp  promoter position
β
-g
a
la
c
to
s
id
a
s
e
 a
c
ti
v
it
y
 (
M
il
le
r 
u
n
it
s
)
MS Aerobic
MS Anaerobic
 
Figure 5.8: Activity of the hcp3831NS promoter encoded by the chromosome or 
pRW500 plasmid 
The figure shows β-galactosidase activities measured in strain BRY01 transformed with 
empty pRW500, as a control, or strain KH001 transformed with pRW500 carrying the 
phcp3831NS fragment fused to lacZ. Cells were grown aerobically or anaerobically at 37°C to 
mid-exponential phase (OD650 0.3-0.5) in minimal salts media supplemented with 10% LB, 
glycerol, sodium fumarate and tetracycline for maintenance of the pRW500 plasmid. Data 
shown are averages of β-galactosidase activity measurements from at least three independent 
experiments, and error bars show one standard deviation from the mean. The KH001 strain 
(no promoter at the lac locus on the chromosome) transformed with the empty pRW500 
plasmid was included as a control (“none”). 
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Table 5.2: Summary of hcp3831NS promoter activity encoded at the chromosomal lac 
locus or by the pRW500 plasmid 
The table lists β-galactosidase activities (in Miller units) measured in strain BRY01 
transformed with empty pRW500, as a control, or strain KH001 transformed with pRW500 
carrying the phcp3831NS fragment fused to lacZ. Cells were grown aerobically or 
anaerobically at 37°C to mid-exponential phase (OD650 0.3-0.5) in minimal salts media 
supplemented with 10% LB, glycerol, sodium fumarate and tetracycline for maintenance of 
the pRW500 plasmid.  Data listed are averages from at least three independent experiments, 
shown ± one standard deviation. The KH001 strain (no promoter at the lac locus on the 
chromosome) transformed with the empty pRW500 plasmid was included as a control 
(“none”). 
 
  β-galactosidase activity  
(Miller units ± one standard deviation) 
 
Growth media Promoter Chromosome Plasmid Ratio 
MS + 10% LB 
 
Aerobic 
 
phcp3831NS 
 
 
329 ± 14 2708 ± 205 8.2 ± 0.01 
MS + 10% LB 
 
Anaerobic 
 
phcp3831NS 1556 ± 167 11647 ± 863 7.5 ± 0.02 
Ratio - 4.7 ± 0.02 4.3 ± 0.03 - 
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based on plasmid copy number (Figure 5.7; Figure 5.8; Table 5.2; Figurski et al., 1979; Kues 
and Stahl, 1989; Lodge et al., 1992). These results suggest that regulation of the class I 
activated hcp promoter is unaffected by change in location from the chromosome to the 
multi-copy plasmid. 
 
5.5 Comparison of chromosome or plasmid-located lac promoter activity 
The lac promoter is activated by CRP acting by a class I activation mechanism and this 
activation is repressed by the presence of glucose in the medium (Hollands, 2009). Hence, 
growth on LB broth or M9 minimal medium supplemented with fructose allowed analysis of 
lac promoter activity at different levels of induction. Therefore KH000 was transformed with 
the empty pRW500 plasmid and the Lac
-
 KH001 strain was transformed with pRW500 
carrying the lacZYA operon including the regulatory region from -93 bp relative to the 
transcription start site. 
Activity of the lac promoter, encoded either by the chromosome or the multi-copy plasmid, 
was measured during mid-late exponential growth phase (OD650 0.3-0.5) in LB broth or M9 
minimal media supplemented with tetracycline. Activity of the lac promoter encoded by the 
chromosome of strain KH000, during growth on M9 minimal media, was increased 
approximately 3.2-fold compared to that during growth on LB broth (Figure 5.9; Table 5.3). 
However, activity of the promoter carried by the pRW500 plasmid was only increased 
approximately 2.6-fold during growth on M9 minimal media, compared to that during growth 
on LB broth (Figure 5.9; Table 5.3). This difference in glucose repression of the lac promoter 
at the chromosomal and plasmid loci is minimal and could potentially be due to inaccuracies 
caused by the extremely high levels of activity achieved when expressed from the plasmid  
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Figure 5.9 Activity of the lac promoter encoded by the chromosome or pRW500 plasmid 
The figure shows β-galactosidase activities measured in strain KH000 transformed with 
empty pRW500, as a control, or strain KH001 transformed with pRW500 carrying the lacZYA 
operon including the lac promoter region. Cells were grown aerobically at 37°C to mid-
exponential phase (OD650 0.3-0.5) in LB broth or M9 minimal media supplemented with 
fructose and tetracycline for maintenance of the pRW500 plasmid. Data shown are averages 
of β-galactosidase activity measurements from at least three independent experiments, and 
error bars show one standard deviation from the mean. The KH001 strain (no promoter at the 
lac locus on the chromosome) transformed with the empty pRW500 plasmid was included as 
a control (“none”). 
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Table 5.3: Summary of lac promoter activity encoded at the chromosomal lac locus or 
by the pRW500 plasmid 
The table lists β-galactosidase activities (in Miller units) measured in strain KH000 
transformed with empty pRW500, as a control, or strain KH001 transformed with pRW500 
carrying the lacZYA operon including the lac promoter region.  Cells were grown aerobically 
in LB broth or M9 minimal medium supplemented with fructose and tetracycline at 37°C to 
mid-exponential phase (OD650 0.3-0.5).  Data listed are averages from at least three 
independent experiments, shown ± one standard deviation. The KH001 strain (no promoter at 
the lac locus on the chromosome) transformed with the empty pRW500 plasmid was included 
as a control (“none”). 
 
  β-galactosidase activity  
(Miller units ± one standard deviation) 
 
Growth media Promoter Chromosome Plasmid Ratio 
LB plac 
 
 
4662 ± 310 28375 ± 698 6.1 ± 0.01 
M9 +  
0.3% fructose 
plac 14805 ± 311 73955 ± 4729 5 ± 0.01 
Ratio - 3.2 ± 0.02 2.6 ± 0.03 - 
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locus during growth on M9 minimal media. Growth in this situation was slower than 
un-induced cells and β-galactosidase activity was detected in the supernatant. 
Expression of lacZYA, during growth on LB broth, was approximately 6-fold stronger when 
encoded by the pRW500 plasmid compared to that at the chromosomally encoded locus 
(Figure 5.9; Table 5.3). The ratio of lacZ expression between the chromosome and plasmid 
was at the lower end of the expected range during growth on LB broth, but below during 
growth on minimal media. Slower growth and the presence of β-galactosidase in the 
supernatant suggests that the cells grown on minimal media and carrying the lacZYA operon 
on the plasmid were stressed and potentially undergoing lysis, due to the massive production 
of the lacZYA gene products. The exceptionally strong activity of the lac promoter may have 
exceeded the limit of that capable of being measured through β-galactosidase assay, therefore 
potentially skewing the ratios measured. 
 
5.6 Discussion 
Promoter activity can be affected by position within the folded chromosome of E. coli through 
mechanisms such as variation of DNA superhelicity, neighbouring gene expression, local 
chromosomal architecture and neighbouring sequence elements (Chapter 4). Therefore the work 
presented here investigated the effect of positioning promoters on an extra-chromosomal piece 
of DNA, an RK2-based lac expression vector, on promoter activity. The expression of lacZ by 
the class I activated promoters, hcp and CC-61.5, was increased by the expected amount due to 
the copy number of the pRW500 plasmid being approximately six to eight per genome 
(Figurski et al., 1979; Kues and Stahl, 1989; Lodge et al., 1992). However the fold difference in 
class II-activated promoter activity between the chromosome and plasmid loci was much lower 
than that of the class I-activated promoters. These results suggest that the class II-activated 
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promoters either have increased activity when encoded by the chromosome or decreased 
activity when encoded by the multi-copy pRW500 plasmid. 
Differences in lac promoter activity between the chromosomally encoded fusion and the 
plasmid fusion were smaller, giving a change of approximately 5-fold during growth on M9 
minimal medium and approximately 6-fold during growth on LB broth. The difference in hcp 
promoter activity, between the chromosomally encoded fusion and the plasmid encoded copy, 
was also less during growth on minimal medium compared to that in LB broth. Growth on 
minimal medium is slower than in the relatively rich LB broth and could cause there to be less 
copies of the plasmid per cell (Kolatka et al., 2010). Therefore this could account for the 
lower fold-difference in lac and hcp promoter activities during growth on minimal medium 
compared to that on LB broth. The ratio of activity between the chromosome and plasmid-
located copies of the lac promoter was smaller than that of the model class I, CRP-activated, 
CC-61.5 promoter and similar to that of the CC-41.5 and TB10a fragment promoters. 
However this lower ratio could well be due to the strength of the lac promoter exceeding that 
of the maximum possible promoter activity measureable through β-galactosidase activity 
assay. This was shown by poor growth and cell lysis, indicated by the presence of 
β-galactosidase in the culture supernatant. 
Differences in the effects of position on different promoters are unlikely to be due to variation 
in plasmid copy number, as the strains used were all of the same genetic background and the 
growth conditions were the same. Hence these variations must be due to some other factor, 
such as plasmid mobility, accessibility by RNAP to the promoter or a change of superhelical 
density. The lacZYA locus on the chromosome is tethered to the rest of the chromosome, 
which is known to be highly structured and compacted with specific macrodomains locating 
to specific home positions within the cell (Espeli et al., 2008). However, the pRW500 plasmid 
should be relatively mobile within the cell, which is evidenced by the fact that fluorescently 
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tagged pRW50 derivative plasmids in E. coli do not form specific fluorescent foci, suggesting 
that they are diffuse (Sánchez-Romero et al., 2012). Further to this, active transcription of a 
highly expressed plasmid can drive plasmids to co-localise to positions on the periphery of the 
E. coli nucleoid, suggesting that there are preferred locations within the cell for transcription 
to take place (Sánchez-Romero et al., 2010). Therefore this increased mobility and 
localisation to the edge of the nucleoid could account for variation, if accessibility to the 
promoter on the chromosome is affecting the promoters differently. However this is unlikely 
as the CC promoters are regulated by the same transcription factors, yet the effect of changing 
the position from chromosome to plasmid is different between class I and class II 
CRP-activated promoters. 
Activation of the CC promoters by CRP may respond differently to variation in negative 
superhelicity due to the fact that the mechanisms of class I and class II activation are different. 
Class I activation at the CC-61.5 promoter acts via simple recruitment of RNAP through a 
single protein-protein interaction to yield the RNAP-promoter closed complex. Whereas, 
class II CRP-dependent activation, at the CC-41.5 promoter, acts via binding of CRP to a 
DNA site overlapping the -35 element. Bound CRP acts to recruit RNAP, as with class I 
activation, but also facilitates post-recruitment promoter open complex formation (Lawson et 
al., 2004). Further to this, to produce the model for class II CRP-dependent activation, large 
changes in DNA geometry within the downstream half-site of the CRP DNA site were 
required to allow the interactions that facilitate isomerisation of the closed complex (Lawson 
et al., 2004). These differences in the class I and class II CRP-dependent activation 
mechanisms could cause them to be differentially responsive to variation in DNA superhelical 
density. Therefore any variation between superhelicity at the chromosomal lac locus and the 
promoter cloning site of pRW500, could differentially affect activity of the different 
promoters used in this study.  
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Chapter 6: 
 
Final discussion 
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To date, study of transcriptional regulation in bacteria has focussed on individual promoters 
and the complex mechanisms of interaction between different transcription factors. These 
studies have yielded vast quantities of information about the mechanisms by which internal 
and external signals are integrated into the transcriptional response at individual promoters. 
However, only a handful of studies have attempted to study the regulation of promoters in 
their natural context within the chromosome. Further to this, little has been done to quantify 
global effects on transcription and to assess the effects of position within the chromosome on 
transcriptional output. The extreme compaction of the bacterial chromosome has been 
expected to have an effect on the process of gene expression since the first studies of the 
bacterial nucleoid in the 1970’s. However, until recently, only 3 studies had directly assessed 
the effect of position within the chromosome on gene expression, therefore the work 
described in this study sought to characterise these effects and any potential mechanisms 
behind them. 
 
6.1 Promoter activity is dependent upon position within the chromosome 
Previous studies by Beckwith et al. (1966), Schmid and Roth, (1987) and Sousa et al. (1997) 
attempted to address the question of whether position within the chromosome can affect gene 
expression (reviewed in chapter 1). These studies reported no effect of location other than that 
expected due to increased copy number of gene loci in proximity to the actively replicating 
origin, oriC. In contrast, the results presented in this thesis report a 310-fold variation in 
promoter activity, which is dependent upon position within the chromosome and unrelated to 
the gene dosage effect. This raises the question as to why this level of position-dependent 
modulation of promoter activity was not previously reported.  
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Details of the experimental differences between the study presented here and previous work 
are discussed in section 3.8.2 and 3.8.3. The major difference appeared to be exposure of the 
promoter sequence, used in this study, to neighbouring local sequences. The gene doctoring 
homologous recombination system, used here, required homology to any desired region of the 
chromosome, unlike previous studies which used transposition systems. This allowed minimal 
amounts of flanking sequence to be used in this study, therefore giving greater exposure to the 
local sequence elements. As was reported in chapter 4, features of the local sequence at each 
of the different locations can affect promoter activity. For example, locally available DNA 
superhelicity played a major role in the high activity seen at the asl and nupG loci, whereas 
this effect may have been blocked if insulating sequence were included.  
DNA superhelicity appeared to be the causative agent of a large portion of the variation 
observed, either through the natural differences across the genome or due to the changes 
induced by neighbouring transcription. The study of Schmid and Roth, (1987) utilised 
transposition of a reporter operon in S. typhimurium to characterise position-dependent effects 
on gene expression, however the only measurable effects were due to gene dosage. Champion 
and Higgins, (2007) demonstrated that the average supercoil density of DNA isolated from 
S. typhimurium was approximately 13% lower than that of E. coli. This data suggests that the 
S. typhimurium chromosome is generally more relaxed than that of E. coli. Therefore, there 
may be less variation in superhelical density, which could account for the smaller differences 
in the results of Schmid and Roth (1987) and those presented here.  
During production of this thesis, a study was published by Block et al. (2012), in which a 
promoter::yfp fusion was inserted at a total of 8 different chromosomal loci within E. coli. The 
results of Block et al. (2012) demonstrated no significant effect of position on promoter 
activity outside of that expected by gene dosage. However, the fusion used was flanked by 
transcriptional terminators and the experiment was repeated without these. Removal of the 
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insulating terminators saw a change in the level of expression at three of the loci tested, 
however these effects were attributed to “local sequence effects”, with no further 
investigation. It was suggested that the effects were potentially due to antisense transcription 
of the reporter from neighbouring operons, which would interfere with transcription of the 
target gene and reduce its expression. Due to an oversight in design of the probe, the system 
reported here did not incorporate a downstream transcription terminator beyond the reporter 
gene, however neighbouring gene terminators were preserved, where possible (Chapter 2). 
This could be a shortcoming of this study, however there are several lines of evidence which 
argue to the contrary. Firstly, no change in fluorescence or egfp mRNA level was detected in 
the absence of IPTG and the levels of egfp mRNA were approximately the same in the 
absence of inducer at several loci. This data demonstrated that the egfp reporter gene was not 
being transcribed by read-through from neighbouring operons. Further to this, no un-induced 
activity is reported during the investigation of neighbouring promoter activity effects in 
section 4.3 of chapter 4. During this experiment, the activity of the lac28::egfp fusion and the 
melAB operon was analysed with the promoter::reporter fusion placed immediately 
downstream of the melAB operon. Activity of both reporters was only detected in the presence 
of the corresponding inducer, but not in the control experiments, therefore indicating no 
read-through from either promoter (Figure 4.6). 
The gene regulatory element used by Block et al. (2012) was a variant of the exceptionally 
strong PL promoter of phage lambda, which was modified to be regulated by the Lac 
repressor, therefore allowing induction of promoter activity by the addition of IPTG to the 
medium (Lutz and Bujard, 1997). The PL promoter is strong in the absence of any activator 
and will bind RNAP efficiently. This is unlike the lac promoter of E. coli, used in this study, 
which requires the assistance of CRP to activate transcription by recruitment of RNAP for 
binding to the promoter (Lutz and Bujard, 1997). Supposing that some locations within the 
cell are more or less conducive to transcription, due to variations in locally available RNAP, 
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the PL promoter would be less sensitive to these effects than the lac promoter. This is because 
the PL promoter does not require the simultaneous presence of both RNAP and an activator, 
like the lac promoter, for transcription initiation. This difference in the rate limiting steps of 
promoter activation could explain why position-dependent effects are not observed by Block 
et al. (2012), but were detected in this study. Further to this, phage DNA can be inserted into 
the host chromosome at secondary integration sites during the phage lysogenic pathway, as 
opposed to the primary integration site attB (Nash, 1981). Therefore the phage promoters 
must be more resistant to position-dependent modulation of promoter activity, due to their 
natural role in phage DNA transcription at different chromosomal integration sites. 
 
6.2 DNA supercoiling: an important factor in position-dependent 
modulation of promoter activity 
The large variation of promoter activity between different chromosomal loci, reported in 
chapter 3, was greater than can be explained by the gene dosage model of Cooper and 
Helmstetter (1968). Further to this, the difference in copy number between the origin and 
terminus during growth on minimal media, as measured by qRT-PCR, did not exceed a 1.5-
fold difference (Figure 3.13). However, a general trend was observed in which promoter 
activity was found to increase with proximity to the origin of replication, despite this effect 
being unrelated to gene dosage (Section 3.5.4). When the promoter was positioned at either of 
two ori-proximal loci, asl and nupG, activity was found to be approximately 11-fold greater 
than activity of the promoter positioned near to the dif site (Figure 3.7). Further investigation 
into the mechanism behind this high level of promoter activity discovered that it was reliant 
upon the activity of DNA gyrase, with the activity being reduced by gyrase inhibition (Section 
4.4). These results suggest that the ori-proximal increase of promoter activity is due to 
258 
variation of locally available DNA superhelicity by the action of DNA gyrase. Further support 
for an oriC to dif gradient of superhelical density comes from the observation made by 
Sobetzko et al. (2012), which highlighted an increase in the density of DNA gyrase binding 
sites with increasing proximity to the origin of replication. This gradient of DNA gyrase 
binding sites is expected to reflect a gradient of superhelical density from the origin of 
replication to the terminus. The work described in this study has demonstrated the importance 
of this gradient of DNA supercoiling for position-dependent modulation of promoter activity. 
Section 3.7 of this study describes experiments in which induction of promoter activity at 
different chromosomal positions was analysed during stationary phase. The patterns of 
position-dependent activity were found to be drastically different to those during exponential 
growth, with no ori-proximal increase in promoter activity. The 11-fold difference in activity 
between the promoter at the oriC-proximal asl locus and the dif-proximal loci was lost during 
stationary phase (Figure 3.21). Loss of the dif to oriC increase in promoter activity is likely to 
be due to changes in DNA supercoiling, heralded by entry into stationary phase. DNA gyrase 
is known to be inhibited upon entry into stationary phase and DNA isolated from cells in 
stationary phase is more relaxed than during exponential growth (Balke and Gralla, 1987; 
Nakanishi et al., 1998; Baquero et al., 1995; Oh et al., 2001). The loss of the oriC-proximal 
increase in promoter activity, upon entry into stationary phase, is most likely due to inhibition 
of the action of DNA gyrase, by the gyrase inhibitor SbmC, and general relaxation of DNA 
superhelicity. This result provides yet more evidence that DNA supercoiling plays an 
exceptionally important role in position-dependent modulation of promoter activity and that 
this effect is coordinated with growth-phase. 
The results presented in this study demonstrate that position of a promoter within the 
chromosome is important for its activity and that DNA supercoiling plays a major role in this 
effect. This phenomenon may be relevant to the natural organisation of the E. coli genome, 
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for example, promoters requiring increased levels of negative superhelicity may be located 
nearer to oriC than to the dif site. The E. coli genome encodes seven rRNA operons, four of 
which are clustered in proximity to the origin of replication, with the other three venturing no 
further from oriC than the boundaries of the less-structured macrodomains. This positioning 
means that during rapid growth there would be increased copies of the rRNA operons, due to 
gene dosage, therefore increasing their transcriptional output in line with physiological need. 
However, activity of the rRNA operons is dependent upon negative superhelicity, in vitro and 
in vivo, which is sensed by the GC-rich “discriminator” sequence, positioned between the -10 
element and transcription start site (Travers, 1980; Glaser et al., 1983; Ohlsen and Gralla, 
1992; Rochman et al., 2002). The “discriminator” sequence acts as a structural barrier to 
isomerisation of closed complexes to the promoter open complex, however this can be 
overcome by negative supercoiling of the promoter DNA (Pemberton et al., 2000). Therefore 
positioning near to the origin would be advantageous for promoter activity, due to the 
increased negative supercoiling in this region. Another excellent example of an oriC-
proximal, supercoiling-sensitive promoter is that of the gene encoding the NAP, FIS. The fis 
promoter is also activated by high negative superhelicity, contains a “discriminator” sequence, 
and is positioned midway between the nupG and asl loci used in this study (Travers et al., 
2001). Therefore the positioning of the supercoiling-sensitive fis and rRNA operon promoters, 
near to the origin of replication, may also be influenced by the apparent gradient of negative 
superhelicity from oriC to the dif site, reflected in the results presented in chapters 3 and 4. 
The position-dependent modulation of promoter activity by variation in DNA supercoiling, 
described in this study, could be an important feature of bacterial gene regulation on a global 
scale. The sexually-transmitted disease-causing bacterium, Mycoplasma genitalium, has the 
smallest known self-replicating genome, which encodes a small number of genes, no 
conventional transcription factors, and only one sigma factor (reviewed in Dorman, 2011). 
This lack of conventional transcriptional regulatory mechanisms raises the question of how 
260 
this bacterium regulates its transcriptional output in response to environmental stimuli. Zhang 
and Baseman, (2011) found that transcription of an osmolarity-responsive gene was affected 
by inhibition of DNA gyrase, through the addition of novobiocin. This data prompted 
Dorman, (2011) to propose that variation of DNA supercoiling composes a major part of the 
regulatory repertoire for such a small genome. The regulation of transcription by DNA 
supercoiling in M. genitalium is likely to manifest a position-dependent modulation of 
promoter activity within the chromosome. Therefore the mechanisms of position-dependent 
modulation of promoter activity, characterised in chapter 4 of this thesis, could be of use in 
determining the mechanisms by which M. genitalium regulates its transcriptional response. 
The effect of differential DNA superhelicity on transcription initiation is difficult to 
characterise, as the effect is expected to vary between different promoters. The work 
presented in chapter 5 analysed the activity of several different promoters when fused to lacZ 
on the chromosome of E. coli or encoded by a multi-copy lac expression vector. The 
difference between the chromosomal and plasmid locus was found to affect class I activated 
promoters differently to class II activated promoters. This result is likely due to the difference 
in physical nature between the chromosomal locus and the plasmid. Mobility of the 
chromosomal locus would be highly restricted compared to the relatively small plasmid, 
which are known to move freely within the cytoplasm and to congregate in one position when 
carrying a strong, active promoter (Sánchez-Romero et al., 2012). This may affect the two 
classes of promoter differently, however this is unlikely due to the promoters utilising the 
same transcription factor and being derived from the same sequence.  
The other difference in the physical characteristics of the chromosomal locus and the plasmid 
is the superhelical density of the template. Due to the plasmid being an extra-chromosomal 
DNA fragment, the superhelical density would not necessarily be the same as that of the 
chromosomal lac locus, used for promoter::lacZ fusions. Therefore, template DNA 
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superhelical density is likely to affect promoters differently, based on the mechanism of 
activation, due to changes in the alignment of promoter elements brought about by variation 
in DNA twist. The majority of promoter characterisation studies to date have used multi-copy 
reporter gene expression plasmids, therefore studying the promoter out of context and on a 
different physical template. The work presented here demonstrates that supercoiling of the 
bacterial chromosome plays a major role in regulation of transcription from the promoters 
encoded by it. Rovinsky et al. (2012) report a “supercoiling sensor” module, which is 50-fold 
more sensitive to changes in superhelical density than a gyrB::lacZ promoter fusion. 
Development of this technology would allow locally available supercoiling to be measured at 
each of the chromosomal loci tested in this study, during different growth phases and 
conditions. Hence I am confident that rapid progress will soon be made in characterisation of 
global supercoiling effects and understanding of the mechanism by which they occur. 
 
6.3 Regulation by organisation of genes within the chromosome 
Changing the chromosomal locus of a promoter not only moves it to a different physical space 
within the cell, but also gives it different neighbouring operons. The promoter may naturally 
be located in a transcriptionally quiet region of the chromosome, which is only transcribed in 
the presence of a specific sugar. Therefore, if this promoter were moved to a different 
location, it may be positioned next to a highly transcribed locus. This could possibly have an 
effect on the optimum transcription level of the promoter of interest. Work described in 
section 4.3 describes the effects of neighbouring promoter activity on the lac promoter at the 
mel locus and the effect of lac promoter induction on melAB activity. Active transcription was 
found to have a negative effect on downstream promoters, but no measurable effect on 
upstream promoters.  
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For a single RNAP elongation complex to proceed with the transcription process, either the 
elongation complex, including its associated mRNA transcript and RNA associated proteins, 
must rotate around the DNA template, or the DNA must rotate around its own axis (Wu et al., 
1988). The former motion is unlikely, due to the fact that the nascent transcript would become 
entwined around the helical DNA template as RNAP tracks around it, therefore requiring an 
unwinding mechanism for which there is currently no explanation (Cook, 2010). Rotation of 
the helical DNA template around its own axis would lead to an increase in negative supercoils 
behind the elongation complex and a loss of negative supercoils, or gain of positive 
supercoiling, ahead of the complex. This effect is referred to as the twin-supercoiled-domain 
model and was first described by Liu and Wang, (1987). Reduction in negative superhelicity, 
or increase in positive supercoiling, ahead of the actively transcribing elongation complex is 
likely to have a negative effect on downstream promoters, which will also become positively 
supercoiled. Over-winding of the promoter DNA, positive supercoiling, would oppose the 
unwinding of DNA around the transcription start site to form the promoter open complex and 
initiation of transcription. Further to this, changes in superhelicity of the promoter could 
misalign the different promoter elements, therefore leading to suppression of transcription 
initiation, much like a promoter activated by conformational change, as described in section 
1.3.3 (Figure 1.8). Therefore the results presented in this study suggest that transcription from 
separate promoters can be topologically coupled by transcription-induced supercoiling, which 
diffuses between neighbouring operons and affects promoter activity. 
Supercoiling-mediated topological coupling of promoters has been suggested to be the 
mechanism behind the supercoiling-sensitive leu-500 promoter mutation, which leads to 
leucine autotrophy in S. typhimurium (Lilley and Higgins, 1991). The work of el Hanafi and 
Bossi, (2000) demonstrated that active transcription of inducible tet or cat gene cassettes, 
inserted upstream of the chromosomal leu locus, caused inhibition of leu promoter activity. 
This result is very similar to that reported here, however the activity of both partners of the 
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topological coupling is reported by this study, demonstrating that both promoters are affected 
by each others activity. The evidence presented here, and that of the leu-500 system, indicate 
that organisation of promoters and genes within the chromosome may be influenced by 
interaction between topologically coupled transcription units. This may be based on the 
signals to which they are responsive and the appropriate integration of different responses. 
Organisation at this complex level would lead to co-operation between divergently oriented 
promoters and antagonism between convergently oriented operons.  
Further evidence of transcriptional regulation by neighbouring promoter activity was 
presented in section 4.3.2, in which the activity of the lac28::egfp fusion was shown to be 
suppressed when positioned downstream of the rrsHileValaVrrlHrrfH highly transcribed 
rRNA operon. Silencing of lac28 promoter activity was shown to be relieved upon entry into 
stationary phase when the transcription of the rRNA operons is inhibited (Jacobson and 
Gillespie, 1968; Paul, et al., 2004; Grainger et al., 2006; Figure 4.7; Figure 4.8). This result is 
most likely due to the positively supercoiled domain that would be created immediately 
downstream of the rrsHileValaVrrlHrrfH operon. This could be tested by measurement of the 
change in superhelical density at the dkgB locus during growth-phase transition by utilisation 
of the “supercoil sensor”, described by Rovinskiy et al. (2012). The dkgB, yafC and yafD 
genes all reside immediately downstream of the rrsHileValaVrrlHrrfH and aspU highly 
transcribed operons and are all transcribed from promoters reliant upon the stationary phase 
sigma factor, σ32 (Figure 4.7). Transcription of these genes would only be required during 
stationary phase when the conditions for transcription at this locus are optimal, suggesting 
that this higher level chromosome organisation may have naturally evolved. However further 
bioinformatic studies into the organisation of differentially regulated genes would be required 
to test this hypothesis. The work of Peter et al. (2004) identified genes responsive to 
supercoiling perturbations. Therefore a bioinformatic study of the orientation and 
transcriptional regulation of genes neighbouring supercoiling-sensitive operons could be 
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analysed to test whether genes are regulated by organisation. This would be a fascinating 
study and would make an excellent contribution, however this work was beyond the scope of 
this thesis. 
The topological coupling of neighbouring promoters could potentially explain why genes 
encoding repressor proteins are often found directly upstream of the target promoter, such as 
is the case at the lac operon. However, a more likely explanation for this organisation is that 
put forward by Janga and colleagues (2009) who utilised a bioinformatics approach to show 
that transcription factors are positioned differently, with respect to their targets on the 
genome, depending on the size of their regulons. Janga et al. (2009) find that the gene for 
transcription factors controlling small regulons are located close to the target genes on the 
chromosome, therefore, due to the coupling of transcription and translation, the protein 
product should be located near to the target DNA site. Data presented in section 3.6 of this 
study provides support for this hypothesis through the analysis of lac28 promoter induction 
with varying distance of the promoter from the lacI gene on the linear chromosomal map. The 
promoter carried by the lac28 fragment was found to be activated in the presence of lower 
inducer concentrations at certain loci. Therefore this work demonstrates that position of the 
target with respect to the gene encoding a transcription factor can have an effect on its 
efficacy.  
Further evidence for this hypothesis has recently been supplied by the work of Kuhlman and 
Cox, (2012) in which visualisation of fluorescently labelled LacI shows limited dispersion and 
distribution based on the position of the lacI gene. Further evidence demonstrates that 
repression of the target promoter is increased with proximity to the lacI gene (Kuhlman and 
Cox, 2012). However these data are in disagreement with the work presented by Block et al. 
(2012), in which no effect of changing the position of the target promoter with respect to the 
gene encoding the transcription factor was measured. Therefore, further work utilising the 
265 
promoter reporter probe inserted at more loci, and super-resolution imaging of the physical 
location of each locus with respect to the lacI gene locus, would provide a definitive answer 
as to whether this level of organisation is important to the regulation of transcription. 
As previously discussed, changing the location of a promoter also alters its neighbours, 
however other local sequences may also play a part in position-dependent modulation of 
promoter activity. Experiments described in section 4.2 were initially designed to assess the 
effect of orientation with respect to replication, however no correlation could be found. This 
result is in agreement with that found by Beckwith et al. (1966), Schmid and Roth, (1987) and 
Block et al. (2012). Analysis of neighbouring promoter sequences at the ara and mel loci 
identified two REP elements at each of the target loci, with one of them being disrupted by 
the insertion. The remaining REP element at the ara locus was found to be a target for DNA 
gyrase, with the orientation-dependent differences in promoter activity being reliant upon the 
action of DNA gyrase. However, orientation-dependent effects at the mel locus were found to 
be unresponsive to gyrase inhibition, therefore these effects were attributed to mRNA 
transcript stabilisation by positioning of the REP element at the 3’ end (Section 4.2). The 
E. coli genome encodes hundreds of REP elements positioned throughout the chromosome in 
extragenic space, therefore these local sequence elements are likely to be involved in 
position-dependent variation of promoter activity. I am confident that greater understanding 
of the effects produced by organisation of REP elements with respect to transcription units 
will advance the understanding of transcription regulation. 
Finally, the results presented in section 4.3.1 demonstrate that activity of the melAB promoter 
is increased by introduction of the lac promoter downstream, even when the lac promoter is 
not activated. These results also show that this effect is greater when the promoters are closer 
on the linear DNA molecule. The increased activity is weakened when the orientation of the 
lac28::egfp reporter is changed and the inter-promoter distance is increased. Both the melAB 
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and lac promoters are activated by the same transcription factor, CRP, therefore introducing 
an additional, lac promoter encoded, CRP DNA binding site downstream of the melAB 
promoter. The additional CRP binding site may act in the same way as the Lac repressor 
pseudo-operators at the lac operon, therefore increasing locally available CRP and increasing 
the probability of transcription initiation. Currently, no other hypothesis can be supplied for 
these results, therefore this would require further investigation. 
 
6.4 Transcription factories and the uneven distribution of RNAP 
Section 1.4.3 introduced the transcription factory model for organisation of the chromosome 
by clustering of actively transcribing RNAP complexes (Cook, 2010). Cook proposes a model 
for chromosomal organisation which is also suggested to play a role in the regulation of 
transcription and how neighbouring promoters interact. Due to the static nature of RNAP 
transcription factories, the DNA template would be pulled into the factory by active 
transcription. Hence, the probability of transcription initiation at downstream neighbouring 
promoters is increased. However, this would potentially be a negative effect for convergently 
oriented promoters, due to the template being pulled in opposite directions by tethered 
elongation complexes. Unfortunately, this hypothesis does not fit with the results presented in 
this thesis (Section 4.3.1), in which downstream promoters are negatively affected by active 
transcription, regardless of their orientation. The twin-domain effect, in which active 
transcription affects local DNA topology, is the more likely explanation for the results 
presented here, however integration of the two hypotheses may be possible in the future. 
One particularly interesting suggestion is that different transcription factories could contain 
specific transcription factors. This puts forward an alternative hypothesis to explain the 
increased activity of the melAB promoter, by the proximity of the lac promoter. If 
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transcription factories do contain specific transcription factors, or at least a bias towards 
certain types, then activation of either of the CRP activated promoters, by movement to a CRP 
factory, would bring the other promoter into more frequent contact with CRP. Recent 
evidence supplied by Wang et al. (2011) demonstrates that the H-NS transcriptional regulator 
and NAP is localised into specific foci within E. coli, similar to that expected due to the 
presence of transcription factories. The H-NS transcriptional regulator is mainly involved in 
repression and is also a major architectural protein, therefore the clustering may not reflect 
any role played in transcription factory formation. Therefore, visualisation of a CRP::GFP 
fusion, expressed at wild type levels from the natural promoter on the chromosome, by 
super-resolution microscopy, would be an appropriate experiment to determine whether CRP 
transcription factories exist. This experiment was beyond the scope of this thesis, but may be 
possible in the near future. While specific transcription factories in bacteria are an appealing 
suggestion, little evidence is provided for their existence. Therefore the more likely 
explanation for these results is that the additional CRP DNA binding site, introduced 
downstream of the melAB promoter, acts like a pseudo-operator, to increase the local CRP 
concentration and probability of transcription activation. 
While transcription factories are unlikely to exist in bacteria in the same way that is evident in 
eukaryotic systems, spatial distribution of RNAP within the cell, and its access to different 
chromosomal regions, is certainly not uniform. The work of Vora et al. (2009), identified 
large regions of the chromosome, tsEPODs, which are bound by higher than average levels of 
protein and encode transcriptionally silent genes. The work described in section 4.5 
demonstrated that positioning within tsEPODs silences transcription of the strong lac 
promoter and that this can be relieved by deletion of the protein bound domain. These results 
confirm that the transcriptionally silent profile of tsEPODs is not merely due to the region 
containing poor promoters, but because of the intrinsic properties of the domain.  
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The tsEPODs have previously been suggested to be the organising centres of the E. coli 
nucleoid,  and would be expected to be buried in the centre of the ribosome- and RNAP-free 
nucleoid space (Bakshi et al. 2012; Vora et al., 2009). This would mean that promoters within 
tsEPODs would be less accessible to RNAP, therefore providing an explanation for the 
silencing of lac promoter activity measured in section 4.5.1. The H-NS protein is a main 
candidate for organisation of the chromosome by tsEPODs, due to the observed clustering of 
the protein into two foci, presented in the fluorescence microscopy studies of Wang et al. 
(2011). This study lends support to the hypothesis that the E. coli chromosome is organised 
and structured with tsEPODs positioned at the centre of the nucleoid and supercoiled loops 
radiating from this central domain. 
The data presented and discussed in this thesis demonstrate that chromosomal architecture 
and the compaction of the nucleoid plays a major role in transcriptional regulation. Data 
presented in section 3.7 demonstrates that the profile of position-dependent effects is shifted 
on entry into stationary phase, therefore suggesting a link between this global level of 
regulation and growth-phase transitions or stress responses. This effect is likely to be 
coordinated by shifting populations of NAPs to form tsEPODs, which silence transcription 
through occlusion of RNAP. Data presented in chapter 4 identifies variation in DNA 
superhelicity as a key mechanism behind position-dependent modulation of promoter activity. 
Further evidence presented in chapter 4 demonstrates that while DNA supercoiling can affect 
promoter activity, active transcription can cause variations in local superhelicity. These results 
suggest that organisation of transcription units within the genome could have an affect on 
their regulation with neighbouring operons being topologically coupled. Finally position of 
the target promoter, with respect to the gene encoding the Lac repressor, was shown to have 
an effect on its regulation. This suggests that organisation of genes with respect to their 
interaction targets can play a role in regulation of the transcriptional output. This thesis, as a 
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whole, demonstrates the importance of promoter position within the chromosome and 
illustrates the complexity of transcriptional regulation in bacteria.  
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